INFLUENZA >>  PANDEMIC INFLUENZA >>

Selected Reading

Abramovich MN, Toner ES, Matheny J. Panalysis: a new spreadsheet-based tool for pandemic planning. Biosecur Bioterror 2008 Mar;6(1):78-92 [Full text]

ACEP (American College of Emergency Physicians). The national report card on the state of emergency medicine: evaluating the environment of emergency care systems state by state. Jan 2006 [Full text]

ACLU (American Civil Liberties Union). Pandemic preparedness: the need for a public health--not a law enforcement/national security--approach. Jan 14, 2008 [Full text]

ACP. The health care response to pandemic influenza. Position paper from the American College of Physicians. 2006 [Full text]

Adini B, Goldberg A, Cohen R, et al. Relationship between standards of procedures for pandemic flu and level of hospital performance in simulated drills. Ann Emerg Med 2008 (published online May 13) [Abstract]

Aiello AE, Murray GF, Perez V, et al. Mask use, hand hygiene, and seasonal influenza-like illness among young adults: a randomized intervention trial. J Infect Dis 2010 (published online Jan 20) [Abstract]

Albright FS, Orlando P, Pavia AT, et al. Evidence for a heritable predisposition to death due to influenza. J Infect Dis 2008 Jan;197 (published online Dec 11, 2007) [Full text]

Alexander ME, Bowman CS, Feng Z, et al. Emergence of drug resistance: implications for antiviral control of pandemic influenza. Proc R Soc B 2007 (published online May 16) [Abstract]

Alford RH, Kasel JA, Gerone PJ, et al. Human influenza resulting from aerosol inhalation. Proc Soc Exp Biol Med 1966 Jul;122(3):800-4

Allen JE, Gardner SN, Vitalis EA, et al. Conserved amino acid markers from past influenza pandemic strains. BMC Microbiology 2009 Apr 22;9:77 [Abstract]

Ambrose CS, Luke C, Coelingh K. Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza. Influenza Other Resp Viruses 2008 Dec 8;2(6):193-202 [Full text]

American Council on Science and Health. Avian influenza, or bird flu: what you need to know. Mar 2006 [Full text]

Anantham D, McHugh W, O'Neill S, et al. Clinical review: Influenza pandemic--physicians and their obligations. Crit Care 2008;12(3):217 (published online Jun 24) [Abstract]

Andreasen V, Viboud C, Simonsen l. Epidemiologic characterization of the 1918 pandemic summer wave in Copenhagen: implications for pandemic control strategies. J Infect Dis 2008 Jan 15;192(2):270-8 [Abstract]

Ang B, Poh BF, Win MK, et al. Surgical masks for protection of health care personnel against pandemic novel swine-origin influenza A (H1N1)-2009: results from an observational study. Clin Infect Dis 2010 (published online Feb 23) [Abstract]

Anikeeva O, Braunack-Mayer AJ, Street JM. How will Australian general practitioners respond to an influenza pandemic? a qualitative study of ethical values. Med J Aust 2008 Aug 4;189(3):148-50 [Abstract]

Ansart S, Pelat C, Boelle PY, et al. Mortality burden of the 1918-1919 influenza pandemic in Europe. Influenza Other Resp Viruses 2009 May;3(3):99-106 [Abstract]

APHA (American Public Health Association). APHA's prescription for pandemic flu. Released Feb 22, 2007 [Full text]

Apisarnthanarak A, Mundy LM. Antiviral therapy for avian influenza virus (H5N1) infection at 2 Thai medical centers: survey findings and implications for pandemic preparedness. Infect Control Hosp Epidemiol 2008;29 (published online Oct 30) [Abstract]

Apisarnthanarak A, Warren DK, Fraser VJ. Issues relevant to the adoption and modification of hospital infection-control recommendations for avian influenza (H5N1 infection) in developing countries. Clin Infect Dis 2007 Nov 15;45(10):1338-42 [Abstract]

Arinaminpathy N, McLean AR. Antiviral treatment for the control of pandemic influenza: some logistical constraints. J R Soc Interface 2007 (published online Aug 28) [Abstract]

Arino J, Bowman CS, Moghadas SM. Antiviral resistance during pandemic influenza: implications for stockpiling and drug use. BMC Infect Dis 2009 Jan 22;9:8 [Abstract]

Arizona Department of Health Services. Modern Methods for Influenza Detection and Sub-typing [PowerPoint presentation]

ASTHO, APHL, CSTE, NACCHO. Public health emergency preparedness: six years of achievement. Sep 29, 2008 [Full text]

ASTHO. At-risk populations and pandemic influenza: planning guidance for state, territorial, tribal, and local health departments. Released Jun 30, 2008 [Home page, with link to full-text PDF]

ASTHO. Nature's terrorist attack: pandemic influenza. Preparedness planning for state health officials. Nov 2002 [Full text]

Atmar RL, Keitel WA, Patel SM, et al. Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations. Clin Infect Dis 2006 Nov 1;43(9):1135?42 [Abstract]

Attaran A. A legislative failure of epidemic proportions. (Editorial) CMAJ 2008 Jul 1;179(1) (published online Jun 12) [Full text]

Auewarakul P, Suptawiwat O, Kongchanagul A, et al. An avian influenza H5N1 virus that binds to a human-type receptor. J Virol 2007 Sep;81(18):9950-5 [Abstract]

Avery GH, Lawley M, Garrett S, et al. Planning for pandemic influenza: lessons from the experiences of thirteen Indiana counties. J Homeland Secur Emerg Manage 2008;5(1):29 (published online Jul 2) [Abstract]

Ayora-Talavera G, Cadavieco-Burgos JM, Canul-Armas AB. Serologic evidence of human and swine influenza. Emerg Infect Dis 2005 Jan;11(1):158-60 [Full text]

Babiuk S, Albrecht R, Berhane Y, et al. 1918 and 2009 H1N1 influenza viruses are not pathogenic in birds. J Gen Virol 2010 Feb;91(2):339-42 [Abstract]

Baden LR, Drazen JM, Kritek PA, et al. H1N1 influenza A disease--information for health professionals. (Editorial) N Engl J Med 2009 (published online May 7) [Full text]

Baig AS, Knapp C, Eagan AE, et al. Health care workers' views about respirator use and features that should be included in the next generation of respirators. Am J Infect Control 2009 (published online Dec 28) [Abstract]

Balicer RD, Huerta M, Davidovitch N, et al. Cost-benefit of stockpiling drugs for influenza pandemic. Emerg Infect Dis 2005 Aug;11(8) [Full text]

Balicer RD, Omer SB, Barnett SB, et al. Local public health workers' perceptions toward responding to an influenza pandemic. BMC Pub Health 2006 (Published online Apr 18) [Full text]

Bannister B, Puro V, Fusco FM, et al. Framework for the design and operation of high-level isolation units: consensus of the European Network of Infectious Diseases. Lancet Infect Dis 2009 Jan;9(1):45-56 [Abstract]

Bansal S, Pourbohloul B, Hupert N, et al. The shifting demographic landscape of pandemic influenza. PLoS One 2010 Feb 26;5(2):e9360 [Full text]

Banzhoff A, Gasparini R, Laghi-Pasini F, et al. MF59-adjuvanted H5N1 vaccine induced immunologic memory and heterotypic antibody responses in non-elderly and elderly adults. PLoS ONE 2009 Feb 6;4(2):e4384 [Full text]

Banzhoff A, Pellegrini M, Del Giudice G, et al. MF59-adjuvanted vaccines for seasonal and pandemic influenza prophylaxis. Influenza Other Resp Viruses 2008 Dec 8;2(6):243-9 [Full text]

Baras B, Stittelaar KJ, Simon JH, et al. Cross-protection against lethal H5N1 challenge in ferrets with an adjuvanted pandemic influenza vaccine. PLoS ONE 2008 Jan 2;3(1):e1401 [Full text]

Barnett DJ, Balicer RD, Lucey DR, et al. A systematic analytic approach to pandemic influenza preparedness planning. PLoS Med 2005 Dec;2(12) [Full text]

Barnett DJ, Balicer RD, Thompson CB, et al. Assessment of local public health workers' willingness to respond to pandemic influenza through application of the extended parallel process model. PLoS ONE 2009 Jul 24;4(7):e6365 [Full text]

Barr M, Raphael B, Taylor M, et al. Pandemic influenza in Australia: using telephone surveys to measure perceptions of threat and willingness to comply. BMC Infect Dis 2008;8:117 (published online Sep 15) [Abstract]

Barrett R, Brown PJ. Stigma in the time of influenza: social and institutional responses to pandemic emergencies. J Infect Dis 2008 Feb 15;197(S1):S34-7 [Abstract]

Barry JM Pandemic reality check: what can be done - and what can't - to protect against H1N1. (Commentary) Washington Post June 23, 2009 [Full text]

Barry JM, Viboud C, Simonsen L. Cross-protection between successive waves of the 1918-1919 influenza pandemic: epidemiological evidence from US Army camps and from Britain. J Infect Dis 2008 (published online Sep 22) [Abstract]

Barry JM. 1918 revisited: lessons and suggestions for further inquiry. In: The threat of pandemic influenza: are we ready? Institute of Medicine. Nov 16, 2004 [Full text]

Barry JM. Nonpharmaceutical interventions implemented during the 1918-1919 influenza pandemic. (Letter) JAMA 2007 Nov 21;298(19):2260-1 [Extract]

Barry JM. Pandemics: avoiding the mistakes of 1918. (Essay) Nature 2009 May 21;459(7245):324-5 [Full text]

Bartlett JG, Borio L. The current status of planning for pandemic influenza and implications for health care planning in the United States. Clin Infect Dis 2008;46 (published online Feb 14) [Abstract]

Bartlett JG. Planning for avian influenza. Ann Intern Med 2006 Jul 18;145(2) (published online Jun 27) [Full text]

Baskin CR, Bielefeldt-Ohmann H, Tumpey TM, et al. Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proc Natl Acad Sci 2009 (published online Feb 13) [Full text]

Basler CF, Aguilar PV. Progress in identifying virulence determinants of the 1918 H1N1 and Southeast Asian H5N1 influenza viruses. Antiviral Res 2008 Sep;78(3):166-78 [Abstract]

Baylor NW. Regulatory issues: pandemic preparedness pacing up. BioPharm Int 2007 Aug (supp) (published online Aug 2) [Full text]

Bean B, Moore BM, Sterner B, at al. Survival of influenza viruses on environmental surfaces. J Infect Dis 1982 Jul;146(1):47-51 [Astract]

Beaton R, Stergachis A, Thompson J, et al. Pandemic policy and planning considerations for universities: findings from a tabletop exercise. Biosecur Bioterror 2007 Dec;5(4):327-34 [Abstract]

Beaumont M, Duggal HV, Mahmood H, et al. A survey of the preparedness for an influenza pandemic of general practitioners in the West Midlands, UK. Eur J Clin Microbiol Infect Dis 2007 (published online Aug 10) [Abstract]

Beck ET, Jurgens LA, Kehl SC, et al. Development of a rapid automated influenza A, influenza B, and respiratory syncytial virus A/B multiplex real-time RT-PCR assay and its use during the 2009 H1N1 swine-origin influenza virus epidemic in Milwaukee, Wisconsin. J Molec Diagn 2010 Jan;12(1):74-81 [Abstract]

Beigel J, Bray M. Current and future antiviral therapy of severe seasonal and avian influenza. Antiviral Res 2008 Apr;78(1):91-102 [Abstract]

Beigi R, Davis G, Hodges JR, et al. Preparedness planning for pandemic influenza among large US maternity hospitals. Emerg Health Threats J 2009 Mar 27;2:e2 [Full text]

Belmont E, Leibold P, Osterholm M. Preparation will pay off: regardless of what happens with swine flu, pandemic bound to strike. (Commentary) Mod Healthc 2009 (published online May 4) [Full text]

Belser JA, Lu X, Szretter KJ, et al. DAS181, a novel sialidase fusion protein, protects mice from lethal avian influenza H5N1 virus infection. J Infect Dis 2007 Nov 15;196(10):1493-9 [Abstract]

Belshe RB. Implications of the emergence of a novel H1 influenza virus. (Editorial) N Engl J Med 2009 (published online May 7) [Full text]

Belshe RB. The origins of pandemic influenza: lessons from the 1918 virus. N Engl J Med 2005 Nov 24;353(21):2209-11 [Full text]

Bennett B. Legal rights during pandemics: federalism, rights and public health laws--a view from Australia. Public Health 2009 (published online Feb 26) [Full text]

Berkman BE. Mitigating pandemic influenza: the ethics of implementing a school closure policy. J Publ Health Manag Pract 2008 Jul-Aug;14(4):372-8 [Abstract]

Bermejo-Martin JF, de Lejarazu RO, Pumarola T, et al. Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza. Crit Care 2009 (published online Dec 11) [Full text]

Bernard H, Fischer R, Mikolajczyk RT, et al. Nurses' contacts and potential for infectious disease transmission. Emerg Infect Dis 2009 Sep (Epub ahead of print) [Full text]

Billharz R, Zeng H, Proll SC, et al. The NS1 protein of the 1918 pandemic influenza virus blocks host interferon and lipid metabolism pathways. J Virol 2009 (published online Aug 12) [Abstract]

Bish A, Michie S. Demographic and attitudinal determinants of protective behaviours during a pandemic: a review. Br J Health Psychol 2010 (published online Jan 30) [Abstract]

Bitar D, Goubar A, Desenclos JC. International travels and fever screening during epidemics: a literature review on the effectiveness and potential use of non-contact infrared thermometers. Eurosurveill 2009 Feb 12;14(6):pii=19115 [Full text]

Black S, Eskola J, Siegrist CA, et al. Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines. Lancet 2009 (published online Oct 31) [Abstract]

Black S, Eskola J, Siegrist CA, et al. Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines. Lancet 2009 Dec;374(9707):2115-22 [Abstract]

Blake KD, Blendon RJ, Viswanath K. Employment and compliance with pandemic influenza mitigation recommendations. Emerg Infect Dis 2010 Feb (published online Dec 29) [Full text]

Blendon RJ, Koonin LM, Benson JM, et al. Public response to community mitigation measures for pandemic influenza. Emerg Infect Dis 2008 May (published online Mar 28) [Full text]

Bloomfield S, Exner M, Fara GM, et al. Prevention of the spread of infection - the need for a family-centred approach to hygiene promotion. Eurosurveillance 2008 May 29;13(22) [Full text]

Blue Ribbon Commission on Mega-Catastrophes. Preparing for pandemic flu: a call to action. From Financial Services Roundtable. Nov 1, 2006 [Full text]

Blumenshine P, Reingold A, Egerter S, et al. Pandemic influenza planning in the United States from a health disparities perspective. Emerg Infect Dis 2008 May (published online Mar 28) [Full text]

Bodewes R, Kreijtz JHCM, Rimmelzwaan GF. Yearly influenza vaccinations: a double-edged sword? (Commentary) Lancet Infect Dis 2009 (published online Oct 30) [Abstract]

Boelle PY, Bernillon P, Desencios JC. A preliminary estimation of the reproduction ratio for new influenza A(H1N1) from the outbreak in Mexico, March-April 2009. Eurosurveill 2009 May 14;14(19):pi=19205 [Full text]

Bogner P, Capua I, Cox, NJ, et al. A global initiative on sharing avian flu data. Nature 2006 (Published online Aug 24) [Full text]

Bootsma CJ, Ferguson NM. The effect of public health measures on the 1918 influenza pandemic in US cities. Proc Natl Acad Sci 2007 (published online Apr 6) [Abstract, with access to free full text]

Booy R, Brown LE, Grohmann GS, et al. Pandemic vaccines: promises and pitfalls. Med J Aust 2006 Nov 20;185(10 suppl):S62-5 [Full text]

Bose ME, Littrell JC, Patzer AD, et al. The influenza primer design resource: a new tool for translating influenza sequence data into effective diagnostics. Influenza Other Resp Viruses 2008 Jan;2(1):23-31 [Abstract]

Bouvier NM, Lowen AC, Palese P. Oseltamivir-resistant influenza A viruses transmit efficiently among guinea pigs by direct contact but not by aerosol. J Virol 2008 Oct;82(20):10052-8 [Abstract]

Boyd M, Clezy K, Lindley R, et al. Pandemic influenza: clinical issues. Med J Aust 2006 Nov 20;185(10 suppl):S44-7 [Full text]

Bradt DA, Epstein D. The rational clinician in a pandemic setting. Med J Aust 2009 (published online Nov 30) [Full text]

Brammer L, Budd A, Cox N. Seasonal and pandemic influenza surveillance considerations for constructing multicomponent systems. Influenza Other Resp Viruses 2009 (published online Feb 12) [Abstract]

Brankston G, Gitterman L, Hirji A, et al. Transmission of influenza A in human beings. Lancet Infect Dis 2007, published online Feb 19 [Abstract]

Branson RD, Johannigman JA, Daugherty EL, et al. Surge capacity mechanical ventilation. Respir Care 2008 Jan;53(1):78-90 [Abstract]

Breiman RF, Nasidi A, Katz MA, et al. Preparedness for highly pathogenic avian influenza pandemic in Africa. (Perspective) Emerg Infect Dis 2007 Oct:13(10):1453-8 [Full text]

Brett AS, Zuger A. The run on Tamiflu: should physicians prescribe on demand? (Perspective) N Engl J Med 2005 Dec 22;353(24):2636-7 [Full text]

Bridges CB, Kuehnert MJ, Hall CB. Transmission of influenza: implications for control in healthcare settings. Clin Infect Dis 2003 Oct 15;37(8):1094-101 [Abstract]

Bright RA, Carter DM, Crevar CJ, et al. Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle. PLoS ONE 2008 Jan 30;3(1):e1501 [Full text]

British Medical Association, Royal College of General Practitioners. Preparing for pandemic influenza: guidance for GP practices. Released Jan 7, 2009 [Link to full text]

Brockmann SO, Schwehm M, Duerr HP, et al. Modeling the effects of drug resistant influenza in a pandemic. Virol J 2008 Oct 30;5(1):133 [Abstract]

Brownstein JS, Freifeld CC, Madoff LC. Digital disease detection--harnessing the Web for public health surveillance. (Perspective) N Engl J Med 2009 (published online May 7) [Full text]

Brownstein JS, Wolfe CJ, Mandl KD. Empirical evidence for the effect of airline travel on inter-regional influenza spread in the United States. PLoS Med 2006 Oct;3(10) [Full text]

Brownstein JS, Wolfe CJ, Mandl KD. Empirical evidence for the effect of airline travel on inter-regional influenza spread in the United States. PLoS Med 2006 Oct;3(10):e401 [Full text]

Brundage JF, Shanks GD. Deaths from bacterial pneumonia during 1918-19 influenza pandemic. Emerg Infect Dis 2008 Aug;14(8) (published online Jul 18) [Full text]

Brundage JF. Cases and deaths during influenza pandemics in the United States. Am J Prev Med 2006 Sep;31(3):252-6 [Abstract]

Brundage JF. Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness. Lancet Infect Dis 2006 May;6(5):303-12 [Abstract]

Buchholz U, Altmann D, Sagebiel D, et al. Stockpiling of anti-influenza drugs in private households: a survey in Germany. Eurosurveillance Weekly 2007 Jan 25;12(1):E070125.4 [Full text]

Buehler JW, Craig AS, Del Rio C, et al. Critical issues in responding to pandemic influenza. (Conference Summary) Emerg Infect Dis 2006 Jul;12(7) [Full text]

Bui HH, Peters B, Assarsson E, et al. Ab and T cell epitopes of influenza A virus, knowledge and opportunities. Proc Natl Acad Sci 2007 Jan 2;104(1):246-51 [Abstract]

Burns A, van der Mensbrugghe D, Timmer H. Evaluating the economic consequences of avian influenza. (World Bank report) Sep 2008 [Full text]

Caley P, Becker NG, Philp DJ. The waiting time for inter-country spread of pandemic influenza. PLoS One 2007 Jan;2(1):e143 [Full text]

Caley P, Philp DJ, McCracken K. Quantifying social distancing arising from pandemic influenza. J R Soc Interface 2007 (published online Oct 4) [Full text]

California Association of Health Facilities (CAHF). Pandemic influenza workbook for long term care providers. Aug 2007 [Full text]

Call SA, Vollenweider MA, Hornung CA, et al. Does this patient have influenza? JAMA 2005 Feb 23;293(8):987-97 [Astract]

Camitz M, Liljeros F. The effect of travel restrictions on the spread of a moderately contagious disease. BMC Med 2006;4(32) (published online Dec 14) [Abstract]

Camitz M. Statflu - a static modelling tool for pandemic influenza hospital load for decision makers. Eurosurveill 2009 Jul 2;14(26):pii=19256 [Full text]

Campbell JD. Pandemic flu vaccine: are we doing enough? Clin Pharmacol Ther 2007 Dec;82(6):633-5 [Full text]

Capua I, Alexander DJ. Avian influenza: recent developments. Avian Pathol 2004 Aug;33(4):393-404 [Abstract]

Capua I, Kajaste-Rudnitski A, Bertoli E, et al. Pandemic vaccine preparedness - have we left something behind? (Opinion) PLoS Pathog 2009 Jun 26;5(6):e1000482 [Full text]

Carrat F, Luong J, Lao H, et al. A 'small-world-like' model for comparing interventions aimed at preventing and controlling influenza pandemics. BMC Med 2006;4(26) (published online Oct 23) [Full text]

Carter NJ, Plosker GL. Prepandemic influenza vaccine H5N1 (split virion, inactivated, adjuvanted) (Prepandrix): a review of its use as an active immunization against influenza A subtype H5N1 virus. BioDrugs 2008;22(5):279-82 [Abstract]

Casanova L, Alfano-Sobsey E, Rutala WA, et al. Virus transfer from personal protective equipment to healthcare employees' skin and clothing. Emerg Infect Dis 2008 Aug (published online Jun 24) [Full text]

Cauchemez S, Ferguson NM, Wachtel C, et al. Closure of schools during an influenza pandemic. Lancet Infect Dis 2009 Aug;9(8):473-81 [Abstract]

Cauchemez S, Valleron AJ, Boelle PY, et al. Estimating the impact of school closure on influenza transmission from Sentinel data. Nature 2008 Apr 10;452(7188):750-4 [Abstract]

CDC. A commentary on the JAMA study's interpretation of the influenza experiences in New York City and Chicago, 1918-19. Jan 17, 2008 [Full text]

CDC. Abbreviated pandemic influenza plan template for primary care provider offices: guidance from stakeholders. Feb 9, 2010 [Full text]

CDC. Advice for parents on talking to children about novel H1N1 flu (formerly swine flu) concerns. May 6, 2009 [Full text]

CDC. CDC influenza pandemic operation plan (OPLAN). Released Dec 20, 2006 [Full text]

CDC. Clinical data collection forms and templates for collection of information on patients infected with novel H1N1 influenza A (H1N1). May 12, 2009 [Full text]

CDC. Guidance from pediatric stakeholders: a coordinated approach to communicating pediatric-related information on pandemic influenza at the community level. Jan 27, 2010 [Full text]

CDC. H1N1 flu resources for businesses and employers. May 8, 2009 [Full text]

CDC. Increased antiviral medication sales before the 2005-06 influenza season: New York City. MMWR 2006 Mar 17;55(10):277-9 [Full text]

CDC. Interim CDC guidance for nonpharmaceutical community mitigation in response to human infections with swine influenza (H1N1) virus. Apr 28, 2009 [Full text]

CDC. Interim CDC-NIH recommendation for raising the biosafety level for laboratory work involving noncontemporary human influenza (H2N2) viruses. Excerpted from draft: Biosafety in microbiological and biomedical laboratories. Ed 5. May 3, 2005 [Full text]

CDC. Interim guidance for airline flight crews and persons meeeting passengers arriving from areas with avian influenza. Published Feb 18, 2004; updated frequently [Web page]

CDC. Interim guidance for employers for protection of migrant and seasonal farmworkers from the novel H1N1 flu virus. May 5, 2009 [Full text]

CDC. Interim guidance for public gatherings in response to human infections with novel influenza A (H1N1). May 10, 2009 [Full text]

CDC. Interim guidance on antiviral recommendations for patients with confirmed or suspected swine influenza A (H1N1) virus infection and close contacts. May 6, 2009 [Full text]

CDC. Interim guidance to assist state and local health departments in developing programs for migrant and seasonal farmworkers in response to human infections with novel influenza A (H1N1) virus. May 5, 2009 [Full text]

CDC. Interim pre-pandemic planning guidance: community strategy for pandemic influenza mitigation in the United States--early, targeted, layered use of nonpharmaceutical interventions. Released Feb 1, 2007 [Full text]

CDC. Interim public health guidance for the use of facemasks and respirators in non-occupational community settings during an influenza pandemic. Released May 3, 2007 [Full text]

CDC. Interim recommendations for facemask and respirator use to reduce novel influenza A (H1N1) virus transmission. May 23, 2009 [Full text]

CDC. Interim recommendations for infection control in health-care facilities caring for patients with known or suspected avian influenza [Webpage]

CDC. Key mental and behavioral health issues related to social distancing for state, local, and tribal health departments and community based organizations. May 5, 2009 [Full text]

CDC. Lab diagnosis. [Webpage]

CDC. Letter to providers promoting PPSV for adults. Nov 10, 2009 [Full text]

CDC. Managing calls and call centers during a large-scale influenza outbreak: implementation tool. July 30, 2009 [Full text]

CDC. New laboratory assay for diagnostic testing of avian influenza A/H5 (Asian lineage). MMWR 2006 Feb 3;55(Early release):1 [Full text]

CDC. Novel H1N1 vaccination recommendations. July 30, 2009 [Full text]

CDC. Novel influenza A (H1N1) virus infections in three pregnant women--United States, April - May 2009. MMWR 2009 May 12;58(Dispatch):1-3 [Full text]

CDC. Outbreak of swine-origin influenza A (H1N1) virus infection - Mexico, March - April 2009. MMWR 2009 Apr 30;58(Dispatch):1-3 [Full text]

CDC. Pandemic influenza: progress made and challenges ahead. Jan 24, 2007, statement by Director Julie L. Gerberding, MD, MPH, before US Senate subcommittee [Full text]

CDC. Plan now to be ready for the next flu pandemic. Aug 2008 fact sheet [Full text]

CDC. Psychological and social support for essential service workers during an influenza pandemic. Apr 30, 2009 [Full text]

CDC. Public health preparedness: mobilizing state by state. Feb 20, 2008 [Full text]

CDC. Q & A on Executive Order adding potentially pandemic influenza viruses to list of quarantinable diseases. Apr 11, 2005 [Full text - See Executive Order under "White House" below]

CDC. Respiratory hygiene/cough etiquette in healthcare settings [Webpage]

CDC. Select Agent Program [Webpage]

CDC. Social distancing law project. 2008 [Full text]

CDC. Swine influenza A (H1N1) infection in two children - Southern California, March - April 2009. MMWR 2009 Apr 21;58(Dispatch):1-3 [Full text]

CDC. Swine-origin influenza A (H1N1) virus infections in a school--New York City, April 2009. MMWR 2009 Apr 30;58(Dispatch):1-3 [Full text]

CDC. The next flu pandemic: what to expect. Aug 2008 fact sheet [Full text]

CDC. Update on influenza A(H5N1) and SARS: Interim recommendations for enhanced U.S. surveillance, testing, and infection controls [Full text]

CDC. Update: Interim guidance for novel H1N1 flu (swine flu): taking care of a sick person in your home. July 8, 2009 [Full text]

CDC. Update: novel influenza A (H1N1) virus infections--worldwide, May 6, 2009. MMWR 2009 May 8;58(17):453-8 [Full text]

CDC. Update: swine influenza A (H1N1) infections--California and Texas, April 2009. MMWR 2009 Apr 24;58(Dispatch);1-3 [Full text]

CDC. Update: What to do if you get flu-like symptoms. July 8, 2009 [Full text]

CDC. Updated interim guidance for laboratory testing of persons with suspected infection with avian influenza A (H5N1) virus in the United States. Jun 7, 2006 [Full text]

CDC. Updated: Interim CDC guidance for colleges, universities, and post-secondary educational institutions in response to human infections with novel influenza A (H1N1) virus. May 11, 2009 [Full text]

CDC. What you should know about using facemasks and respirators during a flu pandemic. Released May 3, 2007 [Full text]

CDC/HICPAC. Guideline for isolation precautions in hospitals, 1994 [Webpage]

CDC/HICPAC. Guidelines for Preventing Healthcare Associated Pneumonia, 2003 [Webpage]

Chaipan C, Kobasa D, Bertram S, et al. Proteolytic activation of the 1918 influenza virus hemagglutinin. J Virol 2009 Apr;83(7):3200-11 [Abstract]

Chakraborti C. Pandemic management and developing world bioethics: bird flu in West Bengal. Dev World Bioeth 2008 (published online Aug 11) [Abstract]

Chamberlain A, Gronvall GK. Immune-boosting adjuvants. Biosecur Bioterror 2007 Sep;5(3):202-5 [Extract]

Chan MC, Cheung CY, Chui WH, et al. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res 2005 Nov 11;6(1) [Full text]

Chang YS, van Hal SJ, Spencer PM, et al. Comparison of adult patients hospitalised with pandemic (H1N1) 2009 influenza and seasonal influenza during the "PROTECT" phase of the pandemic response. Med J Aust 2009 (published online Nov 30) [Full text]

Chen GW, Chang SC, Mok CK, et al. Genomic signatures of human versus avian influenza A viruses. Emerg Infect Dis 2006 Sep;12(9):1353-60 [Full text]

Chen H, Smith GJ, Li KS, et al. Establishment of multiple sublineages of H5N1 influenza virus in Asia: implications for pandemic control. Proc Natl Acad Sci 2006 (published online Feb 10) [Abstract]

Chen H, Subbarao K, Swayne D, et al. Generation and evaluation of a high-growth reassortant H9N2 influenza A virus as a pandemic vaccine candidate. Vaccine 2003 May 16;21(17-18):1983-8 [Abstract]

Chen J, Chen SCY, Stern P, et al. Genetic strategy to prevent influenza virus infections in animals. J Infect Dis 2008 Feb 15;197(S1):S25-8 [Abstract]

Chen LM, Davis CT, Zhou H, et al. Genetic compatibility and virulence of reassortants derived from contemporary avian H5N1 and human H3N2 influenza A viruses. PLoS Pathog 2008 May 23;4(5):e1000072 [Full text]

Chen Z, Santos C, Aspelund A, et al. Evaluation of live attenuated influenza A virus H6 vaccines in mice and ferrets. J Virol 2009 Jan;83(1):65-72 [Abstract]

Cheng X, Eisenbraun M, Xu Q, et al. H5N1 vaccine-specific B cell responses in ferrets primed with live attenuated seasonal influenza vaccines. PLoS ONE 2009 Feb 11;4(2):e4336 [Full text]

Cheng X, Wu C, He J, et al. Serological and genetic characterization analyses of a highly pathogenic influenza virus (H5N1) islolated from an infected man in Shenzhen. J Med Virol 2008 Apr 21;80(6):1058-64 [Abstract]

Chesser A, Ablah E, Hawley SR, et al. Preparedness needs assessment in a rural state: themes derived from public focus groups. Biosecur Bioterror 2006 Dec;4(4):376-83 [Abstract]

Chien YW, Klugman KP, Morens DM. Bacterial pathogens and death during the 1918 influenza pandemic. (Letter) N Engl J Med 2009 Dec 24;361(26):2582-3 [Full text]

Choi SMY, Lam PY. Enhancing legal preparedness for the prevention and control of infectious diseases: experience from severe acute respiratory syndrome in Hong Kong. Public Health 2009 (published online Mar 5) [Abstract]

Choi YK, Ozaki H, Webby RJ, et al. Continuing evolution of H9N2 influenza viruses in southeastern China. J Virol 2004 Aug;78(16):8609-14 [Abstract]

Chotpitayasundondh T, Thisyakorn U, Pancharoen C, et al. Safety, humoral and cell mediated immune responses to two formulations of an inactivated, split-virion influenza A/H5N1 vaccine in children. PLoS ONE 2008 Dec 29;3(12):e4028 [Full text]

Chowell G, Bettencourt LMA, Johnson N, et al. The 1918-1919 influenza pandemic in England and Wales: spatial patterns in transmissibility and mortality impact. Proc R Soc B 2007 (published online Dec 20) [Abstract]

Chowell G, Nishiura H, Bettencourt LMA. Comparative estimation of the reproduction number for pandemic influenza from daily case notification data. J R Soc Interface 2006 (published online Oct 12) [Abstract]

Christian MD, Hawryluck L, Wax RS, et al. Development of a triage protocol for critical care during an influenza pandemic. CMAJ 2006 Nov 21;175(11):1377-81 [Full text]

Christophersen OA, Haug A. Why is the world so poorly prepared for a pandemic of hypervirulent avian influenza? Microb Ecol Health Dis 2006 Dec;18(3-4):113-32 [Abstract]

Chutinimitkul S, Songserm T, Amonsin A, et al. New strain of influenza A virus (H5N1), Thailand. (Letter) Emerg Infect Dis 2007 Mar;13(3) (published online Feb 15) [Full text]

Cinti SK, Barnosky AR, Gay SE, et al. Bacterial pneumonias during an influenza pandemic: how will we allocate antibiotics? Biosecur Bioterror 2009 Sep;7(3):311-6 [Full text]

Coburn BJ, Wagner BG, Blower S. Modeling influenza epidemics and pandemics: insights into the future of swine flu (H1N1). BMC Med 2009 Jun 22;7:30 [Abstract]

Coiras MT, Perez-Brena P, Garcia ML, et al. Simultaneous detection of influenza A, B, and C viruses, respiratory syncytial virus, and adenoviruses in clinical samples by multiplex reverse transcription nested-PCR assay. J Med Virol 2003 Jan;69(1):132-44 [Abstract]

Coker R, Mounier-Jack S. Pandemic influenza preparedness in the Asia-Pacific region. Lancet 2006 (Published online Aug 22) [Abstract]

Coker R. UK preparedness for pandemic influenza. BMJ 2007 May 12;334(7601):965 [Extract]

Coleman CH, Reis A. Potential penalties for health care professionals who refuse to work during a pandemic. (Commentary) JAMA 2008 Mar 26;299(12):1471-3 [Extract]

Colina R, Costa-Mattioli M, Dowling RJO, et al. Translational control of the innate immune response through IRF-7. Nature 2008 Mar 20;452(7185):323-8 (published online Feb 13) [Abstract]

Colizza V, Barrat A, Barthelemy M, et al. Modeling the worldwide spread of pandemic influenza: Baseline case and containment interventions. PLoS Med 2007 Jan 23;4(1):e13 [Full text]

Colizza V, Barrat A, Barthelemy M, et al. The role of the airline transportation network in the prediction and predictability of global epidemics. Proc Natl Acad Sci 2006 (published online Feb 3) [Abstract]

Collignon PJ, Carnie JA. Infection control and pandemic influenza. Med J Aust 2006 Nov 20;185(10 suppl):S54-7 [Full text]

Collins N, Litt J, Moore M, et al. General practice: professional preparation for a pandemic. Med J Aust 2006 Nov 20;185(10 suppl):S66-9 [Full text]

Collins PJ, Haire LF, Lin YP, et al. Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants. Nature 2008 Jun 26;453(7199):1258-61 [Abstract]

Conenello GM, Palese P. Influenza A virus PB1-F2: a small protein with a big punch. (Editorial) Cell Host Microbe 2007 Oct 10;2(4):207-9 [Abstract]

Conenello GM, Zamarin D, Perrone LA, et al. A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog 2007 Oct 5;3(10):e141 [Full text]

Congressional Budget Office. US policy regarding pandemic-influenza vaccines. Released Sep 15, 2008 [Full text]

Conly JM. Personal protective equipment for preventing respiratory infections: What have we really learned? (Commentary) CMAJ 2006 Aug 1;175(3):263-4 [Full text]

Conseil A, Mounier-Jack S, Coker R. Business continuity planning and pandemic influenza in Europe: an analysis of independent sector and national governments' guidance. Report from London School of Hygiene & Tropical Medicine released Jun 4, 2008 (but dated Mar 31) [Link to full text]

Cooper B. Influenza pandemic scenario analysis report: could a pandemic be contained using antiviral agents? Eurosurveillance Weekly 2004 May 6;8(19) [Full text]

Cooper BS, Pitman RJ, Edmunds WJ, et al. Delaying the international spread of pandemic influenza. PLoS 2006 Jun;3(6) [Full text]

Cowling BJ, Chan KH, Fang VJ, et al. Facemasks and hand hygiene to prevent influenza transmission in households. Ann Intern Med 2009 Oct 6 (published online Aug 4) [Full text]

Cowling BJ, Zhou Y, Ip DKM, et al. Face masks to prevent transmission of influenza virus: a systematic review. Epidemiol Infect 2010 (published online Jan 22) [Abstract]

Cox NJ, Subbarao K. Global epidemiology of influenza: past and present. Annu Rev Med 2000 Feb;51:407-21 [Abstract]

Cox NJ, Tamblyn SE, Tam T. Influenza pandemic planning. Vaccine 2003 May 1;21(16):1801-3 [Abstract]

Cox RJ, Madhun AS, Hauge S, et al. A phase I clinical trial of a PER.C6 cell grown influenza H7 virus vaccine. Vaccine 2009 Mar 18;27(13):1889-97 [Abstract]

Crawford PC, Dubovi EJ, Castleman WL, et al. Transmission of equine influenza virus to dogs. Science 2005 Oct 21;310(5747):482-5 [Abstract]

CRS (Congressional Research Service). Pandemic influenza: an analysis of state preparedness and response plans. Released Sep 24, 2007 [Full text]

CRS (Congressional Research Service). Potential farm sector effects of 2009 H1N1 'swine flu': questions and answers. Posted Jun 17, 2009 (but dated May 20) [Full text]

CRS (Congressional Research Service). The 2009 influenza pandemic: an overview. First published Apr 30, 2009; updated regularly [Full text]

CRS (Congressional Research Service). The 2009 influenza pandemic: selected legal issues. First published May 6, 2009; updated regularly [Full text]

CRS (Congressional Research Service). The role of the Department of Defense during a flu pandemic. Released Jun 22, 2009 (but dated Jun 4) [Full text]

CRS (Congressional Research Service). Would an influenza pandemic qualify as a major disaster under the Stafford Act? Posted Jan 19, 2010 (but dated Dec 15) [Full text]

CSTE. Influenza preparedness state plans [Web page]

Cummings KJ, Cox-Ganser J, Riggs MA, et al. Respirator donning in post-hurricane New Orleans. Emerg Infect Dis 2007 May;13(5) (published online Mar 30) [Full text]

Cunha BA. Influenza: historical aspects of epidemics and pandemics. Infect Dis Clin North Am 2004 Mar;18(1):141-5 [Abstract]

Curran MS, Ellis JS, Wreghitt TG, et al. Establishment of a UK National Influenza H5 Laboratory Network. J Med Microbiol 2007 Oct;56(10):1263-7 [Full text]

Damery S, Wilson S, Draper H, et al. Will the NHS continue to function in an influenza pandemic? A survey of healthcare workers in the West Midlands, UK. BMC Public Health 2009 May 14;9:142 [Abstract]

Daniels TL, Talbot TR. Unmasking the confusion of respiratory protection to prevent influenza-like illness in crowded community settings. (Editorial) J Infect Dis 2010 (published online Jan 20) [Full text]

Daugherty EL, Carlson AL, Perl TM. Planning for the inevitable: preparing for epidemic and pandemic respiratory illness in the shadow of H1N1 influenza. Clin Infect Dis 2010 (published online Mar 12) [Abstract]

Daugherty EL, Perl TM, Rubinson L, et al. Survey study of the knowledge, attitudes, and expected behaviors of critical care clinicians regarding an influenza pandemic. Infect Control Hosp Epidemiol 2009 (published online Oct 29) [Abstract]

Davey VJ, Glass RJ, Min HJ, et al. Effective, robust design of community mitigation for pandemic influenza: a systematic examination of proposed US guidance. PLoS ONE 2008 Jul 2;3(7):e2606 [Full text]

Davey VJ, Glass RJ. Rescinding community mitigation strategies in an influenza pandemic. Emerg Infect Dis 2008 Mar;14(3) (published online Feb 4) [Full text]

Dawes M. Using physical barriers to reduce the spread of respiratory viruses. (Editorial) BMJ 2008 Jan 12;336(7635):55-6 [Abstract]

De Clercq E. Antiviral agents active against influenza A viruses. Nature Rev Drug Disc 2006 Dec;5(12):1015-25 [Abstract]

De Jong MD, Simmons CP, Thanh TT, et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. (Letter) Nat Med 2006 Oct:12(10):1203-7 [Abstract]

De Jong MD, Thanh TT, Khank TH, et al. Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med 2005 Dec 22;353(24):2667-72 [Full text]

de Zwart O, Veldhuijzen IK, Elam G, et al. Avian influenza risk perception, Europe and Asia. Emerg Infect Dis 2007 Feb;13(2) (published online Jan 10) [Full text]

Debarre F, Bonhoeffer S, Regoes RR. The effect of population structure on the emergence of drug resistance during influenza pandemics. J R Soc Interface 2007 Oct 22;4(16):893-906 [Abstract]

Democratis J, Pareek M, Stephenson I. Use of neuraminidase inhibitors to combat pandemic influenza. J Antimicrob Chemother 2006 (published online Sep 6) [Abstract]

Department of Health & Children (Ireland). Influenza Pandemic Preparedness in Ireland Joint Assessment Report 2007. Released Nov 26 [Full text]

Department of Health (UK). Exercise Winter Willow: lessons identified. Aug 30, 2007 [Full text]

Department of Health (UK). Links to reports on UK's national plan, including guidance for hospitals, ambulance services, primary care, and adult social care as well as ethical considerations, released Nov 22 [Full text]

Department of Health (UK). Pandemic flu: a national framework for responding to an influenza pandemic. Released Nov 22, 2007 [Full text]

Department of Health (UK). Pandemic influenza: guidance on preparing mental health services in England. Jul 2, 2008 [Full text]

Department of Health (UK). Pandemic influenza: surge capacity and prioritisation in health services (draft for comment). Sep 4, 2008 [Full text]

Department of Health (UK). Responding to pandemic influenza: the ethical framework for policy and planning. Released Nov 22, 2007 [Full text]

Department of Health/Health Protection Agency (UK). Pandemic flu guidance for businesses: risk assessment in the occupational setting. Mar 27, 2009 [Link to full report]

Department of the Treasury (US), FBIIC, FSSCC, et al. The FBIIC/FSSCC pandemic flu exercise of 2007 after action report. Released Jan 24, 2008 [Full text]

Devereaux A, Christian MC, Dichter JR, et al. Summary of suggestions from the Task Force for Mass Critical Care Summit, January 26-27, 2007. Chest 2008 May;133(5 suppl):S1-7 [Full text]

DHS. Creating a culture of preparedness among schools. Released Oct 30, 2007 [Full text]

DHS. National infrastructure protection plan. Released Jun 30, 2006 [Links to full text & executive summary]

DHS. National preparedness guidelines. Released Sep 13, 2007 [Full text]

DHS. Nationwide plan review phase 2 report. Jun 16, 2006 [Full text]

DHS. Planning for 2009 H1N1 influenza: a preparedness guide for small business. Sep 14, 2009 [Full text]

Dimmock NJ, Rainsford EW, Scott PD, et al. Influenza virus protecting RNA: an effective prophylactic and therapeutic antiviral. J Virol 2008 Sep;82(17):8570-78 [Abstract]

DiNapoli JM, Yang L, Suguitan A Jr, et al. Immunization of primates with a Newcastle disease virus-vectored vaccine via the respiratory tract induces a high titer of serum neutralizing antibodies against highly pathogenic avian influenza. J Virol 2007 Nov;81(21):11560-8 [Abstract]

Dinh PN, Long HT, Tien NTK, et al. Risk factors for human infection with avian influenza A H5N1, Vietnam, 2004. Emerg Infect Dis 2006;12(12) (published online Oct 25) [Full text]

DoD (Dept of Defense). Pandemic influenza: clinical guidelines for the military health system. Released May 17, 2007 [Full text]

DoD. Department of Defense implementation plan for pandemic influenza. Released May 9, 2007 [Full text]

Dolin R. Influenza: interpandemic as well as pandemic disease. (Perspective) N Engl J Med 2005 Dec 15;353(24):2535-7 [Extract]

DOT (US Department of Transportation). Sub-sector pandemic influenza planning guidelines (for aviation, highway and motor carrier, maritime, mass transit, and railroad sub-sectors). Released Apr 1, 2008, as annexes to DHS preparedness guidelines [Web site, with links to PDFs]

Dowdle WR. Influenza pandemic periodicity, virus recycling, and the art of risk assessment. Emerg Infect Dis 2006 Jan;12(1):34-9 [Full text]

Draper H, Wilson S, Ives J, et al. Healthcare workers' attitudes towards working during pandemic influenza: a multimedia study. BMC Public Health 2008 Jun 2;8:192 [Abstract]

Du QS, Wang SQ, Chou KC. Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus. Biochem Biophys Res Comm 2007 (published online Aug 13) [Abstract]

Duerr HP, Brockmann SO, Piechotowski I, et al. Influenza pandemic intervention planning using InfluSim: pharmaceutical and non-pharmaceutical interventions. BMC Infect Dis 2007;7:76 (published online Jul 13) [Full text]

Dwyer DE, Smith DW, Catton MG, et al. Laboratory diagnosis of human seasonal and pandemic influenza virus infection. Med J Aust 2006 Nov 20;185(10 suppl):S48-53 [Full text]

ECDC (European Centre for Disease Prevention and Control). Likely evolution of the epidemics/pandemic of a new A(H1N1) influenza. ECDC module, published May 11, updated periodically [PPT]

ECDC (European Centre for Disease Prevention and Control). Likely scenarios for influenza in 2010 and the 2010/2011 influenza season in Europe and the consequent work priorities. Mar 8, 2010 [Full text]

ECDC Technical Emergency Team. Initial epidemiological findings in the European Union following the declaration of pandemic alert level 5 due to influenza A (H1N1). (Rapid communications) Eurosurveill 2009 May 7;14(18):pi=19204 [Full text]

ECDC. ECDC interim risk assessment: influenza A(H1N1) 2009 pandemic. Document released Dec 17, 2009 [Full text]

ECDC. Planning assumptions for the first wave of pandemic A(H1N1) 2009 in Europe. Jul 28, 2009 [Full text]

Edwards JC, Kang J, Silenas R. Promoting regional disaster preparedness among rural hospitals. J Rural Health 2008 Summer;24(3):321-5 [Abstract]

Effler PV, Carcione D, Giele C, et al. Household responses to pandemic (H1N1) 2009-related school closures, Perth, Western Australia. Emerg Infect Dis 2010 Feb (published online Dec 29) [Full text]

Ehrlich HJ, Muller M, Fritsch S, et al. A cell culture (Vero)-derived H5N1 whole-virus vaccine induces cross-reactive memory responses. (Brief report) J Infect Dis 2009 (published online Aug 27) [Abstract]

Ehrlich HJ, Muller M, Oh HML, et al. A clinical trial of a whole-virus H5N1 vaccine derived from cell culture. N Engl J Med 2008 Jun 12;358(24):2573-84 [Full text]

Eichelberger M, Golding H, Hess M, et al. FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10-11, 2007. Vaccine 2008 Aug 12;26(34):4299-303 [Abstract]

Eichner M, Schwehm M, Duerr HP, et al. Antiviral prophylaxis during pandemic influenza may increase drug resistance. BMC Infect Dis 2009 Jan 20;9:4 [Abstract]

Eichner M, Schwehm M, Wilson N, et al. Small islands and pandemic influenza: Potential benefits and limitations of travel volume reduction as a border control measure. BMC Infect Dis 2009 Sep 29;9:160 [Abstract]

Eisenman DP, Cordasco KM, Asch S, et al. Disaster planning and risk communication with vulnerable communities: lessons from Hurricane Katrina. Am J Public Health 2007 (published online Apr 5) [Abstract]

Ekiert DC, Bhabha G, Elsliger MA, et al. Antibody recognition of a highly conserved influenza virus epitope. Science 2009 (published online Feb 26) [Abstract]

Emanuel E, Wertheimer A. Public health: who should get influenza vaccine when not all can? Science 2006 May 12;312(5775):854-5 [Summary with full-text link for subscribers]

Enserink M. Influenza: tense meeting produces some hope for flu-sharing deal. Science 2007 Nov 30;318(5855):1361 [Abstract]

Epico working group. Modelling scenarios of diffusion and control of pandemic influenza, Italy. Eurosurveillance Weekly 2007 Jan 4;12(1):E070104.2 [Full text]

Epstein JM, Goedecke DM, Yu F, et al. Controlling pandemic flu: the value of international air travel restrictions. PLoS One 2007 May;2(5):e401 [Full text]

Epstein JM. Modelling to contain pandemics. (Opinion) Nature 2009 Aug 6;687(7256) (published online Aug 5) [Full text]

Epstein SL. Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature. J Infect Dis 2006 Jan 1;193(1):49-53 [Abstract]

Ethics in the Worst of Times: Rationing to Protect the Public's Health during a Severe Influenza Pandemic Streaming video of panel discussion Jun 5, 2008, from Minnesota Dept of Health and University of Minnesota Center for Public Health Preparedness [http://cpheo.sph.umn.edu/cpheo/ethics/home.html]

European Centre for Disease Prevention and Control (ECDC). Pandemic preparedness in the European Union and European Economic Area--2007. Dec 20, 2007 [Full text]

European Centre for Disease Prevention and Control (ECDC). Technical report: Expert advisory groups on human H5N1 vaccines: public health and operational questions. Released Sep 20, 2007 [Full text]

European Centre for Disease Prevention and Control (ECDC). Technical report: Expert advisory groups on human H5N1 vaccines: scientific questions. Released Aug, 2007 [Full text]

European Centre for Disease Surveillance and Control. Highly pathogenic avian influenza A/H5N1--update and overview of 2006. Eurosurveillance Weekly 2006 Dec 21;11(12):E061221.1 [Full text]

European Commission. Influenza and how the EU should respond to a pandemic. Press release, Mar 31, 2004 [Full text]

European Commission. Timeline of actions by the EC on avian influenza and human flu pandemic preparedness. Aug 25, 2005 [Full text]

Eurosurveillance Editorial Team, Paget J. Considerable progress in European preparations for a potential influenza pandemic. Eurosurveillance Weekly 2004 Dec 23;8(52) [Full text]

Evans D, Cauchemez S, Hayden FG. "Prepandemic" immunization for novel influenza viruses, "swine flu" vaccine, Guillain-Barre syndrome, and the detection of rare severe adverse events. J Infect Dis 2009 (published online Jun 29) [Abstract]

FAO. Bird flu virus in Europe--a hidden danger. Oct 25, 2007, release [Full text]

FAO. Enhancing control of highly pathogenic avian influenza in developing countries through compensation: issues and good practice. Nov 27, 2006 [Full text]

FAO. Update on the avian influenza situation. AIDE News 2006 Jun 19, Issue no. 40 [Full text]

Fasina FO, Bisschop SP, Webster RG. Avian influenza H5N1 in Africa: an epidemiological twist. Lancet Infect Dis 2007 Nov;7(11):696-7 [Full text]

Fauci AS. Pandemic influenza threat and preparedness. Emerg Infect Dis 2006 Jan;12(1):73-7 [Full text]

Fauci AS. Seasonal and pandemic influenza preparedness: science and countermeasures. J Infect Dis 2006 Nov 1;194(suppl 2):S73-6 [Abstract]

Fazekas G, Martosne-Mendi R, Jankovics I, et al. Cross-reactive immunity to clade 2 strains of influenza virus A subtype H5N1 induced in adults and elderly patients by Fluval, a prototype pandemic influenza virus vaccine derived by reverse genetics, formulated with a phosphate adjuvant, and directed to clade 1 strains. Clin Vaccine Immunol 2009 Apr;16(4):437-43 [Abstract]

FDA. Dear Health Care Professionals: 2009 H1N1 flu virus. (Letter) (published online May 7) [Full text]

FDA. FDA approves first U.S. vaccine for humans against the avian influenza virus H5N1. Apr 17, 2007, press release [Full text]

FDA. FDA authorizes emergency use of influenza medicines, diagnostic test in response to swine flu outbreak in humans. Apr 27, 2009, news release [Full text]

FDA. FDA clears first respirators for use in public health medical emergencies. May 8, 2007, news release [Full text]

FDA. FDA pandemic influenza preparedness strategic plan. Released Mar 14, 2007 [Full text]

FDA. Guidance for industry: characterization and qualification of cell substrates and other biological materials used in the production of viral vaccines for infectious disease indications. Released Mar 2, 2010 [Full text]

FDA. Guidance for industry: clinical data needed to support the licensure of pandemic influenza vaccines. May 31, 2007 [Full text]

FDA. Questions and answers on the 2009 H1N1 flu virus and the food industry. (published online May 7) [Full text]

FDA/CDC. FDA and CDC information on potential "spot shortages" of supplies for treating and preventing novel influenza A (H1N1). May 4, 2009, news release [Full text]

Fedson DS, Dunnill P. New approaches to confronting an imminent influenza pandemic. (Commentary) Perm J 2007 summer;11(3):63-9 [Full text]

Fedson DS. Confronting an influenza pandemic with inexpensive generic agents: can it be done? Lancet Infect Dis 2008 (published online Apr 16) [Abstract]

Fedson DS. Confronting the next influenza pandemic with anti-inflammatory and immunomodulatory agents: why they are needed and how they might work. Influenza Other Resp Viruses 2009 Jun 12;3(4):129-42 [Abstract]

Fedson DS. Meeting the challenge of influenza pandemic preparedness in developing countries. (Perspective) Emerg Infect Dis 2009 Mar (published online Feb 2) [Full text]

Fedson DS. Pandemic influenza and the global vaccine supply. Clin Infect Dis 2003 Jun 15;36(12):1552-61 [Abstract]

Fedson DS. Pandemic influenza: a potential role for statins in treatment and prophylaxis. (Viewpoints) Clin Infect Dis 43(2):199-205 [Abstract]

Fedson DS. Vaccination for pandemic influenza and severe acute respiratory syndrome: common issues and concerns. (Editorial Commentary) Clin Infect Dis 2003 Jun 15;36(12):1562-3 [Full text]

Fedson DS. Vaccination for pandemic influenza: a six point agenda for interpandemic years. Pediatr Infect Dis J 2004 Jan;23(1 Suppl):S74-7 [Abstract]

Fell G. Preparedness of residential and nursing homes for pandemic flu. J Public Health 2008 Mar;30(1):99-102 [Abstract]

Ferguson N. Poverty, death, and a future influenza pandemic. Lancet 2006 Dec 23;368(9554);2187-8 [Full text]

Ferguson NM, Cummings DA, Fraser C, et al. Strategies for mitigating an influenza pandemic. (Letter) Nature 2006 (published online Apr 26) [Abstract]

Ferguson NM, Cummings DAT, Cauchemez S, et al. Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature 2005 Sep 8;437:209-14 [Abstract]

Fick J, Lindberg RH, Tysklind M, et al. Antiviral oseltamivir is not removed or degraded in normal sewage water treatment: implications for development of resistance by influenza A virus. PLoS ONE 2007 Oct 3;2(10):e986 [Full text]

Fidler D. Influenza virus samples, international law, and global health diplomacy. Emerg Infect Dis 2008 Jan;14(1):88-94 [Full text]

Finkelstein DB, Mukatira S, Mehta PK, et al. Persistent host markers in pandemic and H5N1 influenza viruses. J Virol 2007 (published online Jul 25) [Abstract]

Florida Dept of Agriculture & Consumer Services. Pandemic influenza: agriculture planning toolkit. Released Apr 28, 2008 [Full text]

Forsberg White L, Pagano M. Transmissibility of the influenza virus in the 1918 pandemic. PLoS ONE 2008 Jan 30;3(1):e1498 [Full text]

Fouchier RAM, Munster V, Wallensten A, et al. Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J Virol 2005 Mar;79(5):2814-22 [Abstract]

Franco-Paredes C, Carraso P, Preciado JI. The first influenza pandemic in the new millennium: lessons learned hitherto for current control efforts and overall pandemic preparedness. J Immune Based Ther Vaccines 2009 Aug 7;7:2 [Full text]

Fraser C, Donnelly CA, Cauchemez S, et al. Pandemic potential of a novel strain of influenza A (H1N1): early findings. Science 2009 (published online May 11) [Full text]

Fraser C. Influenza pandemic vaccines: spread them thin? PLoS Med 2007 Jun;4(6):e228 [Full text]

FSSCC (Financial Services Sector Coordinating Council for Critical Infrastructure Protection and Homeland Security). Statement on preparations for "avian flu." Jan 24, 2006 [Full text]

Gall A, Hoffmann B, Harder T, et al. Design and validation of a microarray for detection, hemagglutinin subtyping, and pathotyping of avian influenza viruses. J Clin Microbiol 2009 Feb;47(2):327-34 [Abstract]

Galli G, Medini D, Borgogni E, Zedda L, et al. Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of productive antibody levels. Proc Natl Acad Sci 2009 (published online Feb 23) [Abstract]

Gambotto A, Barrat-Boyes SM, de Jong MD, et al. Human infection with highly pathogenic H5N1 influenza virus. Lancet 2008 Apr 25;371(9622):1464-75 [Abstract]

Gani R, Hughes H, Fleming D, et al. Potential impact of antiviral use on hospitalizations during influenza pandemic. Emerg Infect Dis 2005 Sep;11(9) [Full text]

GAO (US Government Accountability Office). Influenza pandemic: key securities market participants are making progress, but agencies could do more to address potential Internet congestion and encourage readiness. GAO-10-8. Oct 26, 2009 [Full text]

GAO (US Government Accountability Office). Emergency management: observations on DHS's preparedness for catastrophic disasters. GAO-08-868T. Released Jun 11, 2008 [Full text]

GAO (US Government Accountability Office). Emergency preparedness: state efforts to plan for medical surge could benefit from shared guidance for allocating scarce medical resources. Testimony of Cynthia A. Bascetta, Director, Health Care. GAO-10-381T. Jan 25, 2010 [Full text]

GAO (US Government Accountability Office). Emergency preparedness: states are planning for medical surge, but could benefit from shared guidance for allocating scarce medical resources. GAO-08-668. Released Jul 14, 2008 (but dated Jun 2008) [Full text]

GAO (US Government Accountability Office). Financial market preparedness: significant progress has been made, but pandemic planning and other challenges remain. Report released May 1, 2007 [Full text]

GAO (US Government Accountability Office). Homeland Security: observations on DHS and FEMA efforts to prepare for and respond to major and catastrophic disasters and address related recommendations and legislation. GAO-07-1142T. Jul 31, 2007 [Full text]

GAO (US Government Accountability Office). Influenza pandemic: continued focus on the nation's planning and preparedness efforts remains essential. Jun 3, 2009 [Full text]

GAO (US Government Accountability Office). Influenza pandemic: DOD combatant commands' preparedness efforts could benefit from more clearly defined roles, resources, and risk mitigation. GAO-07-696. Jul 20, 2007 [Full text]

GAO (US Government Accountability Office). Influenza pandemic: efforts to forestall onset are under way; identifying countries at greatest risk entails challenges. Released Jun 20, 2007 [Full text]

GAO (US Government Accountability Office). Influenza pandemic: efforts under way to address constraints on using antivirals and vaccines to forestall a pandemic. GAO-08-92. Released Jan 22, 2008 (but dated Dec 21, 2007) [Full text]

GAO (US Government Accountability Office). Influenza pandemic: federal agencies should continue to assist states to address gaps in pandemic planning. GAO-08-539. Released Jul 21, 2008 (but dated Jun 19) [Full text]

GAO (US Government Accountability Office). Influenza pandemic: federal executive boards' ability to contribute to pandemic preparedness. Senate testimony Sep 28, 2007 [Full text]

GAO (US Government Accountability Office). Influenza pandemic: further efforts are needed to ensure clearer federal leadership roles and an effective national strategy. GAO-07-781. August 14, 2007 [Full text]

GAO (US Government Accountability Office). Influenza pandemic: gaps in pandemic planning and preparedness need to be addressed. GAO 09-909T. July 29, 2009 [Full text]

GAO (US Government Accountability Office). Influenza pandemic: HHS needs to continue its actions and finalize guidance for pharmaceutical interventions. GAO-08-671. Sep 30, 2008 [Full text]

GAO (US Government Accountability Office). Influenza pandemic: increased agency accountability could help protect federal employees serving the public in the event of a pandemic. GAO 09-404. Released Jun 16, 2009 (but dated Jun 12) [Full text]

GAO (US Government Accountability Office). Influenza pandemic: monitoring and assessing the status of the national pandemic implementation plan needs improvement. GAO-10-73. Released Dec 14, 2009 (but dated Nov 24) [Full text]

GAO (US Government Accountability Office). Influenza pandemic: opportunities exist to address critical infrastructure protection challenges that require federal and private sector coordination. GAO-08-36. Released Oct 31, 2007 [Full text]

GAO (US Government Accountability Office). Influenza pandemic: opportunities exist to clarify federal leadership roles and improve pandemic planning. Testimony before the Subcommittee on Emerging Threats, Cybersecurity, and Science and Technology, House Committee on Homeland Security. GAO-07-1257T. September 26, 2007 [Full text]

GAO (US Government Accountability Office). Influenza pandemic: sustaining focus on the nation's planning and preparedness efforts. GAO-09-334. Released Mar 6, 2009 (but dated Feb 26) [Full text]

GAO (US Government Accountability Office). Veterinarian workforce: actions are needed to ensure sufficient capacity for protecting public and animal health. GAO-09-178. Released Feb 18, 2009 [Full text]

Gao W, Soloff AD, Lu X, et al. Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization. J Virol 2006 Feb;80(4):1959-64 [Abstract]

Garcia-Sastre A, Whitley RJ. Lessons learned from reconstructing the 1918 influenza pandemic. J Infect Dis 2006 Nov 1;194(suppl 2):S127-32 [Abstract]

Garcia-Sastre A. Antiviral response in pandemic influenza viruses. Emerg Infec Dis 2006 Jan;12(1):44-7 [Full text]

Garrett L, Fidler DP. Sharing H5N1 viruses to stop a global influenza pandemic. (Commentary) PLoS Med 2007 (published online Nov 20) [Full text]

Garrett L. The next pandemic? Foreign Aff 2005 Jul/Aug;84(4) [Excerpt]

Garrett TA. Pandemic economics: the 1918 influenza and its modern-day implications. Review (Federal Reserve Bank of St Louis) 2008 Mar/Apr;90(2):74-94 [Full text]

Gasink LB, Linkin DR, Fishman NO, et al. Stockpiling drugs for an avian influenza outbreak: examining the surge in osteltamivir prescriptions during heightened media coverage of the potential for a worldwide pandemic. Infect Control Hosp Epidemiol 2009 (published online Feb 23) [Abstract]

Gatrad AR, Shafi S, Memish ZA, et al. Hajj and the risk of influenza (Editorial). BMJ 2006 Dec 9;333(7580):1182-3 [Extract]

Gayer M, Watson JT, Connolly MA. Displaced populations and pandemic influenza. Lancet Infect Dis 2006 Dec;6(12):755-6 [Full text - Free registration required]

Ge J, Deng D, Wen Z, et al. Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses. J Virol 2007 Jan;81(1):150-8 [Abstract]

General Medical Council (UK). Pandemic influenza: good medical practice: responsibilities of doctors in a national pandemic. Oct 2009 [Full text]

Gensheimer KF, Fukuda K, Brammer L, et al. Preparing for pandemic influenza: the need for enhanced surveillance. Vaccine 2002 May 15;20 Suppl 2:S63- [Abstract]

Gerberding JL. Pandemic preparedness: pigs, poultry, and people versus plans, products, and practice. J Infect Dis 2006 Nov 1;194(suppl 2):S77-81 [Abstract]

Germann TC, Kadau K, Longini IM Jr, et al. Mitigation strategies for pandemic influenza in the United States. Proc Natl Acad Sci 2006 Apr 11;103(15):5935-40 [Abstract]

Germann TC, Kadau K, Longini IR, et al. Mitigation strategies for pandemic influenza in the United States. Proc Natl Acad Sci 2006 (published online Apr 3) [Abstract]

Gerrard J, Keijzers G, Zhang P, et al. Clinical diagnostic criteria for isolating patients admitted to hospital with suspected pandemic influenza. (Letter) Lancet 2009 Nov 14;374(9702):1673 [Full text]

Ghedin E, Sengamalay NA, Shumway M, et al. Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolution. Nature 2005 Oct 20;437(7062):1162-6 [Abstract]

Giacomet V, Tarallo L, De Marco G, et al. Preparing for an influenza pandemic in Italy: resources and procedures in paediatric hospital units. Eurosurveillance Monthly 2007 Jul-Aug;12(7-8) (published online Aug 10) [Full text]

Gillim-Ross L, Santos C, Chen Z, et al. Avian influenza H6 viruses productively infect and cause illness in mice and ferrets. J Virol 2008 Nov;82(21):10854-63 [Abstract]

Gilsdorf A, Boxall N, Gasimov B, et al. Two clusters of human infection with influenza A/H5N1 virus in the Republic of Azerbaijan, February-March 2006. Eurosurveillance Monthly 2006 May;11(5) [Full text]

Glass K, Barnes B. How much would closing schools reduce transmission during an influenza pandemic? Epidemiology 2007 Sep;18(5):623-8 [Abstract]

Glass LM, Glass RJ. Social contact networks for the spread of pandemic influenza in children and teenagers. BMC Public Health 2008;8:61 (published online Feb 14) [Abstract]

Glass RJ, Glass LM, Beyeler WE. Targeted social distancing design for pandemic influenza. Emerg Infect Dis 2006 Nov;12(11) (published online Oct 6) [Full text]

Glezen WP. Emerging infections: pandemic influenza. Epidemiol Rev 1996;18(1):64-76

Goji NA, Nolan C, Hill H, et al. Immune responses of healthy subjects to a single dose of intramuscular inactivated influenza A/Vietnam/1203/2004 (H5N1) vaccine after priming with an antigenic variant. J Infect Dis 2008 (published online Jun 24) [Abstract]

Goldrick BA, Goetz AM. Pandemic influenza: what infection control professionals should know. Am J Infect Control 2007 Feb;35(1):7-13 [Abstract]

Goldstein E, Dushoff J, Ma J, et al. Reconstructing influenza incidence by deconvolution of daily mortality time series. Proc Natl Acad Sci 2009 (published online Dec 18) [Abstract]

Gostin L. Public health strategies for pandemic influenza. (Commentary) JAMA 2006 Apr 12;295(14):1700-4 [Extract]

Gostin LO. Influenza A(H1N1) and pandemic preparedness under the rule of international law. (Commentary) JAMA 2009 Jun 10;301(22):2376-8 [Extract]

Gostin LO. Medical countermeasures for pandemic influenza: ethics and the law. JAMA 2006 Feb 1;295(5):554-6 [Extract]

Govorkova EA, Ilyushina NA, McClaren JL, et al. Susceptibility of highly pathogenic H5N1 influenza viruses to the neuraminidase inhibitor oseltamivir differs in vitro and in a mouse model. Antimicrob Agents Chemother 2009 Jul 1;53(7):3088-96 [Abstract]

Govorkova EA, Webby RJ, Humberd J, et al. Immunization with reverse-genetics-produced H5N1 influenza vaccine protects ferrets against homologous and heterologous challenge. J Infect Dis 2006 Jul 15;194(2):159-67 [Full text - See also Hampson below]

Grais RF, Ellis JH, Glass GE. Assessing the impact of airline travel on the geographic spread of pandemic influenza. Eur J Epidemiol 2003;18(11):1065-72 [Abstract]

Gray GC, Baker WS. The importance of including swine and poultry workers in influenza vaccination programs. Clin Pharmacol Ther 2007 Dec;82(6):638-41 [Abstract]

Gray GC, Kayali G. Facing pandemic influenza threats: the importance of including poultry and swine workers in preparedness plans. Poult Sci 2009 Apr;88(4):880-5 [Abstract]

Gray GC, Trampel DW, Roth JA. Pandemic influenza planning: Shouldn't swine and poultry workers be included? Vaccine 2007 May 30;25(22):4376-81 [Abstract]

Grayson ML, Melvani S, Druce J, et al. Efficacy of soap and water and alcohol-based hand-rub preparations against live H1N1 influenza virus on the hands of human volunteers. Clin Infect Dis 2008 (published online Dec 30) [Abstract]

Greatorex JS, Page RF, Curran MD, et al. Effectiveness of common household cleaning agents in reducing the viability of human influenza A/H1N1. PLoS One 2010 Feb 1;5(2):e8987 [Full text]

Green MD, Nettey H, Wirtz RA. Determination of oseltamivir quality by colorimetric and liquid chromatographic methods. Emerg Infect Dis 2008 Apr (published online Mar 5) [Full text]

Griffin BA, Jain AK, Davies-Cole J, et al. Early detection of influenza outbreaks using the DC Department of Health's syndromic surveillance system. BMC Public Health 2009 (published online Dec 22) [Abstract]

Gronvall GK, Borio LL. Removing barriers to global pandemic influenza vaccination. Biosec Bioterr 2006 Jun;4(2):168-75 [Abstract]

Gronvall GK, Smith BT, Matheny J, et al. Biomedical Advanced Research and Development Authority (BARDA) roundtable. Biosecur Bioterror 2007 Jun;5(2):174-9 [Full text]

Gross PA. Preparing for the next influenza pandemic: a reemerging infection. Ann Intern Med 1996;124(7):682-5 [Full text]

Grotto AJ, Tucker JB. Biosecurity: a comprehensive action plan. Center for American Progress. Jun 2006 [Full text]

Gu J, Xie Z, Gao Z, et al. H5N1 infection of the respiratory tract and beyond: a molecular pathology study. Lancet 2007 Sep 29;370(9593):1137-45 [Full text]

Guan Y, Chen H, Li KS, et al. A model to control the epidemic of H5N1 influenza at the source. BMC Infect Dis 2007;7:132 (published online Nov 13) [Abstract]

Guan Y, Poon LLM, Cheung CY, et al. H5N1 influenza: a protean pandemic threat. Proc Natl Acad Sci 2004 May 25;101(21):8156-61 [Abstract]

Gumel AB, Nuno M, Chowell G. Mathematical assessment of Canada's pandemic influenza preparedness plan. Can J Infect Dis Med Microbiol 2008 Mar/Apr;19(2):185-92 [Abstract]

Gupta RK, George R, Nguyen-Van-Tam JS. Bacterial pneumonia and pandemic influenza planning. (Perspectives) Emerg Infect Dis 2008 Aug;14(8) (published online Jul 18) [Full text]

Guralnik M, Rosenbloom RA, Petteruti MP, et al. Limitations of current prophylaxis against influenza virus infection. Am J Ther 2007 Sep-Oct;14(5):449-54 [Abstract]

Gursky EA, Joint Task Force Civil Support Mass Fatality Working Group. A working group consensus statement on mass-fatality planning for pandemics and disasters. J Homeland Secur 2007 Jul 6 [Full text]

Gust ID, Hampson AW, Lavanchy D. Planning for the next pandemic of influenza. Rev Med Virol 2001 Jan-Feb;11(1):59-70 [Abstract]

Haber MJ, Shay DK, Davis XM, et al. Effectiveness of interventions to reduce contact rates during a simulated influenza pandemic. Emerg Infect Dis 2007 Apr;13(4) (published online Mar 5) [Full text]

Hall IM, Gani R, Hughes HE, et al. Real-time epidemic forecasting for pandemic influenza. Epidemiol Infect 2006, published online Aug 24 [Abstract]

Hall JN, Moore S, Shiell A, et al. Assessing the congruence between perceived connectivity and network centrality measures specific to pandemic influenza preparedness in Alberta. BMC Public Health 2010 Mar 10;10:124 [Abstract]

Halloran ME, Ferguson NM, Eubank S, et al. Modeling targeted layered containment of an influenza pandemic in the United States. Proc Natl Acad Sci 2008 (published online Mar 10) [Abstract, with link to free full text]

Hampson AW, Mackenzie JS. The influenza viruses. Med J Aust 2006 Nov 20;185(10 suppl):S39-43 [Full text]

Hampson AW. Ferrets and the challenges of H5N1 vaccine formulation. (Commentary) J Infect Dis 2006 Jul 15;194(2):143-5 [Full text - See also Govorkova above]

Hampson AW. Surveillance for pandemic influenza. J Infect Dis 1997 Aug;176(Suppl 1):S8-13 [Full text]

Hampson AW. Vaccines for pandemic influenza: the history of our current vaccines, their limitations and the requirements to deal with a pandemic threat. Ann Acad Med Singapore 2008 Jun;37(6):510-7 [Full text]

Handel A, Longini IM Jr, Antia R. Neuraminidase inhibitor resistance in influenza: assessing the danger of its generation and spread. PLoS Comp Biol 2007 Dec 7;3(12):e240 [Full text]

Hanson BJ, Boon AC, Lim AP, et al. Passive immunoprophylaxis and therapy with humanized monoclonal antibody specific for influenza A H5 hemagglutinin in mice. Respiratory Res 2006;7:126 (published online Oct 14) [Full text]

Haque A, Hober D, Kasper LH. Confronting potential influenza A (H5N1) pandemic with better vaccines. Emerg Infect Dis 2007 Oct;13(10):1512-8 [Full text]

Harper DR, Davies LM, Gadd EM, et al. Science into policy: preparing for pandemic influenza. J Public Health (Oxf) 2008 (published online Jul 4) [Full text with additional links]

Harrod ME, Emery E, Dwyer DE. Antivirals in the management of an influenza pandemic. Med J Aust 2006 Nov 20;185(10 suppl):S58-61 [Full text]

Hashikura M, Kizu J. Stockpile of personal protective equipment in hospital settings: preparedness for influenza pandemics. Am J Infect Control 2009 (published online Sep 14) [Abstract]

Hatchett RJ, Mecher CE, Lipsitch M. Public health interventions and epidemic intensity during the 1918 influenza pandemic. Proc Natl Acad Sci 2007 (published online Apr 6) [Abstract, with access to free full text]

Hatta M, Hatta Y, Kim JH, et al. Growth of H5N1 influenza A viruses in the upper respiratory tract of mice. PLoS Pathog 2007 Oct 5;3(10):e133 [Full text]

Hatta M, Kawaoka Y. The continued pandemic threat posed by avian influenza viruses in Hong Kong. Trends Microbiol 2002 Jul;10(7):340-4 [Abstract]

Haug A, Brand-Miller JC, Christophersen OA, et al. A food "lifeboat": food and nutrition considerations in the event of a pandemic or other catastrophe. Med J Aust 2007 Dec 3/17;187(11/12):674-6 [Full text]

Hayden F, Croisier A. Transmission of avian influenza viruses to and between humans. (Commentary) J Infect Dis 2005 Oct 15;192(8):1311-4 [Full text - See also Puzelli below]

Hayden FG, Cote KM, Douglas RG Jr. Plaque inhibition assay for drug susceptibility testing of influenza viruses. Antimicrob Agents Chemother 1980 May;17(5):865-70 [Full text]

Hayden FG, Howard WA, Palkonyay L, et al. Report of the 5th meeting on the evaluation of pandemic influenza prototype vaccines in clinical trials: World Health Organization, Geneva, Switzerland, 12-13 February 2009. Vaccine 2009 Jun 24;27(31):4079-89 [Abstract]

Hayden FG, Palese P. Influenza virus. In: Richman DD, Whitley RJ, Hayden FG, eds. Clinical virology. Ed. 2. Washington, DC: ASM Press, 2002

Hayden FG, Pavia AT. Antiviral management of seasonal and pandemic influenza. J Infect Dis 2006 Nov 1;194(suppl 2):S119-26 [Abstract]

Hayes HB. DHS offers advice for ensuring telecom during pandemic. Gov Health IT 2008 (published online Jan 1) [Full text]

Health Law & Policy Institute, University of Houston Law Center. Control measures and public health emergencies: a Texas bench book. 2008 [Full text]

Health Protection Agency and Health Protection Scotland New Influenza A(H1N1) Investigation Teams. Epidemiology of new influenza A(H1N1) in the United Kingdom, April-May 2009. Eurosurveill 2009 May 14;14(19):pi=19213 [Full text]

Heiny AT, Miotto O, Srinivasan KN, et al. Evolutionarily conserved protein sequences of influenza A viruses, avian and human, as vaccine targets. PLoS ONE 2007 Nov 21;2(11):e1190 [Full text]

Henderson DA, Courtney B, Inglesby TV, et al. Public health and medical responses to the 1957-58 influenza pandemic. Biosecur Bioterror 2009 (published online Aug 5) [Full text]

Henle W, Henle G, Stokes J, et al. Experimental exposure of human subjects to viruses of influenza. J Immunol 1946;52:145-65

Henrich N, Holmes B. The public's acceptance of novel vaccines during a pandemic: a focus group study and its application to influenza H1N1. Emerg Health Threats J 2009 Aug 21;2:e8 [Full text]

Herman B, Rosychuk RJ, Bailey T, et al. Medical students and pandemic influenza. Emerg Infect Dis 2007 Nov;13(11):1781-3 [Full text]

Herrmann B, Larsson C, Zweygberg BW. Simultaneous detection and typing of influenza viruses A and B by a nested reverse transcription-PCR: comparison to virus isolation and antigen detection by immunofluorescence and optical immunoassay (FLU OIA). J Clin Microbiol 2001 Jan;39(1):134-8 [Full text]

HHS Agency for Healthcare Research and Quality. Adapting community call centers for crisis support: a model for home-based care and monitoring. Oct 26, 2007 [Full text]

HHS Agency for Healthcare Research and Quality. Emergency preparedness atlas: US nursing home and hospital facilities. Released Jul 19, 2007 [Links to full text]

HHS Agency for Healthcare Research and Quality. Home health care during an influenza pandemic: issues and resources. AHRQ Publication No. 08-0018. Released Jul 8, 2008 [Full text]

HHS Agency for Healthcare Research and Quality. Nursing homes in public health emergencies: special needs and potential roles. Released Jul 19, 2007 [Links to full text]

HHS Office of Inspector General. Local pandemic influenza preparedness: vaccine and antiviral drug distribution and dispensing. Sep 21, 2009 [Full text]

HHS Office of Inspector General. State and local pandemic influenza preparedness: medical surge. Sep 21, 2009 [Full text]

HHS. Assessment of states' operating plans to combat pandemic influenza. Released Jan 15, 2009 [Full text]

HHS. Considerations for antiviral drug stockpiling by employers in preparation for an influenza pandemic. Dec 15, 2008 [Full text]

HHS. Control of pandemic flu virus on environmental surfaces in homes and public places. Fact sheet released May 28, 2008 [Full text]

HHS. Correctional facilities pandemic influenza planning checklist. Released Sep 21, 2007 [Full text]

HHS. Draft guidance on allocating and targeting pandemic influenza vaccine. Released Oct 23, 2007 [Full text]

HHS. Guidance on antiviral drug use during an influenza pandemic. Dec 15, 2008 [Full text]

HHS. HIPAA privacy rule: disclosures for emergency preparedness - a decision tool. Released Jul 5, 2006 [Full text]

HHS. Influenza pandemics: how they start, how they spread, and their potential impact. National Vaccine Program Office [Webpage]

HHS. Interim guidance for cargo trucking crews for the prevention of pandemic influenza. Mar 23, 2009 [Full text]

HHS. Interim guidance on cleaning transit vehicles and facilities during a pandemic. Mar 11, 2009 [Full text of a number of documents]

HHS. Interim guidance on planning for the use of surgical masks and respirators in health care settings during an influenza pandemic. Oct 17, 2006 [Full text]

HHS. Interim guidance on the use and purchase of facemasks and respirators by individuals and families for pandemic influenza preparedness. May 28, 2008 [Full text]

HHS. Law enforcement pandemic influenza planning checklist. Released Sep 21, 2007 [Full text]

HHS. National health security strategy of the United States of America. Released Dec 29, 2009 [Full text]

HHS. Obama Administration calls on nation to begin planning and preparing for fall flu season & the new H1N1 virus. Jul 9, 2009, press release [Full text]

HHS. Pandemic and All-Hazards Preparedness Act progress report. Released Oct 31, 2007 [Full text]

HHS. Pandemic influenza implementation plan. Released Dec 18, 2006 [Full text]

HHS. Pandemic influenza plan. Released Nov 2, 2005 [Links to overview and full text]

HHS. Pandemic influenza planning: a guide for individuals and families. Jan 2006 [Full text]

HHS. Pandemic planning update II. A report from Secretary Michael O. Leavitt. Jun 29, 2006 [Full text]

HHS. Pandemic planning update III: a report from Secretary Michael O. Leavitt. Nov 13, 2006 [Full text]

HHS. Pandemic planning update IV: a report from Secretary Michael O. Leavitt. Jul 18, 2007 [Full text]

HHS. Pandemic planning update VI: a report from Secretary Michael O. Leavitt. Jan 8, 2009 [Full text]

HHS. Pandemic planning update: a report from Secretary Michael O. Leavitt. Mar 13, 2006 [Full text]

HHS. Pandemic update V: a report from Secretary Michael O. Leavitt. Mar 17, 2008 [Full text]

HHS. PandemicFlu.gov [Webpage]

HHS. Proposed considerations for antiviral drug stockpiling by employers in preparation for an influenza pandemic. May 28, 2008 [Full text]

HHS. Proposed guidance on antiviral drug use during an influenza pandemic. May 28, 2008 [Full text]

HHS. Tabletop exercises for pandemic influenza preparedness in local public health agencies. Dec 5, 2006 [Full text]

HHS. Transcript of press briefing on the US government's HHS Pandemic Influenza Plan. Nov 2, 2005 [Full text]

HHS/DHS. Guidance on allocating and targeting pandemic influenza vaccine. Jul 23, 2008 [Full text]

Hick JL, O'Laughlin DT. Concept of operations for triage of mechanical ventilation in an epidemic. Acad Emerg Med 2006 Feb;13(2):223-9 [Abstract]

Hickman D, Hossain MJ, Song H, et al. An avian live attenuated master backbone for potential use in epidemic and pandemic influenza vaccines. J Gen Virol 2008 Nov;89(11):2682-90 [Full text]

Hien TT, de Jong M, Farrar J. Avian influenza: a challenge to global health care structures. N Engl J Med 2004 Dec 2;351(23):2363-5 [Extract]

Higgs ES, Hayden FG, Chotpitayasunondh T, et al. The Southeast Asian Influenza Clinical Research Network: development and challenges for a new multilateral research endeavor. Antiviral Res 2008 Apr;78(1):64-68 [Abstract]

Hill AW, Guralnick RP, Wilson MJC, et al. Evolution of drug resistance in multiple distinct lineages of H5N1 avian influenza. Infect Genet Evol 2008 (published online Oct 30) [Abstract]

Hodge JG Jr, Bhattacharya D, Gray J. Legal preparedness for school closures in response to pandemic influenza and other emergencies: a review and report submitted to the Centers for Disease Control and Prevention. Apr 2008 report from Center for Law & the Public Health [Full text]

Hodge JG Jr, Gostin LO, Vernick JS. The Pandemic and All-Hazards Preparedness Act: improving public health emergency response. (Commentary) JAMA 2007 Apr 18;297(15):1708-11 [Extract]

Hoelscher MA, Jayashankar L, Garg s, et al. New pre-pandemic influenza vaccines: an egg- and adjuvant-independent human adenoviral vector strategy induces long-lasting protective immune responses in mice. Clin Pharmacol Ther 2007 Dec;82(6):665-71 [Full text]

Hoelscher MA, Singh N, Garg S, et al. A broadly protective vaccine against globally dispersed clade 1 and clade 2 H5N1 influenza viruses. J Infect Dis 2008 (published online Mar 18) [Abstract]

Hoffman DR, Nannini A. Planning, surveillance, and reporting for pandemic influenza: a briefing for advance practice nurses. J Am Acad Nurse Pract 2008 Jan;20(1):11-6 [Abstract]

Hollingsworth TD, Ferguson NM, Anderson RM. Frequent travelers and rate of spread of epidemics. Emerg Infect Dis 2007 Sep;13(9):1288-94 [Full text]

Holman DH, Wang D, Raja NU, et al. Multi-antigen vaccines based on complex adenovirus vectors induce protective immune responses against H5N1 avian influenza viruses. Vaccine 2008 May 19;26(21):2627-39 [Abstract]

Holmberg SD, Layton CJ, Ghneim G, et al. State plans for containment of pandemic influenza. Emerg Infect Dis 2006 Sep;12(9) [Full text]

Holodniy M, Penzak SR, Straight TM, et al. Pharmacokinetics and tolerability of oseltamivir combined with probenecid. Antimicrob Agents Chemother 2008 Sep;52(9):3013-21 [Abstract]

Hom GG, Chous AP. The prospect of pandemic influenza: why should the optometrist be concerned about a public health problem? Optometry 2007 Dec;78(12):629-43 [Abstract]

Home Office (UK). Planning for a possible influenza pandemic: a framework for planners preparing to manage deaths. Aug 30, 2007 [Full text]

Horimoto T, Kawaoka Y. Pandemic threat posed by avian influenza A viruses. Clin Microbiol Rev 2001 Jan;14(1):129-49 [Abstract]

Horimoto T, Murakami S, Muramoto Y, et al. Enhanced growth of seed viruses for H5N1 influenza vaccines. Virology 2007 Sep 15;366(1):23-7 [Abstract]

Horstick O, Kaiser R, Ciotti M, et al. Europe makes progress in preparing for influenza pandemic, but further work needed. Eurosurveillance Weekly 2005 Nov 17;10(11) [Full text]

Horvath JS, McKinnon M, Roberts L. The Australian response: pandemic influenza preparedness. Med J Aust 2006 Nov 20;185(10 suppl):S35-8 [Full text]

Hossain MJ, Hickman D, Perez DR. Evidence of expanded host range and mammalian-associated genetic changes in a duck H9N2 influenza virus following adaptation in quail and chickens. PLoS ONE 2008 Sep 9;3(9):e3170 [Full text]

Hsieh YH, Cheng YS. Real-time forecast of multiphase outbreak. Emerg Infect Dis 2006 Jan;12(1) [Full text]

Hsieh YH. Excess deaths and immunoprotection during 1918-1920 influenza pandemic, Taiwan. Emerg Infect Dis 2009 Oct;15(10):1617-9 [Full text]

Hsu EB, Millin MG. A hospital-based strategy for setting priorities for antiviral prophylaxis during an influenza pandemic. Biosecur Bioterror 2008 Jun;6(2):171-8 [Abstract]

Hui DS, Chow BK, Chu LCY, et al. Exhaled air and aerosolized droplet dispersion during application of a jet nebulizer. Chest 2009 Mar;135(3):648-54 [Abstract]

Hulse-Post DJ, Sturm-Ramirez KM, Humberd J, et al. Role of domestic ducks in the propagation and biological evolution of highly pathogenic H5N1 influenza viruses in Asia. Proc Natl Acad Sci 2005 Jul 26;102(30) [Abstract]

Ichinohe T, Tamura SI, Kawaguchi A, et al. Cross-protection against H5N1 influenza virus infection is afforded by intranasal inoculation with seasonal trivalent inactivated influenza vaccine. J Infect Dis 2007 Nov 1;196(9):1313-20 [Abstract]

IDSA (Infectious Diseases Society of America). Detailed comments on the core document and annexes of the HHS pandemic preparedness and response plan. Oct 26, 2004 [Full text]

IDSA (Infectious Diseases Society of America). Pandemic and seasonal influenza principles for US action. Released Jan 25, 2007 [Full text]

India Press Information Bureau. A vison and road map. Document released at the close of 3-day international conference on avian flu. Dec 6, 2007 [Full text]

Influenza team, ECDPC. Influenza transmission: research needs for informing infection control policies and practice. Eurosurveillance Weekly 2007 May 10;12(5):E070510.1 [Full text]

Inglesby TV, Nuzzo JB, O'Toole T, et al. Disease mitigation measures in the control of pandemic influenza. Biosecurity Bioterrorism 2006 Dec;4(4) [Full text]

IOM (Institute of Medicine). Respiratory protection for healthcare workers in the workplace against novel H1N1 influenza A. Sep 3, 2009 [Full text]

IOM (Institute of Medicine). Antivirals for pandemic influenza: guidance on developing a distribution and dispensing program. Released Apr 25, 2008 [Link to full text]

IOM (Institute of Medicine). Medical surge capacity: workshop summary. Jan 28, 2010 [Abstract]

IOM (Institute of Medicine). Modeling community containment for pandemic influenza: a letter report. Released Dec 11, 2006 [Full text]

IOM (Institute of Medicine). Preparing for an influenza pandemic: personal protective equipment for healthcare workers. Sep 18, 2007 [Full text - prepublication proof]

IOM (Institute of Medicine). Research priorities in emergency preparedness and response for public health systems: a letter report. Jan 22, 2008 [Links to free full text]

IOM (Institute of Medicine). Review of the DoD-GEIS influenza programs: strengthening global surveillance and response. Sep 25, 2007 [Full text]

IOM (Institute of Medicine). The domestic and international impacts of the 2009-H1N1 influenza A pandemic: global challenges, global solutions. Dec 29, 2009 [Links to full text]

IOM (Institute of Medicine). The threat of pandemic influenza: are we ready? 2005 [Full text]

IOM. Hospital-based emergency care: at the breaking point. Prepublication proof. Jun 14, 2006 [Full text]

IOM. Reusability of facemasks during an influenza pandemic: facing the flu. Apr 27, 2006 [Full text]

Ip M, Tang JW, Hui DSC, et al. Airflow and droplet spreading around oxygen masks: a simulation model for infection control research. Am J Infect Control 2007 Dec;35(10):684-9 [Abstract]

Irish Council for Bioethics. Ethical dilemmas in a pandemic: proceedings of the Irish Council for Bioethics Conference, 17th October 2006, Dublin. Released Aug 22, 2007 [Full text]

Irvin CB, Cindrich L, Patterson W, et al. Survey of hospital healthcare personnel response during a potential avian influenza pandemic: will they come to work? Prehosp Disaster Med 2008 Jul-Aug;23(4):328-35 [Full text]

Itzwerth RL, MacIntyre CR, Shah S, et al. Pandemic influenza and critical infrastructure dependencies: possible impact on hospitals. Med J Aust 2006 Nov 20;185(10 suppl):S70-2 [Full text]

Ives J, Greenfield S, Parry JM, et al. Healthcare worker's attitudes to working during pandemic influenza: a qualitative study. BMC Public Health 2009 Feb 12;9:56 [Abstract]

Jadhao SJ, Achenbach J, Swayne DE, et al. Development of Eurasian H7N7/PR8 high growth reassortant virus for clinical evaluation as an inactivated pandemic influenza vaccine. Vaccine 2008 Mar 25;26(14):1742-50 [Abstract]

Jefferson T, Demicheli V, Rivetti D, et al. Antivirals for influenza in healthy adults: systematic review. Lancet 2006 Jan 28;367(9507):303-13 [Abstract]

Jefferson T, Foxlee R, Del Mar C, et al. Interventions for the interruption or reduction of the spread of respiratory viruses. Cochrane Database Syst Rev 2007 Oct 17;(4):CD006207 [Abstract]

Jefferson T, Foxlee R, Del Mar C, et al. Physical interventions to interrupt or reduce the spread of respiratory viruses: systematic review. BMJ 2008 Jan 12;336(7635):77-80 [Full text -- see Dawes editorial above]

Jennings LC, Monto AS, Chan PKS, et al. Stockpiling prepandemic influenza vaccines: a new cornerstone of pandemic preparedness plans. Lancet Infect Dis 2008 Oct;8(10):650-8 [Abstract]

Jin R, Lv Z, Chen Q, et al. Influenza vaccine based on baculovirus surface display system of Bombyx mori. PLoS ONE Dec 12;2(12):e3933 [Full text]

Johansson BE, Brett IC. Changing perspective on immunization against influenza. Vaccine 2007 Apr 20;25(16):3062-5 [Abstract]

Johnson AJ, Moore ZS, Edelson PJ, et al. Household responses to school closure resulting from outbreak of influenza B, North Carolina. Emerg Infect Dis 2008 Jul (published online May 28) [Full text]

Johnson DF, Druce JD, Birch C, et al. A quantitative assessment of the efficacy of surgical and N95 masks to filter influenza virus in patients with acute influenza infection. (Brief report) Clin Infect Dis 2009 Jul 15;49(2):275-7 [Abstract]

Johnson NP, Mueller J. Updating the accounts: global mortality of the 1918-1920 "Spanish" influenza pandemic. Bull Hist Med 2002 Spring;76(1):105-15 [Abstract]

Johnson VA. Mass fatality planning for pandemic influenza: a planning model from a seven-county region in Kentucky. J Public Health Manag Pract 2009 Mar-Ap;15(2):176-7 [Abstract]

Joint Commission. Providing a safer environment for health care personnel and patients through influenza vaccination: strategies from research and practice. Jun 24, 2009 [Full text]

Jones DA, Nozick LK, Turnquist MA, et al. Pandemic influenza, worker absenteeism and impacts on freight transportation. Proc 41st Hawaii Intl Conf Syst Sci 2008 (published online Apr 9) [Full text]

Jones JC, Turpin EA, Bultmann H, et al. Inhibition of influenza virus infection by a novel antiviral peptide that targets viral attachment to cells. J Virol 2006 Dec;80(24):11960-7 [Abstract]

Jones JC, Turpin EA, Bultmann H, et al. Inhibition of influenza virus infection by a novel antiviral peptide that targets viral attachment to cells. J Virol 2006, published online Sep 27 [Abstract]

Jones SC, Waters L, Holland O, et al. Developing pandemic communication strategies: preparation without panic. J Bus Res 2009 (published online Feb 27) [Abstract]

Kahn LH. Pandemic influenza school closure policies. (Letter) Emerg Infect Dis 2007 Feb;13(2) (published online Jan 5) [Full text]

Kaiser R, Coulombier D, Baldari M, et al. What is epidemic intelligence, and how is it being improved in Europe? Eurosurveillance Weekly 2006 Feb 2;11(2) [Webpage]

Kaiser R, Coulombier D. Epidemic intelligence during mass gatherings. Eurosurveillance Weekly 2006 Dec 21;11(12):E061221.3 [Full text]

Kaji AH, Lewis RJ. Hospital disaster preparedness in Los Angeles County. Acad Emerg Med 2006 Nov;13(11):1198-1203 [Abstract]

Kamigaki T, Oshitani H. Influenza pandemic preparedness and severity assessment of pandemic (H1N1) 2009 in South-east Asia. Public Health 2010 (published online Jan 19) [Full text]

Kamp C, Heiden M, Henseler O, et al. Management of blood supplies during an influenza pandemic. Transfusion 2009 (published online Dec 9) [Abstract]

Kandun IN, Wibisono H, Sedyaningsih ER, et al. Three Indonesian clusters of H5N1 virus infection in 2005. N Engl J Med 2006 Nov 23;355(21):2186-94 [Full text]

Kang SM, Yoo DG, Lipatov AS, et al. Induction of long-term protective immune responses by influenza H5N1 virus-like particles. PLoS ONE 2009 Mar 2;4(3):e4667 [Abstract]

Karron RA, Callahan K, Luke C, et al. A live attenuated H9N2 influenza vaccine is well tolerated and immunogenic in healthy adults. J Infect Dis 2009 Mar 1;199(5):711-6 [Abstract]

Kash JC, Tumpey TM, Proll SC, et al. Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature 2006 Oct5;443(7111):578-81 [Abstract]

Kass N, Otto J, O'Brien D, et al. Ethics and severe pandemic influenza: maintaining essential functions through a fair and considered response. Biosecur Bioterr 2008 Sep;6(3):227-36 [Abstract]

Katz A, Staiti AB, McKenzie KL. Preparing for the unknown, responding to the known: communities and public health preparedness. Health Aff 2006 Jul/Aug;25(4):946-57 [Abstract]

Katz JM, Veguilla V, Belser JA, et al. The public health impact of avian influenza viruses. Poult Sci 2009 Apr;88(4):872-9 [Abstract]

Kawana A, Naka G, Fujikura Y, et al. Spanish influenza in Japanese armed forces, 1918-1920. Emerg Infect Dis 2007 Apr;13(4) (published online Mar 5) [Full text]

Kayali G, Ortiz EJ, Chorazy ML, et al. Evidence of previous avian influenza infection among US turkey workers. Zoonoses Public Health 2009 (published online Apr 8) [Abstract]

Keawcharoen J, Oraveerakul K, Kuiken T, et al. Avian influenza H5N1 in tigers and leopards. Emerg Infect Dis 2004 Dec;10(12) [Full text]

Keitel WA, Campbell JD, Treanor JJ, et al. Safety and immunogenicity of an inactivated influenza A/H5N1 vaccine given with or without aluminum hydroxide to healthy adults: results of a phase I-II randomized clinical trial. J Infect Dis 2008 (published online Sep 22) [Abstract]

Kelen GD, Kraus CK, McCarthy ML, et al. Inpatient disposition classification for the creation of hospital surge capacity: a multiphase study. Lancet 2006 Dec 2;368(9551):1984-90 [Abstract]

Kelly H, Mercer GN, Cheng AC. Quantifying the risk of pandemic influenza in pregnancy and indigenous people in Australia in 2009. Eurosurveill 2009 Dec 17;14(50):2 [Full text]

Kelso JK, Milne GJ, Kelly H. Simulation suggests that rapid activation of social distancing can arrest epidemic development due to a novel strain of influenza. BMC Public Health 2009 Apr 29;9:117 [Abstract]

Kerneis S, Grais RF, Boelle PY, et al. Does the effectiveness of control measures depend on the influenza pandemic profile? PLoS ONE 2008 Jan 23;3(1):e1478 [Full text]

Kessler N, Ferraris O, Palmer K, et al. Use of the DNA flow-thru chip, a three-dimensional biochip, for typing and subtyping of influenza viruses. J Clin Microbiol 2004 May;42(5):2173-85 [Full text]

Khazeni N, Bravata DM, Holty JEC, et al. Safety and efficacy of extended-duration antiviral chemoprophylaxis against pandemic and seasonal influenza. Ann Intern Med 2009 Oct 6 (published online Aug 4) [Full text]

Khazeni N, Hutton DW, Garber AM, et al. Effectiveness and cost-effectiveness of expanded antiviral prophylaxis and adjuvanted vaccination strategies for an influenza A (H5N1) pandemic. Ann Intern Med 2009 Dec 15;151(12) (published online Oct 6) [Full text]

Kilbourne ED. Influenza pandemics of the 20th century. Emerg Infec Dis 2006 Jan;12(1):9-14 [Full text]

Kilbourne ED. Influenza pandemics: can we prepare for the unpredictable? Viral Immunol 2004;17(3):350-7 [Abstract]

Kilpatrick AM, Chmura AA, Gibbons DW, et al. Predicting the global spread of H5N1 avian influenza. Proc Natl Acad Sci 2006 (published online Dec 7) [Abstract]

Klaiman TA, Ibrahim J, Hausman A. Do state written pandemic plans include Federal recommendations? A National study. J Homeland Secur Emerg Manage 2009 Jun 20;6(1):article 44 [Full text]

Kleinman AM, Bloom BR, Saich A, et al. Avian and pandemic influenza: a biosocial approach. J Infect Dis 2008 Feb 15;197(S1):S1-S3 [Abstract]

Klempner MS, Shapiro DS. Crossing the species barrier: one small step to man, one giant leap to mankind. (Perspective) N Engl J Med 2004 Mar 18;350(12):1171-2 (See also Hien above) [Extract]

Klugman KP, Astley CM, Lipsitch M. Time from illness onset to death, 1918 influenza and pneumococcal pneumonia. (Letter) Emerg Infect Dis 2009 Feb;15(2):346 [Full text]

Kobasa D, Jones SM, Shinya K, et al. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature 2007 Jan 18;445(7125):319-23 [Abstract]

Kobasa D, Takada A, Shinya K, et al. Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature 2004 Oct 7;431(7009):703-7 [Abstract]

Kochs G, Garcia-Sastre A, Martinez-Sobrido L. Multiple anti-interferon actions of the influenza A virus NS1 protein. J Virol 2007 Jul;81(13):7011-21 [Abstract]

Koh GCH, Yee WT, Kwing CS, et al. Avian influenza: a global threat needing a global solution. (Commentary) Asia Pacific Fam Med 2008 Nov 13;7:5 [Abstract]

Kong W-P, Hood C, Yang Z-Y, et al. Protective immunity to lethal challenge of the 1918 pandemic influenza virus by vaccination. Proc Natl Acad Sci 2006 (published online Oct 16) [Abstract]

Kotwal GJ. Genetic diversity-independent neutralization of pandemic viruses (eg, HIV), potentially pandemic (eg, H5N1 strain of influenza) and carcinogenic (eg, HBV and HCV) viruses, and possible agents of bioterrorism (variola) by enveloped virus neutralizing compounds (EVNCs). Vaccine 2008 Jun 6;26(24):3055-8 [Abstract]

Krasnitz M, Levine AJ, Rabadan R. Anomalies in the influenza virus genome database: new biology or laboratory errors? J Virol 2008 Sep;82(17):8947-50 [Abstract]

Krause R. Swine flu and the fog of epidemics. Emerg Infec Dis 2006 Jan;12(1):40-3 [Full text]

Kreijtz JH, Bodewes R, van Amerongen G, et al. Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice. Vaccine 2007 Jan 8;25(4):612-20 [Abstract]

Kreijtz JH, de Mutsert G, van Baalen CA, et al. Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus. J Virol 2008 Jun;82(11):5161-66 [Abstract]

Kreijtz JH, Osterhaus AS, Rimmelzwaan GF. Vaccination strategies and vaccine formulations for epidemic and pandemic influenza. Hum Vaccines 2009 Mar;5(3):13-22 [Abstract]

Kuiken T, Taubenberger JK. Pathology of human influenza revisited. Vaccine 2008 Sep 12;26(suppl 4):D59-66 [Full text]

Kuntz JL, Holley S, Helms CM, et al. Use of a pandemic preparedness drill to increase rates of influenza vaccination among healthcare workers. Infect Control Hosp Epidemiol 2008 Feb;29(2):111-5 [Abstract]

Lackenby A, Thompson CI, Democratis J. The potential impact of neuraminidase inhibitor resistant influenza. Curr Opin Infect Dis 2008 Dec;21(6):626-38 [Abstract]

Lam C, Waldhorn R, Toner E, et al. The prospect of using alternative medical care facilities in an influenza pandemic. Biosecur Bioterror 2006 Dec;4(4):384-90 [Abstract]

Lam PY. Avian influenza and pandemic influenza preparedness in Hong Kong. Ann Acad Med Singapore 2008 Jun;37(6):489-96 [Full text]

Lam TTY, Hon CC, Pybus OG, et al. Evolutionary and transmission dynamics of reassortant H5N1 influenza virus in Indonesia. PLoS Pathog 2008 Aug 22;4(8):e1000130 [Full text]

Lancet Staff. Swine influenza: how much of a global threat? (Editorial) Lancet 2009 (published online Ap 29) [Full text - free access with registration]

Larson RC. Simple models of influenza progression within a heterogeneous population. Oper Res 2007 May-Jun;55(3):399-412 [Full text]

Lau YF, Tang LH, Ooi EE. A TLR3 ligand that exhibits potent inhibition of influenza virus replication and has strong adjuvant activity has the potential for dual applications in an influenza pandemic. Vaccine 2009 Feb 25;27(9):1354-64 [Abstract]

Lauer J, Kastner J, Nutsch A. Primary care physicians and pandemic influenza: an appraisal of the 1918 experience and an assessment of contemporary planning. J Public Health Manag Pract 2008 Jul-Aug;14(4):379-86 [Abstract]

Lautenbach E, Saint S, Henderson DK, et al. Initial response of health care institutions to emergence of H1N1 influenza: experiences, obstacles, and perceived future needs. Clin Infect Dis 2010 (published online Jan 11) [Abstract]

Laver G, Garman E. Pandemic influenza: its origin and control. Microbes Infect 2002 Nov;4(13):1309-16 [Abstract]

Layne SP, Monto AS, Taubenberger JK. Pandemic influenza: an inconvenient mutation. (Letter) Science 2009 Mar 20;323(5921):1560-1 [Full text]

Le QM, Kiso M, Someya K, et al. Isolation of drug-resistant H5N1 virus. Nature 2005 Oct 20;437:1108 [Abstract]

Leask J, Chapman S, Hawe P, et al. What maintains parental support for vaccination when challenged by anti-vaccination messages? A qualitative study. Vaccine 2006 Nov 30;4(49-50):7238-45 [Abstract]

Lee MC, Takaya S, Long R, et al. Respirator-fit testing: does it ensure the protection of healthcare workers against respirable particles carrying pathogens? Infect Control Hosp Epidemiol 2008 (published online Nov 3) [Abstract]

Lee VJ, Chen MI, Chan SP, et al. Influenza pandemics in Singapore, a tropical, globally connected city. Emerg Infect Dis 2007 Jul;13(7):1052-7 [Full text]

Lee VJ, Chen MI. Effectiveness of neuraminidase inhibitors for preventing staff absenteeism during pandemic influenza. Emerg Infect Dis 2007 Mar;13(3) (published online Feb 5) [Full text]

Lee VJ, Phua KJ, Chen MI, et al. Economics of neuraminidase inhibitor stockpiling for pandemic influenza, Singapore. Emerg Infect Dis 2006 Jan;12(1) [Full text]

Legastelois I, Garcia-Sastre A, Palese P, et al. Preparation of genetically engineered A/H5N1 and A/H7N1 pandemic vaccine viruses by reverse genetics in a mixture of Vero and chicken embryo cells. Influenza Other Respir Virus 2007 (published online Jul 26) [Full text]

Lemieux C, Brankston G, Gitterman L, et al. Questioning aerosol transmission of influenza. (Letter) Emerg Infect Dis 2007 Jan;13(1) (published online Dec 8) [Full text]

Lemon SM, Hamburg MA, Sparling PF, et al. Ethical and Legal Considerations in Mitigating Pandemic Disease: Workshop Summary. Book from Board on Global Health and Institute of Medicine released Jun 11, 2007 [Full text]

Leroux-Roels I, Bernhard R, Gerard P, et al. Broad clade 2 cross-reactive immunity induced by an adjuvanted clade 1 rH5N1 pandemic influenza vaccine. PLoS ONE 2008 Feb 27;3(2):e1665 [Full text]

Leroux-Roels I, Leroux-Roels G. Current status and progress of prepandemic and pandemic influenza vaccine development. Expert Rev Vaccines 2009 Apr;8(4):401-23 [Abstract]

Leroux-Roels K, Borkowski A, Vanwolleghem T, et al. Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial. Lancet 2007 Aug 18;370(9587):580-9 [Abstract - Free registration required]

Levie K, Leroux-Roels I, Hoppenbrouwers K, et al. An adjuvanted, low-dose, pandemic influenza A (H5N1) vaccine candidate is safe, immunogenic, and induces cross-reactive immune responses in healthy adults. J Infect Dis 2008 (published online Jun 24) [Abstract]

Levine R. A cure for the Asian flu. (Commentary) Biosecurity Bioterrorism 2006 Sep;4(3):228-30 [Full text]

Li C, Hatta M, Nidom CA, et al. Reassortment between avian H5N1 and human H3N2 influenza viruses creates hybrid viruses with substantial virulence. Proc Natl Acad Sci 2010 (published online Feb 22) [Abstract]

Li KS, Guan Y, Wang J, et al. Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature 2004 Jul 8;430:209-13 [Abstract]

Li KS, Xu KM, Peiris JS, et al. Characterization of H9 subtype influenza viruses from the ducks of southern China: a candidate for the next influenza pandemic in humans? J Virol 2003 Jun;77(12):6988-94 [Full text]

Li Z, Jiang Y, Jiao P, et al. The NS1 gene contributes to the virulence of H5N1 avian influenza virus. J Virol 2006 Nov;80(22):11115-23 [Abstract]

Lien O, Franco C, Gronvall GK, et al. Getting medicine to millions in a public health emergency: can retailers play a role? From University of Pittsburgh Medical Center. 2005 [Full text]

Lien O, Maldin B, Franco C, et al. Getting medicine to millions: new strategies for mass distribution. Biosec Bioterr 2006 Jun;4(2):176-82 [Abstract]

Lim WS, Thomson A, Little P. Preparing for the next flu pandemic (Editorial). BMJ 2007 Feb 10;334(7588):268-9 [Abstract]

Lim WS. Pandemic flu: clinical management of patients with an influenza-like illness during an influenza pandemic. Thorax 2007 Jan;62(suppl 1):1-46 [Extract]

Lin F, Muthuraman K, Lawley M. An optimal control theory approach to non-pharmaceutical interventions. BMC Infect Dis 2010;10(32) (published online Feb 19) [Full text]

Lin J, Zhang J, Dong X, et al. Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial. Lancet 2006 (published online Sep 7) [Abstract - access requires free registration]

Lin JT, Li CG, Wang X, et al. Antibody persistence after 2-dose priming and booster response to a third dose of an inactivated, adjuvanted, whole-virion H5N1 vaccine. J Infect Dis 2009 Jan 15;199(2):184-7 [Abstract]

Lindegardh N, Davies GR, Hien TT, et al. Importance of collection tube during clinical studies of oseltamivir. Antimicrob Agents Chemother 2007 May;51(5):1835-6 [Abstract]

Lipatov AS, Webby RJ, Govorkova EA, et al. Efficacy of H5 influenza vaccines produced by reverse genetics in a lethal mouse model. J Infect Dis 2005 Apr 15;191(8):1216-20 [Abstract]

Lipsitch M, Cohen t, Murray M, et al. Antiviral resistance and the control of pandemic influenza. PLoS Med 2007 Jan 23;4(1):e15 [Full text]

Lipsitch M, Riley S, Cauchemez S, et al. Managing and reducing uncertainty in an emerging influenza pandemic. (Perspective) N Engl J Med 2009 (published online May 27) [Full text]

Liu EC. Would an influenza pandemic qualify as a major disaster under the Stafford Act? Congressional Research Service (CRS) Report. Oct 20, 2008 [Full text]

Lloyd's Emerging Risks Team. Pandemic: potential insurance impacts. Oct 17, 2008 [Full text]

Lofgren E, Fefferman NH, Naumov YN, et al. Influenza seasonality: underlying causes and modeling theories. J Virol 2007 Jun;81(11):5429-36 [Abstract]

Loncarevic G, Payne L, Kon P, et al. Public health preparedness for two mass gathering events in the context of pandemic influenza (H1N1) 2009 - Serbia, July 2009. (Rapid communications) Eurosurveill 2009 Aug 6;14(31):pii=19296 [Full text]

Longini IM Jr, Halloran ME, Nizam A, et al. Containing pandemic influenza with antiviral agents. Am J Epidemiol 2004 Apr 1;159(7):623-33 [Abstract]

Longini IM, Nizam A, Xu S, et al. Containing pandemic influenza at the source. Science 2005 (published online Aug 3) [Abstract - available to subscribers]

Look JL, Butler B, Al-Khalili M, et al. The adjuvant patch: a universal dose sparing approach for pandemic and conventional vaccines. BioPharm Int 2007 Aug (supp) (published online Aug 2) [Full text]

Loosli CG, Lemon HM, Robertson OH, et al. Experimental airborne influenza infection. I. Influence of humidity on survival of virus in air. Proc Soc Exp Biol 1943; 53:205 6

Lotstein D, Seid M, Ricci K, et al. Using quality improvement methods to improve public health emergency preparedness: PREPARE for Pandemic Influenza. Health Aff 2008;27(5):w328-39 (published online Jul 15) [Abstract]

Lovelace K, Bibeau D, Gansneder B, et al. All-hazards preparedness in an era of bioterrorism funding. J Public Health Manage Pract 2007 Sep/Oct;13(5):465-9 [Abstract]

Low DE. Pandemic planning: non-pharmaceutical interventions. Respirology 2008 Mar;13(s1):S44-8 [Full text]

Lucio-Forster A, Bowman DD, Lucio-Martinez B, et al. Inactivation of the avian influenza virus (H5N2) in typical domestic wastewater and drinking water treatment systems. Environ Eng Sci 2006 Nov;23(6):897-903 [Full text]

Luk J, Gross P, Thompson WW. Observations on mortality during the 1918 influenza pandemic. Clin Infect Dis 2001 Oct 15;33(8):1375-8 [Full text]

Luke CJ, Subbarao K. Vaccines for pandemic influenza. Emerg Infec Dis 2006 Jan;12(1):66-72 [Full text]

Luke TC, Kilbane EM, Jackson JL, et al. Meta-analysis: convalescent blood products for Spanish influenza: a future H5N1 treatment? Ann Intern Med 2006 Oct 17;145(8) (early online publication) [Abstract - See also Treanor editorial below]

Luke TC, Rodrique JP. Protecting the public health and global freight transportation systems during an influenza pandemic. Am J Disaster Med 2008 Mar-Apr;3(2):99-107 [Abstract]

Lurie N, Dausey DJ, Knighton T, et al. Community planning for pandemic influenza: lessons from the VA health care system. Disaster Med Public Health Prep 2008 Dec;2(4):251-7 [Abstract]

Ma W, Lager KM, Vincent AL, et al. The role of swine in the generation of novel influenza viruses. Zoonoses Public Health 2009 (published online May 27) [Abstract]

MacIntyre CR, Cauchemez S, Dwyer DE, et al. Face mask use and control of respiratory virus transmission in households. Emerg Infect Dis 2009 Feb;15(2):233 (published online Jan 27) [Full text]

Mackay WG, van Loon AM, Niedrig M, et al. Molecular detection and typing of influenza viruses: are we ready for an influenza pandemic? J Clin Virol 2008 (published online Mar 21) [Abstract]

Madjid M, Lillibridge S, Mirhaji P, et al. Influenza as a bioweapon. J R Soc Med 2003;96(7):345-6 [Abstract]

Madjid M, Mikller CC, Zarubaev VV, et al. Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34 892 subjects. Eur Heart J 2007 (published online Apr 17) [Abstract]

Mahmood K, Bright RA, Mytle N, et al. H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 viruses. Vaccine 2008 Oct 3;26(42):5393-9 [Abstract]

Maines TR, Chen LM, Matsuoka Y, et al. Lack of transmission of H5N1 avian-human reassortant influenza viruses in a ferret model. Proc Natl Acad Sci 2006 Aug 8;103(32):1221-6 [Abstract]

Maines TR, Szretter K, Perrone L, et al. Pathogenesis of emerging avian influenza viruses in mammals and the host innate immune response. Immunol Rev 2008 Oct;225(1):68-84 [Abstract]

Majury A, Ash J, Toye B, et al. Laboratory diagnosis of human infection with avian influenza. CMAJ 2006 Nov 21;175(11):1371-2 [Full text]

Mak TK, Mangtani P, Leese J, et al. Influenza vaccination in pregnancy: Current evidence and selected national policies. Lancet Infect Dis 2008 Jan;8(1):44-52 [Abstract]

Maldin B, Inglesby TV, Nuzzo J, et al. Bulls, bears, and birds: preparing the financial industry for an avian influenza pandemic. Conference report. Biosec Bioterr 2005 Dec;3(4):363-5 [Abstract]

Maldin B, Lam C, Franco C, et al. Regional approaches to hospital preparedness. Biosecur Bioterror 2007 Apr;5(1):43-54 [Full text]

Maldin-Morgenthau B, Toner E, Waldhorn R, et al. Roundtable: promoting partnerships for regional healthcare preparedness and response. Biosecur Bioterror 2007 Jun;5(2):180-5 [Full text]

Maldin-Morgenthau B, Toner E, Wilkinson D, et al. Roundtable discussion: corporate pandemic preparedness. Biosecur Bioterror 2007 Jun;5(2):168-73 [Full text]

Malone JD, Brigantic R, Muller GA, et al. US airport entry screening in response to pandemic influenza: modeling and analysis. Travel Med Infect Dis 2009 (published online Apr 14) [Abstract]

Malone JL, Madjid M, Casscells SW. Telephone survey to assess influenza-like illness, United States, 2006. Emerg Infect Dis 2008 Jan;14(1):129-35 (published online Dec 21) [Full text]

Markel H, Lipman HB, Navarro JA, et al. Nonpharmaceutical interventions implemented by US cities during the 1918-1919 influenza pandemic. JAMA 2007 Aug 8;298(6):644-54 [Abstract]

Markel H, Stern AM, Navarro JA, et al. Nonpharmaceutical influenza mitigation strategies, US communities, 1918-1920 pandemic. Emerg Infect Dis 2006 Dec;12(12) (published online Nov 2) [Full text]

Marsden-Haug N, Foster VB, Gould PL, et al. Code-based syndromic surveillance for influenzalike illness by International Classification of Diseases, Ninth Revision. Emerg Infect Dis 2007 Feb;13(2) (published online Jan 11) [Full text]

Martin R. The role of law in pandemic influenza preparedness in Europe. Public Health 2009 (published online Mar 4) [Abstract]

Martin SD. Pandemic economics: financial survival for home care agencies in a bird flu outbreak. Home Health Care Manage Pract 2008 Jun;20(4):336-41 [Abstract]

Martinese F, Keijzers G, Grant S, et al. How would Australian hospital staff react to an avian influenza admission, or an influenza pandemic? Emerg Med Australas 2009 Feb;21(1):12-24 [Abstract]

Mason B. Citizen engagement in emergency planning for a flu pandemic: a summary of the October 23, 2006 workshop of the Disasters Roundtable. Report by the National Research Council of the National Academies, released Apr 13, 2007 [Full text]

Mathews JD, Chesson JM, McCaw JM, et al. Understanding influenza transmission, immunity, and pandemic threats. Influenza Other Resp Viruses 2009 Jun 15;3(4):143-9 [Abstract]

Mathews JD, McCaw CT, McVernon J, et al. A biological model for influenza transmission: pandemic planning implications of asymptomatic infection and immunity. PLoS ONE 2007 Nov 28;2(11):e1220 [Full text]

May L, Cote T, Hardeman B, et al. A model "go-kit" for use at Strategic National Stockpile points of dispensing. J Pub Health Manag Pract 2007 Jan/Feb;13(1):23-30 [Abstract]

McAuley JL, Hornung F, Boyd KL, et al. Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. Cell Host Microbe 2007 Oct 10;2(4):240-9 [Abstract]

McCaw JM, Wood JG, McCaw CT, et al. Impact of emerging antiviral drug resistance on influenza containment and spread: influence of subclinical infection and strategic use of a stockpile containing one or two drugs. PLoS ONE 2008 Jun 4;3(6):e2362 [Full text]

McCullers JA. Planning for an influenza pandemic: thinking beyond the virus. (Editorial commentary) J Infect Dis 2008 (published online Aug 18) [Full text]

McKibbin WJ. Global macroeconomic consequences of pandemic influenza. Lowy Institute for International Policy. Feb 2006 [Full text]

McKimm-Breschkin J, Trivedi T, et al. Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir. Antimicrob Agents Chemother. 2003 Jul;47(7):2264-72 [Full text]

McKinnon M. Clinical scenarios [pandemic influenza]. Med J Aust 2006 Nov 20;185(10 suppl):S32-4 [Full text]

McLeod MA, Baker M, Wilson N, et al. Protective effect of maritime quarantine in South Pacific jurisdictions, 1918-19 influenza pandemic. Emerg Infect Dis 2008 Mar;14(3) (published online Feb 4) [Full text]

McSwiggen JA, Seth S. A potential treatment for pandemic influenza using siRNA targeting conserved regions of influenza A. Expert Opin Biol Ther 2008 Mar;8(3):299-313 [Abstract]

McVernon J, McCaw CT, Mathews JD. Model answers or trivial pursuits? The role of mathematical models in influenza pandemic preparedness planning. Influenza Other Respir Virus 2007 Mar;1(2):43-54 [Abstract]

Medema JK, Zoellner YF, Ryan J, et al. Modeling pandemic preparedness scenarios: health economic implications of enhanced pandemic vaccine supply. Virus Res 2004 Jul;103(1-2):9-15 [Abstract]

Mehle A, Doudna JA. Adaptive strategies of the influenza virus polymerase for replication in humans. Proc Natl Acad Sci 2009 (published online Dec 7) [Abstract]

Mehle A, Doudna JA. An inhibitory activity in human cells restricts the function of an avian-like influenza virus polymerase. Cell Host Microbe 2008 Aug 14;4(2):111-22 [Abstract]

Meijer A, Lackenby A, Hay A, et al. Influenza antiviral susceptibility monitoring activities in relation to national antiviral stockpiles in Europe during the winter 2006/2007 season. Eurosurveillance Monthly 2007 Apr;12(4) [Full text]

Melnychuk RM, Kenny NP. Pandemic triage: the ethical challenge (Commentary). CMAJ 2006 Nov 21;74(11):1393-4 [Full text]

Meltzer MI. Pandemic influenza, reopening schools, and returning to work. (Commentary) Emerg Infect Dis 2008 Mar;14(3):509-10 [Full text]

Menon KU. Risk communication: in search of a pandemic. (Commentary) Ann Acad Med Singapore 2008 Jun;37(6):525-34 [Full text]

Middaugh JP. Pandemic influenza preparedness and community resiliency. (Commentary) JAMA 2008 Feb 6;299(5):566-8 [Extract]

Middleton D, Rockman S, Pearse M, et al. Evaluation of vaccines for H5N1 influenza virus in ferrets reveals the potential for protective single-shot immunisation. J Virol 2009 Aug;83(15):7770-8 [Abstract]

Miller G, Randolph S, Patterson JE. Responding to simulated pandemic influenza in San Antonio, Texas. Infect Control Hosp Epidemiol 2008 Apr;29(4):320-6 [Abstract]

Miller MA, Viboud C, Balinska M, et al. The signature features of influenza pandemics -- implications for policy. (Perspective) N Engl J Med 2009 (published online May 7) [Full text]

Miller MA, Viboud C, Olson DR, et al. Prioritization of influenza pandemic vaccination to minimize years of life lost. J Infect Dis 2008 (published online Jun 17) [Abstract]

Mills CE, Robins JM, Bergstrom CT, et al. Pandemic influenza: risk of multiple introductions and the need to prepare for them. PLoS Med 2006 Jun;3(6) [Full text]

Mills CE, Robins JM, Lipsitch M. Transmissibility of 1918 pandemic influenza. (Letter) Nature 2004;432:904-6 [Abstract]

Milne G, Kelso J, Kelly H. Strategies for mitigating an influenza pandemic with pre-pandemic H5N1 vaccine. J R Soc Interface 2009 (published online Sep 15) [Abstract]

Milne GJ, Kelso JK, Kelly HA, et al. A small community model for the transmission of infectious diseases: comparison of school closure as an intervention in individual-based models of an influenza pandemic. PLoS ONE 2008 Dec 23;3(12):e4005 [Full text]

Minnesota Center for Health Care Ethics. Allocating pandemic influenza vaccines in Minnesota: recommendations of the pandemic influenza ethics work group. Sep 2006 [Abstract]

Minnesota Pandemic Ethics Project. For the good of us all: ethically rationing health resources in Minnesota in a severe influenza pandemic. Preliminary report released Jan 30, 2009 [Link to full text]

Minnesota Pandemic Ethics Project. Implementing ethical frameworks for rationing scarce health resources in Minnesota during severe influenza pandemic. Preliminary report released Jan 30, 2009 [Full text]

Minor PD. Vaccines against seasonal and pandemic influenza and the implications of changes in substrates for virus production. Clin Infect Dis 2010 (published online Jan 19) [Abstract]

Mishin VP, Hayden FG, Gubareva LV. Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors. Antimicrob Agents Chemother 2005 Nov;49(11):4515-20 [Abstract]

Mitchell RL. Heads in the sand: procrastinating about bird flu. Computerworld 2007 (published online Jan 8) [Full text--links to other resources]

Mitchell RL. How can IT respond to a flu pandemic? Computerworld Malaysia 2007 Jun;17(8) [Full text]

Moghadas SM, Bowman CS, Rost G, et al. Population-wide emergence of antiviral resistance during pandemic influenza. PLoS ONE 2008 Mar 19;3(3):e1839 [Full text]

Moghadas SM, Bowman CS, Rost G, et al. Post-exposure prophylaxis during pandemic outbreaks. BMC Med 2009;7:73 (published online Dec 2) [Abstract]

Monto AS, Comanor L, Shay DK, et al. Epidemiology of pandemic influenza: use of surveillance and modeling for pandemic preparedness. J Infect Dis 2006 Nov 1;194(suppl 2):S92-7 [Abstract]

Monto AS, Whitley RJ. Seasonal and pandemic influenza: a 2007 update on challenges and solutions. Clin Infect Dis 2008;46 (published online Feb 21) [Abstract]

Monto AS. The threat of an avian influenza pandemic. (Perspective) N Engl J Med 2005 Jan 27;352(4):323-4 [Full text]

Monto AS. Vaccines and antiviral drugs in pandemic preparedness. Emerg Infec Dis 2006 Jan;12(1):55-60 [Full text]

Moore CL, Smagala JA, Smith CB, et al. Evaluation of MChip with historic subtype H1N1 influenza A viruses, including the 1918 "Spanish Flu" strain. J Clin Microbiol 2007 Nov;45(11):3807-10 [Abstract]

Morens DM, Fauci AS. The 1918 influenza pandemic: insights for the 21st century. J Infect Dis 2007 Apr 1;195(7):1018-28 [Abstract]

Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 2008 (published online Aug 18) [Full text]

Morrison D, Roy S, Rayner C, et al. A randomized, crossover study to evaluate the pharmacokinetics of amantadine and oseltamivir administered alone and in combination. PLoS ONE 2007 Dec 12;2(12):e1305 [Full text]

Morse SS, Garwin RL, Olsiewski PJ. Next flu pandemic: What to do until the vaccine arrives? [Policy Forum]. Science Nov 10;314(5801):929 [Abstract]

Mortimer P. Influenza-related death rates for pregnant women (letter). Emerg Infect Dis 2006 Nov;12(11) (published online Oct 19) [Full text]

Moscona A. Oseltamivir resistance: disabling our influenza defenses. (Perspective) N Engl J Med 2005 Dec 22;353(24):2633-6 [Full text]

Moser MR, Bender TR, Margolis HS, et al. An outbreak of influenza abroad a commercial airliner. Am J Epidemiol 1979;110(1):1-6

Mossong J, Hens N, Jit M, et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med 2008 Mar 25;5(3):e74 [Full text]

Mounier-Jack S, Coker RJ. How prepared is Europe for pandemic influenza? Analysis of national plans. Lancet 2006 (published online Apr 20) [Abstract]

Mounier-Jack S, Jas R, Coker R. Progress and shortcomings in European national strategic plans for pandemic influenza. Bull World Health Organ 2007;85 (published online Sep 21) [Full text]

Mubareka S, Palese P. Human genes and influenza. J Infect Dis 2008 Jan;197 (published online Dec 11, 2007) [Full text]

Mubareka SM, Lowen AC, Steel J, et al. Transmission of influenza virus via aerosols and fomites in the guinea pig model. J Infect Dis 2009 (published online Feb 9) [Abstract]

Murray CJ, Lopez AD, Chin B, et al. Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918-20 pandemic: a quantitative analysis. Lancet 2006 Dec 23;368(9554):2211-8 [Full text]

Mylius SD, Hagenaars TJ, Lugner AK, et al. Optimal allocation of pandemic influenza vaccine depends on age, risk and timing. Vaccine 2008 Jul 4;26(29-30):3742-9 [Abstract]

NAACHO. Local health department guide to pandemic influenza planning. Version 1.0. Jul 2006 [Full text]

Nap RE, Andriessen MPHM, Meessen NEL, et al. Pandemic influenza and excess intensive-care workload. Emerg Infect Dis 2008 Oct;14(10):1518-25 [Full text]

Nap RE, Andriessen MPHM, Meessen NEL, et al. Pandemic influenza and hospital resources. Emerg Infect Dis 2007 Nov;13(11):1714-9 [Full text]

NASCIO (National Association of State Chief Information Officers). Pandemic planning and response for state IT: where's my staff? Released Nov 12, 2007 [Full text]

National Governors Association Center for Best Practices. Pandemic preparedness in the states: an assessment of progress and opportunity. Sep 15, 2008 [Full text]

National Governors Association Center for Best Practices. Preparing for a pandemic influenza: a primer for governors and senior state officials. Released Jul 18, 2006 [Full text]

National Governors Association Center for Best Practices. Sustaining the state workforce: strategies for effective pandemic planning. Released Feb 19, 2009 [Full text]

National Infectious Diseases Day (Canada). A call for a national infectious diseases strategy. Oct 18, 2007 [Full text]

National Security Council. National strategy for pandemic influenza. Nov 1, 2005 [Full text]

National Security Council. National strategy for pandemic influenza: implementation plan. May 2006 [Full text]

Nature editorial staff. The long war against flu. (Editorial) Nature 2008 Jul 10;454(7201):137 [Full text]

Nature editors. Lessons from a pandemic. (Editorial) Nature 2010 Jan 14;463(7278):135-6 [Full text]

Needham H, on behalf of the Influenza Project Team, ECDC. H5N1 in wild and domestic birds in Europe--remaining vigilant in response to an ongoing public threat. Eurosurveillance Weekly 2007 Dec 6;12(12):E017206.1 [Full text]

Nelson MI, Holmes EC. The evolution of epidemic influenza. Nature Rev Genet 2007 Mar;8(3):196-205 [Abstract]

Neumann G, Kawaoka Y. Host range restriction and pathogenicity in the context of influenza pandemic. (Perspective) Emerg Infect Dis 2006 Jun;12(6) [Full text]

Newall AT, Wood JG, Oudin N, et al. Cost-effectiveness of pharmaceutical-based pandemic influenza mitigation strategies. Emerg Infect Dis 2010 Feb;16(2):224-30 [Full text]

Newton DW, Mellen CF, Baxter BD, et al. Practical and sensitive screening strategy for detection of influenza virus. J Clin Microbiol 2002 Nov;40(11):4353-6 [Full text]

Nguyen JT, Hoopes JD, Smee DF, et al. Triple combination of oseltamivir, amantadine, and ribavirin displays synergistic activity against multiple influenza virus strains in vitro. Antimicrob Agents Chemother 2009 (published online Jul 20) [Abstract]

Nguyen-Van-Tam JS, Hampson AW. The epidemiology and clinical impact of pandemic influenza. Vaccine 2003 May 1;21(16):1762-8 [Abstract]

NIAID. NIAID announces contracts to develop vaccine against H5N1 avian influenza. May 27, 2004 [Press release]

NIAID. Timeline of human flu pandemics [Web page]

Nichol KL, Treanor JJ. Vaccines for seasonal and pandemic influenza. J Infect Dis 2006 Nov 1;194(suppl 2):S111-8 [Abstract]

Nicholls JM, Chan MC, Chan WY, et al. Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract. Nature Med 2007 Feb;13(2):147-9 [Abstract]

Nicoll A, Coulombier D. Europe's intial experience with pandemic (H1N1) 2009 - mitigation and delaying policies and practices. Eurosurveill 2009 Jul 23;14(29):pii=19279 [Full text]

Nicoll A, on behalf of the Influenza Project Team. Public health measures in an influenza pandemic--the importance of surveillance. Eurosurveillance Weekly 2007 Nov 1;12(11):E071101.4 [Full text]

Nicoll A. Children, avian influenza H5N1, and preparing for the next pandemic. Arch Dis Childhood 2008 May;93(5):433-8 [Abstract]

Nicoll A. Human H5N1 infections: so many cases - why so little knowledge? Eurosurveill Monthly 2006 May;11(5) [Full text]

Nicoll A. Personal (nonpharmaceutical) protective measures for reducing transmission of influenza - ECDC interim recommendations. Eurosurveill Wkly 2006 Oct 12;11(10):E061012.1 [Full text]

Nicoll S, Kreidl P, on behalf of the Influenza Project Team. Preparing for the next pandemic--half way there. Eurosurveillance Weekly 2007 Dec 20;12(12):E071220.5 [Full text]

Nightingale SL, Prasher JM, Simonson S. Emergency Use Authorization (EUA) to enable use of needed products in civilian and military emergencies, United States. Emerg Infect Dis 2007 Jul;13(7):1046-51 [Full text]

Nishiura H, Klinkenberg D, Roberts M, et al. Early epidemiological assessment of the virulence of emerging infectious diseases: a case study of an influenza pandemic. PLoS ONE 2009 Aug 31;4(8):e6852 [Full text]

Nishiura H, Wilson N, Baker MG. Quarantine for pandemic influenza control at the borders of small island nations. BMC Infectious Dis 2009 Mar 11;9:27 [Abstract]

Nomille D. Flu virus research yields results but no magic bullet for pandemic. (News analysis) Science 2008 Feb 29;319(5687):1178-9 [Full text]

Nougairede A, Ninove L, Zandotti C, et al. Point of care strategy for rapid diagnosis of novel A/H1N1 influenza virus. PLoS One 2010 Feb 17;5(2):e9215 [Full text]

Novel Swine-Origin Influenza (H1N1) Virus Investigation Team. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009 (published onine May 7) [Full text]

Nuno M, Chowell G, Gumel AB. Assessing the role of basic control measures, antivirals and vaccine in curtailing pandemic influenza: scenarios for the US, UK and the Netherlands. J R Soc Interface 2006 (published online Dec 13) [Abstract]

Nuno M, Chowell G, Gumel AB. Assessing the role of basic control measures, antivirals and vaccine in curtailing pandemic influenza: scenarios for the US, UK and the Netherlands. J R Soc Interface 2007 Jun 22;4(14):505-21 [Abstract]

Nuno M, Reichert TA, Chowell G, et al. Protecting residential care facilities from pandemic influenza. Proc Natl Acad Sci 2008 (published online Jul 22) [Abstract]

NYC Department of Health and Mental Hygiene. Pandemic influenza preparedness and response plan. Released Jul 10, 2006 [Full text]

Ohkusa Y, Sugawara T. Simulation model of pandemic influenza in the whole of Japan. Jpn J Infect Dis 2009 Mar;62(2):98-106 [Abstract]

Okazaki K, Takada A, Ito T, et al. Precursor genes of future pandemic influenza viruses are perpetuated in ducks nesting in Siberia. Arch Virol 145(5):885-93 [Abstract]

Olsen SJ, Ungchusak K, Birmingham M, et al. Surveillance for avian influenza in human beings in Thailand. Lancet Infect Dis 2006 Dec;6(12):757-8 [Full text - Free registration required]

Olson DR, Simonsen L, Edelson PJ, et al. Epidemiological evidence of an early wave of the 1918 influenza pandemic in New York City. Proc Natl Acad Sci 2005 (published online Jul 26) [Abstract]

Oner AF, Bay A, Arslan S, et al. Avian influenza A (H5N1) infection in eastern Turkey in 2006. N Engl J Med 2006 Nov 23;355(21):2179-85 [Full text]

Ong AK, Hayden FG. John F. Enders lecture 2006: antivirals for influenza. J Infect Dis 2007 Jul 15;196(2):181-90 [Abstract]

Opstelten W, van Steenbergen JE, van Essen GA, et al. Threat of an influenza pandemic: family physicians in the front line. (Correspondence) BMC Fam Pract 2009 Feb 3;10:11 [Abstract]

Ortiz JR, Kamimoto L, Aubert RE, et al. Oseltamivir prescribing in pharmacy-benefits database, United States, 2004-2005. Emerg Infect Dis 2008 Aug (published online Jul 23) [Full text]

Ortiz JR, Shay DK, Liedtke LA, et al. A national survey of the Infectious Diseases Society of America Emerging Infections Network concerning neuraminidase inhibitor prescription practices and pandemic influenza preparations. Clin Infect Dis 2006 Aug 15;43(4):494-7 [Abstract]

Ortiz JR, Sotomayor V, Uez OC, et al. Strategy to enhance influenza surveillance worldwide. Emerg Infect Dis 2009 (published online Jun 25) [Full text]

Ortu G, Mounier-Jack S, Coker R. Pandemic influenza preparedness in Africa is a profound challenge for an already distressed region: analysis of national preparedness plans. Health Policy and Planning 2008;23(3):161-9 (published online Apr 1) [Abstract]

OSHA. Guidance on preparing workplaces for an influenza pandemic. Released Feb 6, 2007 [Full text]

OSHA. National strategy for pandemic influenza implementation plan: two year summary. Released Oct 17, 2008 [Full text]

OSHA. Pandemic influenza preparedness and response guidance for healthcare workers and healthcare employers. Released May 21, 2007 [Full text]

Oshitani H, Kamigaki T, Suzuki A. Major issues and challenges of influenza pandemic preparedness in developing countries. Emerg Infect Dis 2008 Jun (published online Apr 3) [Full text]

Osterhaus ADME, Poland GA (eds). Influenza vaccines: research, development and public health challenges. Vaccine 2008 Sep 12;26(suppl 4):D1-174 [Abstract]

Osterholm MT, Branswell H. Emerging pandemic: costs and consequences of an avian influenza outbreak. Webcast of presentation at Woodrow Wilson International Center for Scholars. Sep 19, 2005 [Web page with links]

Osterholm MT, Kelley N, McClure E, et al. Comments on federal Draft Guidance on Allocating and Targeting Pandemic influenza Vaccine. Submitted to HHS Dec 31, 2007 [Full text]

Osterholm MT. A weapon the world needs. Nature 2005 May 26;435(7041):417-8 [Full text]

Osterholm MT. Avian flu: addressing the global threat. Testimony before the House Committee on International Relations. Dec 7, 2005 [Full text]

Osterholm MT. Pandemic influenza vaccine: the US government is not doing enough. Clin Pharmacol Ther 2007 Dec;82(6):635-7 [Full text]

Osterholm MT. Preparing for the next pandemic. (Perspective) N Engl J Med 2005 May 5;352(18):1839-42 [Full text]

Osterholm MT. Preparing for the next pandemic. Foreign Aff 2005 Jul/Aug;84(4) [Full text]

Osterholm MT. Unprepared for a pandemic. Foreign Aff 2007 Mar/Apr;86(2) (published online Feb 26) [Extract]

Oxford JS, Lambkin R, Guralnik M, et al. In vivo prophylactic activity of QR-435 against H3N2 influenza virus infection. Am J Ther 2007 Sep-Oct;14(5):462-8 [Abstract]

Oxford JS, Lambkin R, Guralnik M, et al. Preclinical in vitro activity of QR-435 against influenza A virus as a virucide and in paper masks for prevention of viral transmission. Am J Ther 2007 Sep-Oct;14(5):455-61 [Abstract]

Oxford JS, Lambkin R, Sefton A, et al. A hypothesis: the conjunction of soldiers, gas, pigs, ducks, geese and horses in Northern France during the Great War provided the conditions for the emergence of the "Spanish" influenza pandemic of 1918-1919. Vaccine 2005 Jan 4;23(7):940-5 [Abstract]

Oxford JS. Influenza A pandemics of the 20th century with special reference to 1918: virology, pathology and epidemiology. Rev Med Virol 2000 Mar-Apr;19(2):119-33 [Abstract]

Oxford JS. Preparing for the first influenza pandemic of the 21st century. Lancet Infect Dis 2005 Mar 1;5(3) [Extract - Access requires free registration]

Oxford JS. Preparing for the first influenza pandemic of the 21st century. Lancet Infect Dis 2005 Mar 1;5(3):129-31 [Listing]

Pachucki CT, Khurshid MA, Nawrocki J. Utility of reverse transcriptase PCR for rapid diagnosis of influenza a virus infection and detection of amantadine-resistant influenza a virus isolates. J Clin Microbiol. 2004 Jun;42(6):2796-8 [Full text]

Palache B, Krause R. Progress with human H5N1 vaccines: a perspective from industry. Expert Rev Vaccines 2009 Apr;8(4):391-400 [Abstract]

Panagiotopoulos T, Bonovas S, Danis K, et al. Cluster of new influenza A(H1N1) cases in travellers returning from Scotland to Greece - community transmission within the European Union? (Rapid communications) Eurosurveill 2009 May 28;14(21):pi=19226 [Full text]

Pandemic Flu May 26 issue of Nature featuring a collection of commentaries and other articles on pandemic and avian influenza [Links to full text]

Pappaioanou M. Highly pathogenic H5N1 avian influenza virus: cause of the next pandemic? Comp Immunol Microbiol Infect Dis 2009 Jul;32(4):287-300 [Abstract]

Pappas C, Aguilar PV, Basler CF, et al. Single gene reassortants identify a critical role for PB1, HA, and NA in the high virulence of the 1918 pandemic influenza virus. Proc Natl Acad Sci 2008 (published online Feb 19) [Abstract]

Pappas C, Matsuoka Y, Swayne DE, et al. Development and evaluation of an influenza virus subtype H7N2 vaccine candidate for pandemic preparedness. Clin Vaccine Immunol 2007 Nov;14(11):1425-32 [Abstract]

Paranthaman K, Conlon CP, Parker C, et al. Resource allocation during an influenza pandemic. (Letter) Emerg Infect Dis 2008 Mar;14(3):520-1 [Full text]

Pareek M, Clark T, Dillon H, et al. Willingness of healthcare workers to accept voluntary stockpiled H5N1 vaccine in advance of pandemic activity. Vaccine 2009 Feb 18;27(8):1242-7 [Abstract]

Patel A, Gorman SE. Stockpiling antiviral drugs for the next influenza pandemic. (Opinion) Clin Pharmacol Therapeutics 2009 Sep;86(3):241-3 [Abstract]

Patel MS, Phillips CB, Pearce C, et al. General practice and pandemic influenza: a framework for planning and comparison of plans in five countries. PLoS ONE 2008 May 28;3(5):e2269 [Full text]

Pavia AT. IDSA statement concerning pandemic influenza before House Committee on Energy and Commerce Subcommittee on Health. May 26, 2005 [Full text]

Pawitan JA. Averting avian influenza pandemic: SOS from a developing country. Lancet Infect Dis 2006;6(12):756-7 [Full text - Free registration required]

Peiris JS, de Jong MD, Guan Y. Avian influenza virus (H5N1): a threat to human health. Clin Microbiol Rev 2007 Apr;20(2):243-67 [Abstract]

Peleg K, Kellermann AL. Enhancing hospital surge capacity for mass casualty events. (Commentary) JAMA 2009 Aug 5;302(5):562-4 [Extract]

Peng Z. Preparing for the real storm during the calm: a comparison of the crisis preparation strategies for pandemic influenza in China and the US. J Homeland Secur Emerg Manage 2008 Sep 18;5(1):article 47 [Abstract]

Perdue ML. Molecular diagnostics in an insecure world. Avian Dis 2003;47(3 Suppl):1063-8 [Abstract]

Perez DR, Webby RJ, Hoffmann E, et al. Land-based birds as potential disseminators of avian mammalian reassortant influenza A viruses. Avian Dis 2003;47(3 Suppl):1114-7 [Abstract]

Perlroth DJ, Glass RJ, Davey VJ, et al. Health outcomes and costs of community mitigation strategies for an influenza pandemic in the United States. Clin Infect Dis 2009 (published online Dec 18) [Abstract]

Perrone LA, Ahmad A, Veguilla V, et al. Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge. J Virol 2009 Jun;83(11):5726-34 (published online Mar 25) [Abstract]

Perrone LA, Plowden JK, Garcia-Sastre A, et al. H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog 2008 Aug 1;4(8):e1000115 [Full text]

Petric M, Comanor L, Petti CA. Role of the laboratory in diagnosis of influenza during seasonal epidemics and potential pandemics. J Infect Dis 2006 Nov 1;194(suppl 2):S98-110 [Abstract]

PHAC (Public Health Agency of Canada). The Canadian pandemic influenza plan for the health sector. Released Dec 9, 2006 [Full text]

Phelps R, McMenamin J, Kieffer D. The microbiological threat to financial institutions and the global economy: advanced pandemic planning for executives. (White paper) 2007 [Full text]

Phelps R, McMenamin J, Kieffer D. The microbiological threat to the national power grid: advanced pandemic planning for utilities executives. (White paper) 2007 [Full text]

Phin NF, Davies L. Resource allocation during an influenza pandemic. (Letter in response to Paranthaman et al letter; see above) Emerg Infect Dis 2008 Oct;14(10):1676 [Full text]

Phin NF, Rylands AJ, Allan J, et al. Personal protective equipment in an influenza pandemic: a UK simulation exercise. J Hosp Infect 2008 (published online Nov 17) [Abstract]

Pitzer VE, Olsen SJ, Bergstrom CT, et al. Little evidence for genetic susceptibility to influenza A (H5N1) from family clustering data. Emerg Infect Dis 2007 Jul;13(7):1074-6 [Full text]

Plotinsky RN, Talbot EA, Yeager D, et al. Epidemic preparedness in New Hampshire: assessment of increased airborne infection isolation capacity 1 year after distribution of portable isolation units. Infect Control Hosp Epidemiol 2007 Sep;28(9):1093-5 [Abstract]

POGO (Progress on Government Oversight). Pandemic flu: lack of leadership and disclosure plague vaccine program. Mar 6, 2008 [Full text]

Poland GA, Jacobson RM, Targonski PV. Avian and pandemic influenza: An overview. Vaccine 2007 Apr 20;25(16):3057-61 [Abstract]

Poland GA. Vaccines against avian influenza--a race against time. (Editorial) N Engl J Med 2006 Mar 30;354(13):1411-13 [Full text]

Poon LL, Leung YH, Nicholls JM, et al. Vaccinia virus-based multivalent H5N1 avian influenza vaccines adjuvanted with IL-15 confer sterile cross-clade protection in mice. J Immunol 2009 Mar 1;182(5):3063-71 [Abstract]

Pooruk P, Lerdsamran H, et al. Kinetics and longevity of antibody response to influenza A H5N1 virus infection in humans. Clin Vaccine Immunol 2009 (published online May 20) [Abstract]

Powell T, Christ KC, Birkhead GS. Allocation of ventilators in a public health disaster. Disaster Med Public Health Preparedness 2008 Mar;2(1):20-6 [Abstract]

Pratt MK. New strategies for new disasters. Computerworld 2008 (published online Mar 31) [Full text]

President's Council of Advisors on Science and Technology. Report to the President on U.S. preparations for 2009-H1N1 influenza. Aug 24, 2009 [Full text]

Public Health and Law Enforcement Emergency Preparedness Workgroup. A framework for improving cross-sector coordination for emergency preparedness and response: action steps for public health, law enforcement, the judiciary and corrections. Jul 2008 [Ful text]

Public Health and Law Enforcement Emergency Preparedness Workgroup. Coordinated implementation of community response measures (including social distancing) to control the spread of pandemic respiratory disease: a guide for developing a memorandum of understanding (MOU) for public health, law enforcement, corrections, and the judiciary. Jul 2008 [Full text]

Pushko P, Tumpey TM, Van Hoeven N, et al. Evaluation of influenza-like particles and Novasome adjuvant as candidate vaccine for avian influenza. Vaccine 2007 May 22;25(21):4283-90 [Abstract]

Putthasri W, Lertiendumrong J, Chompook P, et al. Capacity of Thailand to contain an emerging influenza pandemic. Emerg Infect Dis 2009 Mar;15(3):423-32 [Full text]

Puzelli S, De Trani L, Fabiani C, et al. Serological analysis of serum samples from humans exposed to avian H7 influenza viruses in Italy between 1999 and 2004. J Infect Dis 2005 Oct 15;192(8):1318-22 [Full text - See also Hayden above]

Qi L, Kash JC, Dugan VG, et al. Role of sialic acid binding specificity of the 1918 influenza virus hemagglutinin protein in virulence and pathogenesis for mice. J Virol 2009 Apr 15;83(8):3754-61 [Abstract]

Rabadan R, Levine AJ, Robins H. Comparison of avian and human influenza A viruses reveals a mutational bias on the viral genomes. J Virol 2006 Dec;80(23):11887-91 [Abstract]

Radonovich LJ Jr, Bender BS, Small PA Jr. Children should be among the highest priority groups to receive immunization for seasonal and pandemic influenza. (Letter) Biosecur Bioterror 2007 Dec;5(4):363-6 [Extract]

Radonovich LJ, Magalian PD, Hollingsworth MK, et al. Stockpiling supplies for the next influenza pandemic. Emerg Infect Dis 2009 Jun;15(6) (published online May 1) [Full text]

Rameix-Welti MA, Agou F, Buchy P, et al. Natural variation can significantly alter the sensitivity of influenza A (H5N1) viruses to oseltamivir. Antimicrob Agents Chemother 2006 Nov;50(11):3809-15 [Abstract]

Ramirez A, Capuano AW, Wellman DA, et al. Preventing zoonotic influenza virus infection. Emerg Infect Dis 2006 Jun;12(6):997-1000 [Full text]

Rashid H, Haworth E, Shafi S, et al. Pandemic influenza: mass gatherings and mass infection. (Commentary) Lancet Infect Dis 2008 Sep;8(9):526-7 [Full text]

Rasmussen SA, Jamieson DJ, Bresee JS. Pandemic influenza and pregnant women. (Perspective) Emerg Infect Dis 2008 Jan;14(1):95-100 (published online Dec 21) [Full text]

Raude J, Setbon M. Lay perceptions of the pandemic influenza threat. Eur J Epidemiol 2009 (published online May 30) [Abstract]

Rebmann T, English JF, Carrico R. Disaster preparedness lessons learned and future directions for education: results from focus groups conducted at the 2006 APIC conference. Am J Infect Control 2007 Aug;35(6):374-81 [Abstract]

Rebmann T, Wilson R, LaPointe S, et al. Hospital infectious disease emergency preparedness: a 2007 survey of infection control professionals. Am J Infect Control 2008 (published online Dec 10) [Abstract]

Recker M, Pybus OG, Nee S, et al. The generation of influenza outbreaks by a network of host immune responses against a limited set of antigenic types. Proc Natl Acad Sci 2007 May 1;104(18):7711-6 (published online Apr 25) [Abstract]

Reece PA. Neuraminidase inhibitor resistance in influenza viruses. J Med Virol 2007 Aug 17;79(10):1577-86 [Abstract]

Regoes RR, Bonhoeffer S. Emergence of drug-resistant influenza virus: population dynamical considerations. (Perspective) Science 2006 Apr 21;312(5772):389-91 [Full text]

Reid AH, Taubenberger JK, Fanning TC, et al. The 1918 Spanish influenza: integrating history and biology. Microbes Infect 2001 Jan;3(1):81- [Abstract]

Richard SA, Sugaya N, Simonsen L, et al. A comparative study of the 1918-1920 influenza pandemic in Japan, USA, and UK: mortality impact and implications for pandemic planning. Epidemiol Infect 2009 (published online Feb 12) [Abstract]

Riley RL. Airborne infection. Am J Med 1974; 57:466 75

Riley S, Wu JT, Leung GM. Optimizing the dose of pre-pandemic influenza vaccines to reduce the infection attack rate. PLoS Med 2007 Jun;4(6):e218 [Full text]

Riley S. Large-scale spatial-transmission models of infectious disease. Science 2007 Jun 1;316(5829):1298-301 [Abstract]

Rimmelzwaan GF, McElhaney JE. Correlates of protection: novel generations of influenza vaccines. Vaccine 2008 Sep 12;26(suppl 4):D41-44 [Full text]

Rimmelzwaan GF, Sutter G. Candidate influenza vaccines based on recombinant modified vaccinia virus Ankara. Expert Rev Vaccines 2009 Apr;8(4):4447-54 [Abstract]

Ritvo P, Wilson K, Gibson JL, et al. Canadian survey on pandemic flu preparations. BMC Public Health 2010 Mar 11;10:125 [Abstract]

Rizzo, C, Bella A, Viboud C, et al. Trends for influenza-related deaths during pandemic and epidemic seasons, Italy, 1969-2001. Emerg Infect Dis 2007 May;13(5) (published online Apr 11) [Full text]

Roberge RJ. Effect of surgical masks worn concurrently over N95 filtering facepiece respirators: extended service life versus increased user burden. J Public Health Manage Pract 2008 Mar/Apr;14(2):E-19-26 [Abstract]

Roberts MG, Baker M, Jennings LC, et al. A model for the spread and control of pandemic influenza in an isolated geographical region. J R Soc Interface 2006 (published online Nov 28) [Abstract]

Rodrigue JP, Luke T, Osterholm M. Transportation and pandemics, in The Geography of Transport Systems, Hofstra University, Department of Economics & Geography. 2008 [Full text]

Roose K, Fiers W, Saelens X. Pandemic preparedness: toward a universal influenza vaccine. Drug News Perspect 2009 Mar;22(2):80 [Abstract]

Rosychuk RJ, Bailey T, Haines C, et al. Willingness to volunteer during an influenza pandemic: perspectives from students and staff at a large Canadian university. Influenza and Other Resp Viruses 2008 Mar;2(2):71-9 (published online Apr 14) [Abstract]

Rothstein MA, Talbott MK. Encouraging compliance with quarantine: a proposal to provide job security and income replacement. Am J Public Health 2007 (published online Apr 5) [Abstract]

Rowe T, Abernathy RA, Hu-Primmer J, et al. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol 1999 Apr;37(4):937-43 [Full text]

Rubinson L, Brnason RD, Pesik N, et al. Positive-pressure ventilation equipment for mass casualty respiratory failure. Biosec Bioterr 2006 Jun;4(2):183-94 [Abstract]

Rumke HC, Bayas JM, de Juanes JR, et al. Safety and reactogenicity profile of an adjuvanted H5N1 pandemic candidate vaccine in adults within a phase III safety trial. Vaccine 2008 May 2;26(19):2378-88 [Abstract]

Sadique MZ, Adams EJ, Edmunds WJ. Estimating the costs of school closure for mitigating an influenza pandemic. BMC Public Health 2008 Apr 24;8:135 [Abstract]

Sadique MZ, Edmunds WJ, Smith RD, et al. Precautionary behavior in response to perceived threat of pandemic influenza. Emerg Infect Dis 2007 Sep;13(9):1307-13 [Full text]

Safdar A, Rodriguez MA, Fayad LE, et al. Dose-related safety and immunogenicity of baculovirus-expressed trivalent influenza vaccine: a double-blind, controlled trial in adult patients with non-Hodgkin B cell lymphoma. J Infect Dis 2006 Nov 15;194(10):1394-97 [Abstract]

Salinsky E. Strong as the weakest link: medical response to a catastrophic event. National Health Policy Forum Background Paper No. 65 2008 Aug 8 [Full text]

Salomon R, Webster RG. The influenza virus enigma. Cell 2009 Feb 6;136(3):402-10 [Abstract]

Salzberg S. The contents of the syringe. (Commentary) Nature 2008 Jul 10;454(7201):160-1 [Full text]

Sambhara S, Stephenson I. Moving influenza vaccines forward. (Editorial) Expert Rev Vaccines 2009 Apr;8(4):375-77 [Full text]

Sander B, Nizam A, Garrison LP Jr, et al. Economic evaluation of influenza pandemic mitigation strategies in the United States using a stochastic microsimulation transmission model. Value Health 2008 (published online Jul 30) [Abstract]

Sandman P. Pandemics: good hygiene is not enough. (Commentary) Nature 2009 May 21;459(7245):322-23 [Full text]

Sandman PM, Lanard J. Bird flu: communicating the risk. Perspect Health 2005;19(2) [Full text]

Santhia K, Ramy A, Jayaningsih P, et al. Avian influenza A H5N1 infections in Bali province, Indonesia: a behavioral, virological, and seroepidemiological study. Influenza Other Resp Viruses 2009 (published online Mar 3) [Abstract]

Sarikaya O, Erbaydar T. Avian influenza outbreak in Turkey through health personnel's views: a qualitative study. BMC Public Health 2007;7(1):330 (published online Nov 15) [Abstract]

Sasaki A, Gatewood A, Ozonoff A, et al. Evidenced-based tool for triggering school closures during influenza outbreaks, Japan. Emerg Infect Dis 2009 Nov (published online Oct 2) [Full text]

Scanlon J, McMahon T, van Haastert C. Handling mass death by integrating the management of disasters and pandemics: lessons from the Indian Ocean tsunami, the Spanish flu and other incidents. J Contingen Crisis Manage 2007 Jun;15(2):80-94 [Abstract]

Schirmer P, Holodniy M. Oseltamivir for treatment and prophylaxis of influenza infection. Exp Opin Drug Saf 2009 (published online Apr 9) [Abstract]

Schoch-Spana M, Franco C, Nuzzo JB, et al. Community engagement: leadership tool for catastrophic health events. Biosecur Bioterror 2007 Apr;5(1):8-25 [Full text]

Schoch-Spana M. Implications of pandemic influenza for bioterrorism response. Clin Infect Dis 2000 Dec;31(6):1409-13 [Abstract]

Schrauder A, Schweiger B, Buchholz U, et al. Laboratory exposure to influenza A H2N2, Germany, 2004-2005. (Letter) Emerg Infect Dis 2006 Dec;12(12) (published online Nov 14) [Full text]

Schull MA, Gillim-Ross L, Santos C, et al. Avian influenza virus glycoproteins restrict virus replication and spread through human airway epithelium at temperatures of the proximal airways. PLoS Pathog 2009 May 15;5(5):e1000424 [Full text]

Schull MJ, Stukel TA, Vermeulen MJ, et al. Surge capacity associated with restrictions on nonurgent hospital utilization and expected admissions during an influenza pandemic: lessons from the Toronto severe acute respiratory syndrome outbreak. Acad Emerg Med 2006 Nov;13(11):1228-31 [Abstract]

Schulman JL. Experimental transmission of influenza virus infection in mice. IV. Relationship between transmissibility of different strains of virus and recovery of airborne virus in the environment of infector mice. J Exp Med 1967;125:479-88

Schunemann HJ, Hill SR, Kakad M, et al. WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus. Lancet Infect Dis 2007 Jan;7(1):21-31 [Abstract]

Schwartz B, Gellin B. Vaccination strategies for an influenza pandemic. (Commentary) J Infect Dis 2005 Apr 15;191(8):1207-9 [Abstract]

Schwartz JAl, Buonocore L, Roberts A, et al. Vesicular stomatitis virus vectors expressing avian influenza H5 HA induce cross-neutralizing antibodies and long-term protection. Virology 2007 Sep 15;366(1):166-73 [Abstract]

Scoones I, Forster P. The international response to highly pathogenic avian influenza: science, policy and politics. (STEPS Centre report) Released Oct 23, 2008 [Full text]

Security and Prosperity Partnership of North America. North American plan for avian & pandemic influenza. Released Aug 21, 2007 [Full text]

Sedyaningsih ER, Isfandari S, Setiawaty V, et al. Epidemiology of cases of H5N1 virus infection in Indonesia, July 2005-June 2006. J Infect Dis 2007 Aug 15;196(4):522-7 [Abstract]

Selgelid MJ. Pandethics. Public Health 2009 (published online Feb 14) [Full text]

Sellwood C, Asgari-Jirhandeh N, Salimee S. Bird flu: if or when? Planning for the next pandemic. Postgrad Med J 2007 Jul;83(981):445-50 [Full text]

Shaw FE, McKie KL, Liveoak CA, et al. Variation in quarantine powers among the 10 most populous US states in 2004. Am J Public Health 2007 (published online Apr 5) [Abstract]

Shay DK, Ridenhour BJ. Can we "hedge" against the development of antiviral resistance among pandemic influenza viruses. (Perspective) PLoS Med 2009 Jun 30;6(6):e1000103 [Full text]

Shi D, Yang J, Yang D, et al. Anti-influenza viral prodrug oseltamivir is activated by carboxylesterase HCE1 and the activation is inhibited by anti-platelet agent clopidogrel. J Pharmacol Exp Ther 2006 (published online Sep 11) [Abstract]

Shin JY, Song MS, Lee EH, et al. Isolation and characterization of novel H3N1 swine influenza viruses from pigs with respiratory diseases in Korea. J Clin Microbiol 2006 Nov;44(11):3923-7 [Abstract]

Shinde V, Bridges CB, Uyeki TM, et al. Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009. N Engl J Med 2009 (published online May 7) [Full text]

Shipman A, Clarke G. Cell-culture-based manufacturing: meeting the challenge of 21st century influenza. BioPharm Int 2007 Aug (supp) (published online Aug 2) [Full text]

Shoji Y, Bi H, Musiychuk K, et al. Plant-derived hemagglutinin protects ferrets against challenge infection with the A/Indonesia/05/05 strain of avian influenza. Vaccine 2009 Feb 11;27(7):1087-92 [Abstract]

Siddiqui MR, Edmunds WJ. Cost-effectiveness of antiviral stockpiling and near-patient testing for potential influenza pandemic. Emerg Infect Dis 2008 Feb;14(2):267-75 [Full text]

Silas N, Johnson N, Rexe K. Safety is not negotiable: the importance of occupational health and safety to pandemic planning. HealthcarePapers 2007;8(1)2007;8(1):10-6 [Abstract]

Simmons C, Farrar J. Insights into inflammation and influenza. N Engl J Med 2008 Oct 9;359(15):1621-3 [Extract]

Simonsen L, Olson DR, Viboud C, et al. Pandemic influenza and mortality: past evidence and projections for the future. In: The threat of pandemic influenza: are we ready? Institute of Medicine. Nov 16, 2004 [Full text of book]

Singer AC, Nunn MA, Gould EA, et al. Potential risks associated with the proposed widespread use of Tamiflu. Environ Health Perspect 2006 (published online Oct 11) [Abstract]

Skowronski DM, Li Y, Tweed SA, et al. Protective measures and human antibody response during an avian influenza H7N3 outbreak in poultry in British Columbia, Canada. CMAJ 2007 Jan 2;176(1):47-53 [Full text]

Sloan FA, Berman S, Rosenbaum S, et al. The fragility of the U.S. vaccine supply. N Engl J Med 2004 Dec 2;351(23):2443-7 [Extract]

Smallman-Raynor M, Cliff AD. Avian influenza A (H5N1) age distribution in humans. (Letter) Emerg Infect Dis 2007 Mar;13(3) (published online Feb 2) [Full text]

Smith DJ, Lapedes AS, de Jong JC, et al. Mapping the antigenic and genetic evolution of influenza virus. Science 2004 Jul 16:305(5682):371-6 [Abstract]

Smith DJ. Predictability and preparedness in influenza control. (Perspective) Science 2006 Apr 21;312(5772):392-4 [Full text]

Smith GJD, Bahl J, Vijaykrishna D, et al. Dating the emergence of pandemic influenza viruses. Proc Natl Acad Sci 2009 (published online Jul 13) [Abstract]

Smith GJD, Fan XH, Wang J, et al. Emergence and predominance of an H5N1 influenza variant in China. Proc Natl Acad Sci 2006 (published online Oct 30) [Abstract]

Smith PW, Anderson AO, Christopher GW, et al. Designing a biocontainment unit to care for patients with serious communicable diseases: a consensus statement. Biosecur Bioterror 2006 Dec;4(4):351-5 [Abstract]

Smith PW, Hansen K, Spanbauer L, et al. Pandemic influenza preparedness: a survey of businesses. Am J Infect Control 2007 Sep;35(7):484-5 [Abstract]

Smith PW, Shostrom V, Smith A, et al. Preparedness for pandemic influenza in nursing homes: a 2-state survey. (Letter) JAMA 2008 Jul 23/30;300(4):392-4 [Extract]

Solovyov A, Palacios G, Briese T, et al. Cluster analysis of the origins of the new influenza A(H1N1) virus. (Rapid communications) Eurosurveill 2009 May 28;14(21):pi=19224 [Full text]

Song L, Nakaar V, Kavita U, et al. Efficacious recombinant influenza vaccines produced by high yield bacterial expression: a solution to global pandemic and seasonal needs. PLoS ONE 2008 May 21;3(5):e2257 [Abstract]

Sorrell TC, Lonsdale C. Urgent strategic research into influenza to inform health policy and protect the public. Med J Aust 2006 Nov 20;185(10 suppl):S77-9 [Full text]

Southwell BG, Hwang Y, Torres A. Avian influenza and US TV news. (Letter) Emerg Infect Dis 2006 Nov;12(11) (published online Oct 13) [Full text]

Srinivasan A, Viswanathan K, Raman R, et al. Quantitative biochemical rationale for differences in transmissibility of 1918 pandemic influenza A viruses. Proc Natl Acad Sci 2008 (published online Feb 19) [Abstract]

Starko KM. Salicylates and pandemic influenza mortality, 1918-1919: pharmacology, pathology, and historic evidence. Clin Infect Dis 2009 (published online Sep 29) [Abstract]

Starr I. Influenza in 1918: recollections of the epidemic in Philadelphia. Ann Intern Med 2006 Jul 18;145(2) (published online Jun 27) [Full text]

Stebbins S, Downs JS, Vukotich CJ Jr. Using nonpharmaceutical interventions to prevent influenza transmission in elementary children: parent and teacher perspectives. J Public Health Manag Pract 2009 Mar-Apr;15(2):112-7 [Abstract]

Steel J, Lowen AC, Mubareka S, et al. Transmission of influenza virus in a mammalian host is increased by PB2 amino acids 627K or 627E/701N. PLoS Pathog 2009 Jan 2;5(1):e1000252 [Full text]

Stephenson I, Bugarini R, Nicholson KG, et al. Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/duck/Singapore/97 (H5N3) vaccine: a potential priming strategy. J Infect Dis 2005 Apr 15;191(8):1210-5 [Abstract]

Stephenson I, Nicholson KG, Hoschler K, et al. Antigenically distinct MF59-adjuvanted vaccine to boost immunity to H5N1. (Letter) N Engl J Med 2008 Oct 9;359(15):1631-3 [Full text]

Stephenson I, Nicholson KG, Wood JM, et al. Confronting the avian influenza threat: vaccine development for a potential pandemic. Lancet Infect Dis 2004 Aug;4(8):499-509 [Abstract]

Stern AM, Cetron MS, Markel H. Closing the schools: lessons from the 1918-19 U.S. influenza pandemic. Health Aff 2009 (published online Sep 29) [Abstract]

Stevens J, Blixt O, Glaser L, et al. Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. J Molec Biol 2006 Feb 3;355(5):1143-55 [Full text]

Stevens J, Blixt O, Tumpey TM, et al. Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science 2006 (published online Mar 20) [Abstract]

Stier DD, Goodman RA. Mutual aid agreements: essential legal tools for public health preparedness and response. Am J Public Health 2007 (published online Apr 5) [Abstract]

Stier DD, Nicks D, Cowan GJ. The courts, public health, and legal preparedness. Am J Public Health 2007 (published online Apr 5) [Abstract]

Stier DD, Thombley ML. Public health mutual aid agreements: a menu of suggested provisions. CDC Public Health Law Program Jul 2008 [Full text]

Stilianakis NI, Drossinos Y. Dynamics of infectious disease transmission by inhalable respiratory droplets. J R Soc Interface 2010 (published online Feb 17) [Full text]

Stohr K, Esveld M. Public health: enhanced: will vaccines be available for the next influenza pandemic? Science 2004 Dec 24;306(5705):2195-6 [Abstract]

Stohr K. Avian influenza and pandemics: research needs and opportunities. (Editorial) N Engl J Med 2005 Jan 27;352(4):405-7 [Extract]

Straetemans M, Buchholz U, Reiter S, et al. Prioritization strategies for pandemic influenza vaccine in 27 countries of the European Union and the Global Health Security Action Group: a review. BMC Public Health 2007 (published online Sep 7) [Abstract]

Sugrue RJ, Tan BH, Yeo DSY, et al. Antiviral drugs for the control of pandemic influenza virus. Ann Acad Med Singapore 2008 Jun;37(6):518-24 [Full text]

Suguitan AL Jr, McAuliffe J, Mills KL, et al. Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets. PLoS Med 2006 Sep;3(9) [Full text]

Sui J, Hwang WC, Perez S, et al. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol 2009 (published online Feb 22) [Abstract]

Sun J, Madan R, Karp CL, et al. Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nature Med 2009 Mar;15(3):277-84 [Abstract]

Surveillance Group for New Influenza A(H1N1) investigation and Control in Spain. New influenza A(H1N1) virus infections in Spain, April-May 2009. Eurosurveill 2009 May 14;14(19):pi=19209 [Full text]

Suwannakarn K, Chutinimitkul S, Payungporn S, et al. Assay to detect H5N1 oseltamivir resistance. (Letter) Emerg Infect Dis 2006 Dec;12(12) (published online Nov 15) [Full text]

Swaminathan A, Martin R, Gamon S, et al. Personal protective equipment and antiviral drug use during hospitalization for suspected avian or pandemic influenza. Emerg Infect Dis 2007 Oct;13(10):1541-7 [Full text]

Swayne DE, Kapczynski D. Strategies and challenges for eliciting immunity against avian influenza virus in birds. Immunol Rev 2008 Oct;225(1):312-31 [Abstract]

Syrett JI, Benitez JG, Livingston WH 3rd, et al. Will emergency health care providers respond to mass casualty incidents? J Healthc Prot Manage 2007;23(2):27-40 [Abstract]

Tabery J, Mackett CW 3rd, University of Pittsburgh Medical Center Pandemic Influenza Task Force's Triage Review Board. Ethics of triage in the event of an influenza pandemic. Disaster Med Public Health Prep 2008 Jun;2(2):114-8 [Abstract]

Takeuchi MT. Avian influenza risk communication, Thailand. (Letter) Emerg Infect Dis 2006 Jul;12(7) [Full text]

Talmor D, Jones A, Rubinson L, et al. A simple triage scoring system predicting death and need for critical resources for use during epidemics. Crit Care Med 2007 May;35(5):1251-6 [Abstract]

Tam DKP, Lee S, Lee SS. Impact of SARS on avian influenza preparedness in healthcare workers. Infection 2007 (published online Sep 19) [Abstract]

Tam JS. Influenza A (H5N1) in Hong Kong: an overview. Vaccine 2002 May 15;20 Suppl 2:S77-81 [Abstract]

Tambyah PA. Update on influenza antivirals. Respirology 2008 Mar;13(s1):S19-21 [Full text]

Tambyah PA. Update on influenza vaccines. Respirology 2008 Mar;13(s1):S41-3 [Full text]

Taubenberger JD, Reid AH, Fanning TG. Capturing a killer flu virus. Sci Am 2005 Jan;292(1):62-72 [Excerpt]

Taubenberger JK, Morens DM, Fauci AS. The next influenza pandemic: can it be predicted? (Commentary) JAMA 2007 May 9;297(18):2025-7 [Extract]

Taubenberger JK, Morens DM. 1918 influenza: the mother of all pandemics. Emerg Infec Dis 2006 Jan;12(1):15-22 [Full text]

Taubenberger JK, Morens DM. Influenza revisited. Emerg Infec Dis 2006 Jan;12(1):1-2 [Full text]

Taubenberger JK, Reid AH, Lourens RM, et al. Characterization of the 1918 influenza virus polymerase genes. (Letter) Nature 2005;Oct 6;437(7060):889-93 [Full text]

Tellier R. Review of aerosol transmission of influenza A virus. Emerg Infect Dis 2006 Nov;12(11) (published online Sep 25) [Full text]

Temperton NJ, Hoschler K, Major D, et al. A sensitive retroviral pseudotype assay for influenza H5N1-neutralizing antibodies. Influenza Other Respir Virus 2007 (published online Jul 26) [Full text]

Ten Eyck RP. Ability of regional hospitals to meet projected avian flu pandemic surge capacity requirements. J Prehosp Disaster Med 2008 Mar-Apr;23(2):103-12 [Abstract]

The Global Influenza Programme. Expert consultation on diagnosis of H5N1 avian influenza infections in humans. Influenza Other Resp Viruses 2007 Jul;1(4):131-8 (available online Nov 5) [Full text]

Thibodeau P. Financial firms confident about pandemic plans--but telecommuting may be wishful thinking. Computerworld 2008 (published online Jan 25) [Full text]

Thibodeau P. Flu pandemic could choke Internet, requiring usage restrictions: expected surge in online traffic puts telework plans at risk. Computerworld 2007 Feb 12 [Full text]

Thibodeau P. Pandemic planning not a priority in U.S., despite bird-flu threat. Computerworld 2007 (published online Jul 3) [Full text]

Thibodeau P. Pandemic test undertaken by financial services paints dire scenario. Computerworld 2007 (published online Oct 24) [Full text]

Thibodeau P. Pandemic threat still getting IT's attention. Computerworld 2007 (published online Dec 3) [Full text]

Thibodeau P. Remember the pandemic threat? (Some) IT planners do. Computerworld 2007 (published online Nov 28) [Full text]

Thitithanyanont A, Engering A, Ekchariyawat P, et al. High susceptibility of human dendritic cells to avian influenza H5N1 virus infection and protection by IFN-alpha and TLR ligands. J Immunol 2007 Oct 15;179(8):5220-7 [Abstract]

Thomas A, Guldager N, Hermansen K. Pandemic flu preparedness: a manufacturing perspective. BioPharm Int 2007 Aug (supp) (published online Aug 2) [Full text]

Thomas JC, Dasgupta N, Martinot A. Ethics in a pandemic: a survey of the state pandemic influenza plans. Am J Public Health 2007 (published online Apr 5) [Abstract]

Thomas PG, Keating R, Hulse-Post DJ, et al. Cell-mediated Protection in Influenza Infection. Emerg Infec Dis 2006 Jan;12(1):48-54 [Full text]

Thomas Y, Vogel G, Wunderli W, et al. Survival of influenza virus on banknotes. Appl Environ Microbiol 2008 May;74(10):3002-7 [Abstract]

Tompkins SM, Zhao Z-S, Lo C-Y, et al. Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1. Emerg Infect Dis 2007 Mar;13(3) (published online Feb 15) [Full text]

Toner E, Waldhorn R, Maldin B, et al. Hospital preparedness for pandemic influenza. Meeting report. Biosec Bioterror 2006 Jun;4(2) [Full text]

Toner E, Waldhorn R. What hospitals should do to prepare for an influenza pandemic. Biosecur Bioterror 2006 Dec;4(4):397-402 [Abstract]

Torda A. Ethical issues in pandemic planning. Med J Aust 2006 Nov 20;185(10 suppl):S73-6 [Full text]

Tracht SM, Del Valle SY, Hyman JM. Mathematical modeling of the effectiveness of facemasks in reducing the spread of novel influenza A (H1N1). PLoS One 2010 Feb 10;5(2):e9018 [Full text]

Trades Union Congress (UK). Pandemic flu guidance for unions. Released Jun 15, 2007 [Full text]

Treanor J. Influenza vaccine: outmaneuvering antigenic shift and drift. (Perspective) N Engl J Med 2004 Jan 15;350(3):218-20 [Abstract]

Treanor JJ, Campbell JD, Zangwill KM, et al. Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. N Engl J Med 2006 Mar 30;354(13):1343-51 [Full text]

Treanor JJ. Avian influenza: exploring all the avenues. (Editorial) Ann Intern Med 2006 Oct 17;145(8) (early online publication) [Full text - See also Luke above]

Trilla A, Trilla G, Daer C. The 1918 "Spanish flu" in Spain. Clin Infect Dis 2008 Sep 1;47(5):668-73 [Abstract]

Trust for America's Health. Blueprint for a healthier America: modernizing the federal public health system to focus on prevention and preparedness. Oct 21, 2008 [Links to full report, press release, & audio]

Trust for America's Health and American Academy of Pediatrics. Pandemic influenza: warning, children at-risk. Oct 17, 2007 [Full text]

Trust for America's Health. A killer flu? Jun 2005 [Full text]

Trust for America's Health. It's not flu as usual: what businesses need to know about pandemic flu planning. 2005 [Full text]

Trust for America's Health. Pandemic flu and the potential for U.S. economic recession: a state-by-state analysis. Released Mar 22, 2007 [Links to news release and full report]

Trust for America's Health. Pandemic flu: lessons from the frontlines. Jun 4, 2009 [Links to press release and full report]

Trust for America's Health. Ready or not? Protecting the public's health from disease, disasters, and bioterrorism, 2005. Dec 2005 [Links to executive summary and full text]

Trust for America's Health. Ready or not? Protecting the public's health from disease, disasters, and bioterrorism, 2006. Released Dec 12, 2006 [Links to executive summary and full report]

Trust for America's Health. Ready or not? Protecting the public's health from disease, disasters, and bioterrorism, 2007. Released Dec 18, 2007 [Links to executive summary and full report]

Trust for America's Health. Ready or not? Protecting the public's health from disease, disasters, and bioterrorism, 2008. Released Dec 9, 2008 [Links to press release & full report]

Trust for America's Health. Ready or not? Protecting the public's health from diseases, disasters, and bioterrorism, 2009. Released Dec 15, 2009 [Full text]

Trust for America's Health/Infectious Diseases Society of America. Pandemic influenza: the state of the science. Oct 2006 [Full text]

Tsang KWT, Eng P, Liam CK, et al. H5N1 influenza pandemic: contingency plans. (Comment) Lancet 2005 Aug 13;366(9485):533-4 [Full text - Access requires free registration]

Tsiodras S, Mooney JD, Hatzakis A. Role of combination antiviral therapy in pandemic influenza and stockpiling implications. BMJ 2007 Feb 10;334(7588):293-4 [Abstract]

Tumpey TA, Maines TR, Hoeven NV, et al. A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission. Science 2007 Feb 2;315(5812):655-9 [Abstract]

Tumpey TM, Basler CF, Aguilar PV, et al. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 2005 Oct 7;310(5745):77-80 [Abstract]

Tumpey TM, Garcia-Sastre A, Mikulasova A, et al. Existing antivirals are effective against influenza viruses with genes from the 1918 pandemic virus. Proc Natl Acad Sci 2002 Oct 15;99(21):13849-54 [Abstract]

Tumpey TM, Garcia-Sastre A, Taubenberger JK, et al. Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus. Proc Natl Acad Sci 2004 Mar 2;101(9):3166-71 [Abstract]

UN System Influenza Coordinator & World Bank. Responses to avian influenza and state of pandemic readiness: fourth global progress report. Released Oct 15, 2008 [Full text]

UN System Influenza Coordinator & World Bank. Responses to avian influenza and state of pandemic readiness: third global progress report. Released Nov 29, 2007 [Full text]

UN System Influenza Coordinator. Simulation exercises on influenza pandemic responses in the Asia-Pacific region. Oct 2008 [Full text]

Ungchusak K, Auewarakul P, Dowell SF, et al. Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med 2005 Jan 27;352(4):333-40 [Full text]

University of Toronto Joint Centre for Bioethics Pandemic Influenza Working Group. Stand on guard for thee: ethical considerations in preparedness planning for pandemic influenza. Nov 2005 [Full text]

US Department of State. Fact sheet: Avian influenza A (H5N1) and pandemic influenza. Updated Sep 27, 2008 [Full text]

US Equal Employment Opportunity Commission. Pandemic preparedness in the workplace and the Americans with Disabilities Act. Oct 5, 2009 [Full text]

US government. Federal guidance to assist states in improving state-level pandemic influenza operating plans. Mar 11, 2008 [Full text]

US House of Representatives Committee on Homeland Security. Getting beyond getting ready for pandemic influenza. Released Jan 14, 2009 [Full text]

US Office of Personnel Management. Accomplishing work during a pandemic health crisis. Jul 7, 2006 [Full text]

US Office of Personnel Management. Human capital management policy for a pandemic influenza: Q & A. Jul 7, 2006 [Full text]

Uscher-Pines L, Chernak E, Alles S, et al. College and university planning for pandemic influenza: a survey of Philadelphia schools. Biosecur Bioterror 2007 Sep;5(3):249-54 [Abstract]

Uscher-Pines L, Omer SB, Barnett DJ, et al. Priority setting for pandemic influenza: an analysis of national preparedness plans. PLoS Med 2006 Oct;3(10) (published online Oct 17) [Full text]

USDA Office of Inspector General. USDA's implementation of the National Strategy for Pandemic Influenza. Audit report released Jan 15, 2008 [Full text]

USDA/APHIS. Agricultural Bioterrorism Protection Act of 2002: Possession, use, and transfer of biological agents and toxins. Final Rule 7 CFR Part 331 and 9 CFR Part 121. Fed Reg 2005 Mar 18;70(52):13242-92 [Full text]

USDA/APHIS. Questions and answers on the Agricultural Bioterrorism Protection Act of 2002: Possession, use, and transfer of select agents and toxins. APHIS factsheet. May 2005 [Full text]

Utah Dept of Health. Governor's Taskforce for Pandemic Influenza Preparedness: Final Report. Released Apr 3, 2007 [Full text]

Uyeki TM, Bresee JS. Detecting human-to-human transmission of avian influenza A (H5N1). (Letter) Emerg Infect Dis 2007 Dec;13(12):1969-70 (published online Nov 6) [Full text]

Uyeki TM. Global epidemiology of human infections with highly pathogenic avian influenza A (H5N1) viruses. Respirology 2008 Mar;13(s1):S2-9 [Full text]

Vajo Z, Kosa L, Szilvasy I, et al. Safety and immunogenicity of a prepandemic influenza A (H5N1) vaccine. Pediatr Infect Dis J 2008 (published online Oct 30) [Abstract]

Vajo Z, Kosa L, Visontay I, et al. Inactivated whole virus influenza A (H5N1) vaccine. (Letter) Emerg Infect Dis 2007 May;13(5) (published online Mar 29) [Full text]

Vajo Z, Wood J, Kosa L, et al. A single-dose influenza A (H5N1) vaccine safe and immunogenic in adult and elderly patients: an approach to pandemic vaccine development. J Virol 2010 Feb;84(3):1237-42 [Abstract]

Van D, McLaws ML, Crimmins J, et al. University life and pandemic influenza: attitudes and intended behaviour of staff and students towards pandemic (H1N1) 2009. BMC Public Health 2010 Mar 14;10:130 [Abstract]

van der Laan JW, Herberts C, Lambkin-Williams R, et al. Animals models in influenza vaccine testing. Expert Rev Vaccines 2008 Aug;7(6):783-93 [Abstract]

van der Sande M, Teunis P, Sabel R. Professional and home-made face masks reduce exposure to respiratory infections among the general population. PLoS ONE 2008 Jul 8;3(7):e2618 [Full text]

van Genugten ML, Heijnen ML. The expected number of hospitalisations and beds needed due to pandemic influenza on a regional level in the Netherlands. Virus Res 2004 Jul;103(1-2):17-23 [Abstract]

Van Hoeven N, Belser JA, Szretter KJ, et al. Pathogenesis of 1918 pandemic and H5N1 influenza virus infection in a guinea pig model: the antiviral potential of exogenous alpha-interferon to reduce virus shedding. J Virol 2009 Apr;83(7):2851-61 [Abstract]

Van Hoeven N, Belser JA, Szretter KJ, et al. Pathogenesis of 1918 pandemic and H5N1 influenza virus infections in a guinea pig model: antiviral potential of exogenous alpha interferon to reduce virus shedding. J Vriol 2009 Apr;83(7):2851-61 [Abstract]

Van Hoeven N, Pappas C, Belser JA, et al. Human HA and polymerase subunit PB2 proteins confer transmission of an avian influenza virus through the air. Proc Natl Acad Sci 2009 (published online Feb 11) [Abstract]

Vardavas R, Breban R, Blower S. Can influenza epidemics be prevented by voluntary vaccination? PLoS Comp Biol 2007 May;3(5):e85 [Full text]

Vawter DE, Gervais KG, Garrett JE. Allocating pandemic influenza vaccines in Minnesota: recommendations of the Pandemic Influenza Ethics Work Group. Vaccine 2007 Aug 29;25(35):6522-36 [Abstract]

Viboud C, Bjornstad ON, Smith DL, et al. Synchrony, waves, and spatial hierarchies in the spread of influenza. Science 2006 (published online Mar 30) [Abstract]

Viboud C, Tam T, Fleming D, et al. 1951 influenza epidemic, England and Wales, Canada, and the United States. Emerg infect Dis 2006 Apr;12(4) [Full text]

Viscusi DJ, Bergman M, Sinkule E, et al. Evaluation of the filtration performance of 21 N95 filtering face piece respirators after prolonged storage. Am J Infect Control 2009 (published online Feb 2) [Abstract]

Vogel R, Caillet C, Kusters IC, et al. Emulsion-based adjuvants for influenza vaccines. Expert Rev Vaccines 2009 Apr;8(4):483-92 [Abstract]

von Itzstein M. The war against influenza: discovery and development of sialidase inhibitors. Nat Rev Drug Discov 2007 Dec;6(12):967-74 [Abstract]

Vong S, Ly S, Van Kerkhove MD, et al. Risk factors associated with subclinical human infection with avian influenza A (H5N1) virus - Cambodia, 2006. J Infect Dis 2009 (published onlin May 5) [Full text]

Voyles BA. Orthomyxoviruses. In: The biology of viruses. Ed 2. New York, NY: McGraw-Hill, 2002:147

Wallace LA, McAulay KA, Douglas JD, et al. Influenza diagnosis: from dark isolation into the molecular light. West of Scotland Respiratory Virus Study Group. J Infect 1999 Nov;39(3):221-6 [Abstract]

Wallinga J, Hagenaars TJ, van Genugten M. Scenario analysis: estimating the effect of different interventions during an influenza pandemic. Eurosurveillance Weekly 2004 May 6;8(19) [Full text]

Wallinga J, van Bovena M, Lipsitch M. Optimizing infectious disease interventions during an emerging epidemic. Proc Natl Acad Sci 2009 (published online Dec 28) [Abstract]

Wan H, Sorrell EM, Song H, et al. Replication and transmission of H9N2 influenza viruses in ferrets: evaluation of pandemic potential. PLoS ONE 2008 Aug 13;3(8):e2923 [Full text]

Wang H, Feng Z, Shu Y, et al. Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China. Lancet 2008 Apr 25;371(9622):1427-34 [Abstract]

Ward P, Small I, Smith J, et al. Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic. J Antimicrob Chemother 2005 Feb;55(Suppl 1):i5-i21 [Abstract]

Wasserman J, Jacobson P, Lurie N, et al, for HHS. Organizing state and local health departments for public health preparedness. RAND Corp technical report series. 2006 [Full text]

Watanabe T, Watanabe S, Shinya K, et al. Viral RNA polymerase complex promotes optimal growth of 1918 virus in the lower respiratory tract of ferrets. Proc Natl Acad Sci 2008 (published online Dec 29) [Abstract]

Watkins RE, Cooke FC, Donovan RJ, et al. Influenza pandemic preparedness: motivation for protection among small and medium businesses in Australia. BMC Public Health 2007;7:157 (published online Jul 17) [Full text]

Watkins RE, Cooke FC, Donovan RJ, et al. Tackle the problem when it gets here: pandemic preparedness among small and medium businesses. Qual Health Res 2008 Jul;18(7):902-12 [Full text]

Watkins RJ, Barnett DJ, Links JM. Corporate preparedness for pandemic influenza: a survey of pharmaceutical and biotechnology companies in Montgomery County, Maryland. Biosecur Bioterr 2008 Sep;6(3):219-226 [Abstract]

Webby RJ, Perez DR, Coleman JS, et al. Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines. Lancet 2004 Apr 3;363(9415):1099-103 [Abstract]

Webby RJ, Webster RG. Are we ready for pandemic influenza? Science 2003 Nov 28;302(5650):1519-22 [Abstract]

Webster RG, Govorkova EA. H5N1 influenza--continuing evolution and spread. N Engl J Med 2006 Nov 23;355(21):2174-7 [Full text]

Webster RG. Influenza virus: transmission between species and relevance to emergence of the next human pandemic. Arch Virol Suppl 1997;13:105-13 [Abstract]

Webster RG. Predictions for future human influenza pandemics. J Infect Dis 1997 Aug;176(Suppl 1):S14-9 [Full text]

Webster RG. The importance of animal influenza for human disease. Vaccine 2002 May 15;20 Suppl 2:S16-20 [Abstract]

Weinberg A. Evaluation of three influenza a and B rapid antigen detection kits?update. Clin Diagn Lab Immunol 2005 Aug;12(8):1010 [Listing with link]

Weingartl HM, Albrecht RA, Lager K, et al. Experimental infection of pigs with the human 1918 pandemic influenza virus. J Virol 2009 May;83(9):4287-96 [Abstract]

Weiss MM, Weiss PD, Weiss DE, et al. Disrupting the transmission of influenza A: face masks and ultraviolet light as control measures. Am J Public Health 2007 (published online Apr 5) [Abstract]

Weiss TR. Case study: pandemic "dress rehearsal" uncovered glitches for one small firm. Computerworld 2009 (published online Dec 2) [Full text]

Wetherall NT, Trivedi T, Zeller J, et al. Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: report of the neuraminidase inhibitor susceptibility network. J Clin Microbiol 2003 Feb;41(2): [Full text]

White DB, Katz MH, Luce JM, et al. Who should received life support during a public health emergency? Using ethical principles to improve allocation decisions. Ann Intern Med 2009 Jan 20;150(2):132-8 [Abstract]

White House Homeland Security Council. Fact sheet: Implementation of the national strategy for pandemic influenza: a one-year summary of efforts to better protect our nation against the threat of pandemic flu. Released Jul 17, 2007 [Full text]

White House Homeland Security Council. National strategy for pandemic influenza implementation plan: one year summary. Released Jul 17, 2007 [Full text]

White House Homeland Security Council. National strategy for pandemic influenza implementation plan: two year summary. Released Oct 17, 2008 [Full text]

White House Homeland Security Council. National strategy for pandemic influenza implementation plan: two year summary. Released Oct 17, 2008 [http://www.kingcounty.gov/healthservices/health/preparedness/pandemicflu/comicbook.aspx#pdf]

White House. Executive order: amendment to Executive Order 13295 relating to certain influenza viruses and quarantinable communicable diseases. Apr 1, 2005 [Full text - See also CDC Q & A above]

White House. Homeland Security Presidential Directive/HSPD-21: Public health and medical preparedness. Oct 18, 2007 [Full text]

Whitley RJ, Bartlett J, Hayden FG. Seasonal and pandemic influenza: recommendations for preparedness in the United States. J Infect Dis 2006 Nov 1;194(suppl 2):S155-61 [Abstract]

Whitley RJ. The role of oseltamivir in the treatment and prevention of influenza in children. Expert Opin Drug Metab Toxicol 2007 Oct;3(5):755-67 [Abstract]

WHO (Writing Committee of the Second WHO Consultation on Clinical Aspects of Human Infection with Avian Influenza A [H5N1] Virus). Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med 2008 Jan 17;358(3):261-73 [Full text]

WHO (Writing Committee of WHO Consultation on Human Influenza A/H5). Avian influenza A (H5N1) infection in humans. N Engl J Med 2005 Sep 29;353(13):1374-85 [Full text]

WHO Director-General Dr. Margaret Chan. World now at the start of 2009 influenza pandemic. Jun 11, 2009, statement [Full text]

WHO Global Influenza Programme. Whole-of-society pandemic readiness: WHO guidelines for pandemic preparedness and response in the non-health sector. Released Nov 3, 2009 (but dated July) [Full text]

WHO Interdisciplinary Working Group on Pandemic Influenza Preparedness. Sharing of influenza viruses and access to vaccines and other benefits. Oct 9, 2007 [Full text]

WHO Writing Group. Nonpharmaceutical interventions for pandemic influenza, international measures. Emerg Infect Dis 2006 Jan;12(1) [Full text]

WHO Writing Group. Nonpharmaceutical interventions for pandemic influenza, national and community measures. Emerg Infect Dis 2006 Jan;12(1) [Full text]

WHO. A description of the process of seasonal and H5N1 influenza vaccine virus selection and development (draft). Nov 19, 2007 [Full text]

WHO. A summary of tracking avian influenza A (H5N1) specimens and viruses shared with WHO from 2003 to 2007. Released Jan 21, 2008 [Full text]

WHO. Addressing ethical issues in pandemic influenza planning. Dec 12, 2008 [Full text]

WHO. Advice on use of oseltamivir. Mar 17, 2006 [Full text]

WHO. Antigenic and genetic characteristics of influenza A(H5N1) and influenza A(H9N2) viruses and candidate vaccine viruses developed for potential use in human vaccines. Updated Feb 18, 2010 [Full text]

WHO. Antiviral drugs: their role during a pandemic [Webpage]

WHO. Assessing the severity of an influenza pandemic. May 11, 2009 [Full text]

WHO. Assessment of risk to human health associated with outbreaks of highly pathogenic H5N1 avian influenza in poultry. May 14 [Full text]

WHO. Availability of H5N1 prototype strains for influenza pandemic vaccine development. Feb 2005 [Full text]

WHO. Avian influenza ("bird flu"): fact sheet. Jan 2006 [Full text]

WHO. Avian influenza and the pandemic threat in Africa: risk assessment for Africa. Oct 28, 2005 [Full text]

WHO. Avian influenza, including influenza A (H5N1), in humans; WHO interim infection control guideline for health care facilities. Revised May 10, 2007 [Full text]

WHO. Avian influenza: assessing the pandemic threat. Jan 2005 [Full text]

WHO. Avian influenza: significance of mutations in the H5N1 virus. Feb 20, 2006 [Full text]

WHO. Avian influenza: update: implications of H5N1 infections in pigs in China. Aug 25, 2004 [Webpage]

WHO. Comparing deaths from pandemic and seasonal influenza. Pandemic (H1N1) 2009 briefing note 20. Dec 22, 2009 [Full text]

WHO. Consultation on priority public health interventions before and during an influenza pandemic [Full text]

WHO. Current WHO phase of pandemic alert [Webpage]

WHO. Development of a vaccine effective against avian influenza H5N1 infection in humans: update 4. Jan 20, 2004 [Webpage]

WHO. Early release of influenza viruses for pandemic influenza vaccine development. Feb 1, 2007 [Full text]

WHO. Epidemiology of WHO-confirmed human cases of avian influenza A(H5N1) infection. Wkly Epidemiol Rec 2006 Jun 30;81(26):249-56 [Full text]

WHO. Estimating the impact of the next influenza pandemic: enhancing preparedness. Dec 8, 2004 [Full text]

WHO. Ethical considerations in developing a public health response to pandemic influenza. Final report from 2006 WHO meetings. Dec 2007 [Full text and link to meeting information]

WHO. Evolution of H5N1 avian influenza viruses in Asia. Emerg Infect Dis 2005 Oct;11(10) [Full text]

WHO. Expert report: Patent issues related to influenza viruses and its genes. Working paper released Oct 16, 2007 [Full text]

WHO. Global consultation on addressing ethical issues in pandemic influenza planning: summary of discussions, 24-25 October 2006, Geneva, Switzerland. Released May 16, 2007 [Full text]

WHO. Global pandemic influenza action plan to increase vaccine supply. Oct 23, 2006 [Full text]

WHO. Infection control recommendations for avian influenza in health-care facilities. Apr 2008 [Full text]

WHO. Infection control recommendations for avian influenza in health-care. Apr 19, 2006 (concise guide based on full recommendations updated Feb 9, 2006) [Full text]

WHO. Influenza A (H5N1): interim infection control guidelines for health care facilities. Mar 10, 2004 [Full text]

WHO. Influenza pandemic preparedness and response. Jan 20, 2005 [Full text]

WHO. Influenza-like illness in the United States and Mexico. Apr 24, 2009 [Full text]

WHO. Inter-country consultation: influenza A/H5N1 in humans in Asia. May 6-7, 2005; Manila, The Phillipines. [Full text]

WHO. Interim WHO guidance for the surveillance of human infection with swine influenza A(H1N1) virus. Apr 27, 2009 [Full text]

WHO. Options for the use of human H5N1 influenza vaccines and the WHO H5N1 vaccine stockpile. Released May 16, 2008 [Full text]

WHO. Pandemic contingency planning checklist for National Influenza Centres (NICs) and other national influenza laboratories. Aug 20, 2009 [Full text]

WHO. Pandemic flu: communicating the risks. Bull WHO 2006 Jan;84(1) [Full text]

WHO. Pandemic influenza preparedness and mitigation in refugee and displaced populations. Apr 7, 2006 [Full text]

WHO. Pandemic influenza preparedness and response: a WHO guidance document. Released Apr 26, 2009 [Full text]

WHO. Proposals to finalize remaining elements of the 'Pandemic Influenza Preparedness Framework for sharing influenza viruses and access to vaccines and other benefits.' Sep 18, 2009 [Full text]

WHO. Questions and answers on pandemic influenza vaccine. May 9, 2007 [Full text]

WHO. Recommendations of the Strategic Advisory Group of Experts (SAGE) on influenza A (H1N1) vaccines. May 19, 2009 [Full text]

WHO. Recommended laboratory tests to identify influenza A/H5 in specimens from patients with influenza-like illness [Full text]

WHO. Report of the WHO consultation on surveillance for pandemic influenza. Based on Dec 10-12, 2007, meeting in Geneva. Released Mar 3, 2009 [Full text]

WHO. Responding to the avian influenza pandemic threat: recommended strategic actions. Released Sep 2, 2005 [Full text]

WHO. Safety of pandemic vaccines: pandemic (H1N1) 2009 briefing note 6. Aug 6, 2009 [Full text]

WHO. Status of candidate vaccine virus development for the current influenza A(H1N1). May 8, 2009 [Full text]

WHO. Summary report of a high-level consultation: new influenza A (H1N1). May 20, 2009 [Full text]

WHO. Swine flu illness in the United States and Mexico--update 2. Apr 26, 2009 [Full text]

WHO. Swine influenza frequently asked questions. May 2, 2009 [Full text]

WHO. Swine influenza. Apr 29, 2009, statement by Director-General Dr Margaret Chan, explaining move from pandemic alert phase 4 to phase 5 [Full text]

WHO. The role of National Influenza Centres (NICs) during interpandemic, pandemic alert and pandemic periods. Interim document released May 16, 2007 [Full text]

WHO. Use of antiviral drugs against influenza A(H1N1). May 5, 2009 [Full text]

WHO. Vaccines for the new influenza A(H1N1). May 2, 2009 [Full text]

WHO. WHO case definitions for human infections with influenza A(H5N1) virus. Aug 29, 2006 [Full text]

WHO. WHO checklist for influenza pandemic preparedness planning. 2005 [Full text]

WHO. WHO consultation on priority public health interventions before and during an influenza pandemic. Apr 27, 2004 [Full text]

WHO. WHO global influenza preparedness plan: the role of WHO and recommendations for national measures before and during pandemics. Released Apr 12, 2005 [Full text]

WHO. WHO guidance on pandemic influenza preparedness and response--request for comments on draft document. Oct 15-Nov 3, 2008 [Full text]

WHO. WHO inter-country consultation: influenza A/H5N1 in humans in Asia. Manila May 6-7, 2005 [Full text]

WHO. WHO interim protocol: Rapid operations to contain the initial emergence of pandemic influenza. Updated Oct 2007 [Full text]

WHO. WHO pandemic influenza draft protocol for rapid response and containment. May 30, 2006 [Full text]

WHO. WHO pandemic phase descriptions and main actions by phase. Released Apr 26, 2009 [Full text]

WHO. WHO rapid advice guidelines on pharmacological management of humans infected with avian influenza A (H5N1) virus. May 2006 [Summary with link to full text]

WHO. WHO recommendations relating to travellers coming from and going to countries experiencing outbreaks of highly pathogenic H5N1 avian influenza. Nov 2005 [Full text]

WHO. WHO recommended H5N1 prototype strains for influenza pandemic vaccine development remain the same. Oct 28, 2005 [Full text]

WHO. WHO/ECDC frequently asked questions for oseltamivir resistance. Epidemic and Pandemic Alert Response (EPR). Jan 31, 2008 [Full text]

Wilgis J. Strategies for providing mechanical ventilation in a mass casualty incident: distribution versus stockpiling. Respir Care 2008 Jan;53(1):78-90 [Abstract]

Wilson K, von Tigerstrom B, McDougall C. Protecting global health security through the International Health Regulations: requirements and challenges. CMAJ 2008 Jul 1;719(1):44-8 (published online Jun 12) [Full text]

Wilson N, Baker MG. The emerging influenza pandemic: estimating the case fatality ratio. (Rapid communications) Eurosurveill 2009 Jul 2;14(26):pii=19255 [Full text]

Wilson N, Mansoor O, Lush D, et al. Modeling the impact of pandemic influenza on Pacific islands. Emerg Infect Dis 2005 Feb;11(2) [Full text]

Wong SSY, Yuen KY. Avian influenza virus infections in humans. Chest 2006;129(1):156-68 [Full text]

Wong SSY, Yuen KY. Human infection by avian influenza A h5n1. Hong Kong Med J 2005;11(3):189-99 [Full text]

Wood J, McCaw J, Becker N, et al. Optimal dosing and dynamic distribution of vaccines in an influenza pandemic. Am J Epidemiol 2009 Jun;169(12):1517-24 [Abstract]

Wood JG, Zamani N, MacIntyre CR, et al. Effects of internal border control on spread of pandemic influenza. Emerg Infect Dis 2007 Jul;13(7):1038-45 [Full text]

Wood JM, Robertson JS. Development of a vaccine for humans against highly pathogenic avian influenza virus. Eurosurveillance Weekly 2004 Jun 17;8(25) [Full text]

Wood JM, Robertson JS. From lethal virus to life-saving vaccine: developing inactivated vaccines for pandemic influenza. Nat Rev Microbiol 2004 Oct;2(10):842-7 [Abstract]

Wood K, Supinski SB. Pandemic influenza tabletop exercises: a primer for the classroom and beyond. J Homeland Secur Emerg Manage 2008;5(1):36 (published online Aug 7) [Abstract]

World Bank. Avian and human influenza: financing needs and gaps. Jan 12, 2006 [Full text]

World Economic Forum. Global risks 2006 [Full text]

Wright PF. Vaccine preparedness--are we ready for the next influenza pandemic? (Perspective) N Engl J Med 2008 Jun 12;358(24):2540-3 [Full text]

Wu J, Fang HH, Chen JT, et al. Immunogenicity, safety, and cross-reactivity of an inactivated, adjuvanted, prototype pandemic influenza (H5N1) vaccine: a phase II, double-blind, randomized trial. Clin Infect Dis 2009 (published online Mar 12) [Abstract]

Wu JT, Cowling BJ, Lau EHY, et al. School closure and mitigation of pandemic (H1N1) 2009, Hong Kong. Emerg Infect Dis 2010 (published online Feb 2) [Full text]

Wu JT, Lee CK, Cowling BJ, et al. Logistical feasibility and potential benefits of a population-wide passive-immunotherapy program during an influenza pandemic. Proc Natl Acad Sci 2010 (published online Feb 1) [Abstract]

Wu JT, Leung GM, Lipsitch M, et al. Hedging against antiviral resistance during the next influenza pandemic using small stockpiles of an alternative chemotherapy. PLoS Med 2009 May 19;6(5):e1000085 [Full text]

Wu JT, Riley S, Fraser C, et al. Reducing the impact of the next influenza pandemic using household-based public health interventions. PLoS Med 2006 Aug 8 [Full text]

Wu JT, Riley S, Leung GM. Spatial considerations for the allocation of pre-pandemic influenza vaccination in the United States. Proc R Soc B 2007 (published online Sep 4) [Abstract]

Wu TSJ, Shih FYF, Yen MY, et al. Establishing a nationwide emergency department-based syndromic surveillance system for better public health responses in Taiwan. BMC Public Health 2008 Jan 18;8:18 [Full text]

Xu X, Zhu X, Dwek RA, et al. Structural characterization of the 1918 influenza virus H1N1 neuraminidase. J Virol 2008 Nov;82(21):10493-501 [Abstract]

Yamada S, Suzuki Y, Suzuki T, et al. Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature 2006 Nov 16;444(7117):378-82 [Abstract]

Yamada T. Poverty, wealth, and access to pandemic influenza vaccines. (Perspective) N Engl J Med 2009 (published online Aug 12) [Full text]

Yamazaki Y, Doy M, Okabe N, et al. Serological survey of avian H5N2-subtype influenza virus infections in human populations. Arch Virol 2009 (published online Feb 3) [Abstract]

Yan J, Lu Y, Mao H, et al. Pathogenic and molecular characterization of the H5N1 avian influenza virus isolated from the first human case in Zhejiang province, China. Diagn Microbiol Infect Dis 2007 Aug;58(4):399-405 [Abstract]

Yang Y, Halloran ME, Sugimoto J, et al. Detecting human-to-human transmission of avian influenza A (H5N1). Emerg Infect Dis 2007 Sep;13(9):1348-53 [Full text]

Yasuda H, Yoshizawa N, Kimura M, et al. Preparedness for the spread of influenza: prohibition of traffic, school closure, and vaccination of children in the commuter towns of Tokyo. J Urban Health 2008 (published online May 2) [Abstract]

Yazdanbakhsh M, Kremsner PG. Influenza in Africa. (Commentary) PLoS Med 2009;6(12):e1000182 (published online Dec 15) [Full text]

Yen HL, Ilyushina NA, Salomon R, et al. Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo. J Virol 2007 Nov;81(22):12418-26 [Abstract]

Yen HL, Monto AS, Webster RG, et al. Virulence may determine the necessary duration and dosage of oseltamivir treatment for highly pathogenic A/Vietnam/1203/04 influenza virus in mice. J Infect Dis 2005 Aug 15;192(4):665-72 [Abstract]

Yoldascan E, Kurtaran B, Koyuncu M, et al. Modeling the economic impact of pandemic influenza: a case study in Turkey. J Med Syst 2008 (published online Oct 14) [Abstract]

Yu H, Feng L, Peng Z, et al. Estimates of the impact of a future influenza pandemic in China. Influenza Other Resp Viruses 2009 (published online Jul 15) [Abstract]

Yu X, Tsibane T, McGraw PA, et al. Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature 2008 (published online Aug 17) [Abstract]

Zamora JE, Murdoch J, Simchison B, et al. Contamination: a comparison of 2 personal protective systems. CMAJ 2006 Aug 1;175(3):249-54 [Full text]

Zangwill KM, Treanor JJ, Campbell JD, et al. Evaluation of the safety and immunogenicity of a booster (third) dose of inactivated subvirion H5N1 influenza vaccine in humans. J Infect Dis 2008 (published online Jan 29) [Abstract]

Zeng H, Goldsmith C, Thawatsupha P, et al. Highly pathogenic avian influenza H5N1 viruses elicit an attenuated type I interferon response in polarized human bronchial epithelial cells. J Virol 2007 Nov;81(22):12439-49 [Abstract]

Zerwekh T, McKnight J, Hupert N, et al. Mass medication modeling in response to public health emergencies: outcomes of a drive-thru exercise. J Pub Health Manag Pract 2007 Jan/Feb;13(1):7-15 [Abstract]

Zhang G, Shoham D, Gilichinsky D, et al. Evidence of influenza A virus RNA in Siberian lake ice. J Virol 2006 Dec;80(24):12229-35 [Abstract]

Zhong NS, Zeng GQ. Pandemic planning in China: applying lessons from severe acute respiratory syndrome. Respirology 2008 Mar;13(s1):S33-5 [Full text]

Zhou B, Zhong N, Guan Y. Treatment with convalescent plasma for influenza A (H5N1) infection. (Letter) N Engl J Med 2007 Oct 4;357(14):1450-1 [Extract]

Zhou L, Liao Q, Dong L, et al. Risk factors for human illness with avian influenza A (H5N1) virus infection in China. J Infect Dis 2009 (published online May 5) [Full text]

Zhou N, He S, Zhang T, et al. Influenza infection in humans and pigs in southeastern China. Arch Virol 1996;141(3-4):649-61 [Abstract]

Zimmerman RK. Rationing of influenza vaccine during a pandemic: ethical analyses. Vaccine 2007 Mar 1;25(11):2019-26 [Abstract]